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1Chapter 1
1.1  VIRUS
Coronaviruses
Coronaviruses infect many animal species and are associated with a range of respiratory, enteric, hepatic, 
and neurological diseases of varying severity. Coronaviruses belong to the family of Coronaviridae, 
which falls under the order of Nidovirales. This order of viruses is characterised by a similar genome 
organisation and by the production of subgenomic or nested (Latin: nidus) mRNAs. The Coronaviridae 
possess the largest known RNA genomes of all viruses, which consist of a monopartite, 25 to 32 kb, 
positive sense, single stranded RNA molecule, which is capped and polyadenylated. The Coronaviridae 
are further divided in two subfamilies; the Torovirinae and the Coronavirinae. The Coronavirinae in 
turn, are divided into the genera Alpha-, Beta-, Gamma- and Deltacoronaviruses on the basis of pairwise 
FRPSDULVRQV RI FRQVHUYHGGRPDLQV LQ WKH JHQRPH  6HTXHQFHEDVHGPRGHOOLQJRI FRURQDYLUXV
evolution, indicates that the last common coronavirus ancestor diverged several million years ago (4) 
into two major lineages; the bat-borne ancestor of the Alpha- and Betacoronaviruses and the avian-
borne ancestor of the Gamma- and Deltacoronaviruses (5) (Fig. 1).
Coronavirus virion, genome organisation and replication.
Coronaviruses are enveloped viruses and their name is derived from the club-shaped trimeric spike 
proteins (S) that protrude from the envelope and make the virion look like a crown (Latin, corona). The 
spike protein is the main antigenic determinant of the virus and it mediates both binding to and entry 
into the host cell. The viral envelope also contains the membrane (M) and the envelope (E) proteins. 
Inside the envelope resides the ssRNA genome, which is tightly associated with the nucleocapsid (N) 
proteins (6) (Fig. 2A). More than two-thirds of the genome of coronaviruses consists of two large 
replicase genes, ORF1a and ORF1b. When the genomic RNA is released into the host cell, ORF1a 
and ORF1b are translated directly from the genomic RNA via a ribosomal frameshift mechanism (Fig, 
2B). Depending on the genus, these polyproteins autoproteolytically cleave themselves into 15 or 16 
non-structural proteins (nsps), (7) (Fig 2B, Gammacoronavirus genome). The variation in number of 
nsps is explained by the fact that the genome of both Gamma- and Deltacoronaviruses do not contain 
QVS2QHRIWKH¿UVWVWHSVGXULQJFRURQDYLUXVLQIHFWLRQLVWKHDVVHPEO\RIPHPEUDQHERXQGUHSOLFDWLRQ
transcription complexes (RTC) that transcribe the (+) strand RNA genome into full length (-) stranded 
copies of the genome, which in turn, serve as template for production of (+) strand RNA genomes. 
Additionally, the RTCs transcribe subgenomic (-) strand RNAs from the genomic (+) RNA, through a 
process of discontinuous transcription involving the transcription regulation sites (TRS) and the 5’ leader 
VHTXHQFH5HYLHZHGLQ)URPWKHVHVXEJHQRPLF51$VPDQ\VWUDQGHG51$VDUHSURGXFHG
that serve as mRNAs for translation of the spike (S), membrane (M), envelope (E), and nucleocapsid 
(N) proteins (Fig. 2B). In addition to these structural proteins, coronaviruses encode between one and 
eight accessory proteins, a number which varies between genera and even between individual strains 
within a genus (9). These accessory proteins have generally been found dispensable for viral replication 
in vitro (10-15), but some of them have been shown important for coronavirus infection in vivo (10, 
16). Functional studies have revealed that coronavirus accessory proteins modulate various cellular 
processes, such as apoptosis, cell proliferation, and DNA synthesis. However, most accessory proteins 
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have been found to modulate the interferon response, which is an important host-defence mechanism 
against viruses (summarised in Table 1).
MHV
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Fig. 1  Taxonomy and host species of coronaviruses
The top panel displays the taxonomical organisation of coronaviruses. The probable host species of the common 
ancestors of both Alpha- and Beta- and Gamma- and Deltacoronaviruses is also indicated. Bottom panels show 
prominent members of each genus and their host species. Type species are displayed at the top in a bold typeset. 
FCoV, Feline coronavirus; CCov, Canine coronavirus; HCoV, human coronavirus; PEDV, porcine epidemic 
diarrhea virus; TGEV, transmissible gastroenteritis; PRCV, porcine respiratory coronavirus; MHV, mouse hepatitis 
virus; SARS-CoV severe acute respiratory syndrome coronavirus; MERS-CoV, Middle East respiratory syndrome 
coronavirus; PHEV, porcine hemagglutinating encephalomyelitis virus; BCoV, bovine coronavirus; GiCoV, Giraffe 
Coronavirus; IBV, infectious bronchitis virus; DCoV, duck coronavirus; TCoV, turkey coronavirus; PhCoV, pheasant 
coronavirus; SW1-CoV, Belugawhale coronavirus SW1; BuCoV, Bulbul coronavirus; MuCoV, Munia coronavirus; 
ThCoV, Thrush coronavirus; SDCV, swine Deltacoronavirus.
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Fig. 2  Virion structure and genome organisation of infectious bronchitis virus
(A) Schematic drawing of the IBV virion, displaying the location of the structural proteins within the virion. The (+)
ssRNA genome is fully covered by nucleocapsid proteins.  (B) All coronaviruses share a similar genome organisation; 
this is a graphical representation of the genomic RNA and the subgenomic RNAs of Gammacoronavirus IBV, 
strain Beaudette. The components of the virion are not drawn to scale. Two open reading frames (ORF1a and 
ORF1b) are translated directly from the genome to yield two large polyproteins, pp1a and pp1ab, the latter via 
a ribosomal frameshift mechanism. These polyproteins cleave autoproteolytically into 15 non-structural proteins 
(nsps). Subgenomic (-) strand RNAs are transcribed from the genomic (+) RNA, through a process of discontinuous 
WUDQVFULSWLRQLQYROYLQJWKHWUDQVFULSWLRQUHJXODWLRQVLWHV756DQGWKH¶OHDGHUVHTXHQFH)URPWKHVHVXEJHQRPLF
(-) RNAs, many (+) stranded RNAs are produced from which the four structural proteins, spike (S), membrane (M), 
envelope (E) and nucleocapsid (N) as well as (at least) four accessory proteins (purple), are translated. Both the 
genomic and the subgenomic RNAs are capped and polyadenylated. 
A
B
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Table 1. Current knowledge on how coronavirus accessory proteins influence the host
Coronavirus Accessory protein Influence on the host
SARS-CoV
3a $FWLYDWHV1)ț%DQG,OUHSRUWHUVLQGXFHVDSRSWRVLVLQ9HURFHOOV
3b ,QKLELWV DFWLYDWLRQRI ,IQȕDQG1)ț% UHSRUWHUV DQG LQKLELWV WUDQVORFDWLRQand phosphorylation of IRF3 (19, 20)
6
,QKLELWV DFWLYDWLRQRI ,IQȕDQG1)ț% UHSRUWHUV DQG LQKLELWV WUDQVORFDWLRQ
and phosphorylation of IRF3(19). Inhibits nuclear translocation but not 
phosphorylation of STAT1 (21)
7a $FWLYDWHV1)ț%DQG,OUHSRUWHUVLQGXFHVDSRSWRVLVLQ9HURFHOOV
7b ?
8a Induces apoptosis and promotes viral replication (22)
8b Stimulates DNA synthesis (23)
9b Induces apoptosis (24)
MHV
NS2 Antagonises the antiviral OAS-RnaseL pathway (25)
HE Virulence factor in vivo, not present in all strains (26)
4 ?
5a Increases resistance to IFN-treatment in vitro, mechanism unknown (27)
TGEV
3a ?
3b ?
7 ,QKLELWVSKRVSKRU\ODWLRQRIH,)Į ,QKLELWVWUDQVFULSWLRQDQGWUDQVODWLRQRIDQWLYLUDOJHQHVLQFOXGLQJ,IQȕ
FIPV
3 ? not necessary for replication in vitro and in vivo (29)
7a Confers resistance to IFN-treatment via unknown mechanism (30)
7b ?
MERS-CoV
3 -
4a ,QKLELWV DFWLYDWLRQ RI ,IQȕ UHSRUWHU DQG WUDQVORFWLRQ RI ,5)  %LQGVGV51$,QKLELWVDFWLYDWLRQRI,IQȕDQG,65(UHSRUWHUV
4b 'HFUHDVHVDFWLYDWLRQRI5LJ,,5)DQG1)ț%UHSRUWHUV
5 5HGXFHVDFWLYDWLRQRI,IQȕUHSRUWHU
IBV
3a
?
Not necessary for replication in vivo (34) and in vitro (13, 14, 35, 36)
3b
5a
5b
‘?’ indicates that no function has been elucidated thus far.
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Infectious Bronchitis Virus
The Gammacoronavirus infectious bronchitis virus (IBV) is the causative agent of a highly contagious 
UHVSLUDWRU\GLVHDVH,%9ZDV¿UVWGHVFULEHGLQWKH86$LQWKH¶VDQGKDVVLQFHWKHQVSUHDGWR
almost every country with a poultry industry. In fact, infectious bronchitis has become one of the most 
important diseases in the poultry industry, and is responsible for large economic losses worldwide (38). 
IBV enters the avian host through the respiratory tract where it leads to nasal discharge, snicking, and 
rales. Depending on the strain, IBV can spread to other epithelial surfaces such as the gastrointestinal 
tract, the kidneys and the oviduct, causing reduced growth of chickens and a decrease in egg production 
DQG TXDOLW\  ,%9DVVRFLDWHG PRUWDOLW\ SULPDULO\ RFFXUV ZKHQ DQLPDOV JHW VLPXOWDQHRXVO\
LQIHFWHGZLWKDQRWKHUSDWKRJHQLFYLUXVEDFWHULXPRUP\FRSODVPD6XFKFRLQIHFWLRQVRFFXUIUHTXHQWO\
since IBV facilitates entry of other pathogens by compromising epithelial barriers during infection.
Serotypes
Control of IBV is hindered by the continuous occurrence of new serotypes of the virus (44), (Fig. 3). 
Mutation of the virus can be attributed to the error rate of the Coronavirus RNA-dependent RNA-
SRO\PHUDVHDQGE\WKHKLJKIUHTXHQF\RIUHFRPELQDWLRQEHWZHHQGLIIHUHQWVWUDLQVRI,%9
These effects are aggravated by the large population sizes of its hosts in the poultry industry and the 
possibility that IBV can be carried over great distances by migratory birds (47, 50).
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Fig. 3  Phylogenetic tree of various IBV isolates, including the location where they were isolated 
The phylogenetic tree was constructed by neighbour joining analysis using the Bionumerics software package, using 
ESVHFWLRQVRIWKH6JHQHESDVEDVHGRQWKHJHQRPHVHTXHQFHRI$UN'3,,%9LVRODWHV
XVHG LQ WKHFXUUHQW VWXG\DUH LQGLFDWHG LQEROG7KLV¿JXUHZDVNLQGO\VXSSOLHGE\--GH:LWDQG5'LMNPDQ
Gezondheidsdienst voor dieren, Deventer, The Netherlands. Branch lengths represent nucleotide substitutions per 
position. Colours were chosen arbitrarily.
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Vaccines and challenges
Because of the economic impact of infectious bronchitis on the poultry industry, much effort has gone 
LQWRWKHGHYHORSPHQWRIYDFFLQHVDJDLQVW,%97KH¿UVWYDFFLQHVGHYHORSHGLQWKH¶VFRQVLVWHG
of live viruses that were attenuated by multiple passages in embryonated chicken eggs. Depending on 
WKH¿HOGSUHVVXUHDQGWKHOLIHH[SHFWDQF\RIWKHFKLFNHQLQYROYHGEURLOHUEUHHGHURUOD\HUGLIIHUHQW
vaccination schemes may be applied. Commonly, animals are primed by spraying them with a live-
attenuated virus. This treatment can be repeated after a every few weeks to further boost the immune 
response. To establish lasting immunity during the laying period, all layers receive an intramuscular 
injection with an inactivated IBV vaccine before the onset of lay. It is common practise to combine 
multiple strains of IBV in one vaccine, since cross-protection between strains is limited (38, 42, 51, 52). 
    All commercially-available IBV vaccines contain either inactivated or attenuated viruses, 
which are produced in embryonated chicken eggs. Although this method of production has proven 
very successful, the use of embryonated eggs is associated with various safety and supply issues. 
7KHHJJVXVHGIRUPDQXIDFWXULQJRI,%9YDFFLQHVIUHTXHQWO\FRQWDLQYLUDORUEDFWHULDOSDWKRJHQV
ZKLFK FDQ VXEVHTXHQWO\ JHW LQWURGXFHG LQWR WKH YDFFLQHV PDGH XVLQJ WKHVH HJJV 7R SUHYHQW VXFK
SDWKRJHQV IURP HQGLQJ XS LQ WKH ¿QDO SURGXFW D UDQJH RI FRVWO\ TXDOLW\ FRQWURO WHVWV QHHG WR EH
performed on a regular basis. Another safety concern about existing live IBV vaccines is their 
potential to revert to virulence. Current vaccine strains have been attenuated through serial passaging 
in embryonated eggs. Attenuation of a virus through this method relies on introduction of random 
mutations to the genome, making it unclear which mutation(s) is/are responsible for the attenuation, 
let alone why the virus is attenuated. Several studies have shown that these IBV vaccine strains can 
UHYHUWWRYLUXOHQFHLQWKH¿HOGWKURXJKPXWDWLRQDQGUHFRPELQDWLRQZLWK¿HOGVWUDLQV,Q
addition to these disadvantages, the supply of eggs can be halted by issues with bacterial or viral 
LQIHFWLRQVDWWKHHJJVXSSOLHURUE\DEDQRQHJJWUDQVSRUWIROORZLQJDQRXWEUHDNRIDYLDQLQÀXHQ]D 
       A considerable improvement to the safety and supply issues of current IBV-vaccines would be to 
abandon the use of embryonated eggs, for example by shifting to the use of subunit vaccines. Several of 
VXFKVXEXQLWYDFFLQHVKDYHEHHQWHVWHGEXWDOORIWKHPSURYLGHGLQDGHTXDWHSURWHFWLRQDJDLQVWFKDOOHQJH
with virulent strains of IBV (56-59). Another strategy that has proven successful for production of viral 
vaccines is based on the use of cell lines for virus production. Production of IBV using cell lines was 
achieved by adaption of the avirulent IBV Beaudette strain to propagation in Vero and HeLa cell lines. 
Unfortunately, vaccination using Beaudette does not provide protection against virulent strains of IBV 
(60, 61). A third method, which could increase the safety of current IBV vaccines while maintaining 
production in embryonated eggs, would be to minimise the chance of reversion of vaccine strains to a 
virulent form. This could be achieved by using IBV strains that carry deletions in multiple virulence 
determining regions within the genome. These rationally-attenuated vaccines have been developed 
for several viruses (reviewed in (62)) and indeed, attempts to create rationally-attenuated, replication-
competent coronaviruses have yielded promising results (63, 64). However, the development of such 
DYDFFLQHIRU,%9UHTXLUHVH[WHQVLYHNQRZOHGJHDERXWWKHLQWHUDFWLRQEHWZHHQYLUXVSURWHLQVDQGKRVW
FHOOV&XUUHQWO\NQRZOHGJHDERXWZKLFKSDUWVRIWKHJHQRPHFRXOGEHVSHFL¿FDOO\WDUJHWHGWRDWWHQXDWH
IBV is too restricted to develop a rationally-attenuated vaccine against IBV.
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1.2 HOST
The type I interferon response protects against RNA viruses.
The innate immune response is an evolutionarily conserved part of the immune system providing 
immediate defence against invading pathogens. The innate immune response consists of a network 
of antimicrobial mechanisms, of which the type I interferon (IFN) response is an essential defence 
mechanism against viruses. The IFN response to RNA viruses is triggered by detection of aberrant 
RNA molecules, generated by the replicating virus. Detection of these molecules drives production 
of antiviral proteins and secretion of type I interferon cytokines, which act as a danger-signal to 
neighbouring cells. Binding of IFN by a neighbouring cell induces the production of antiviral proteins, 
thereby establishing an antiviral state.
The type I interferon response in detail
Two families of pattern recognition receptors (PRRs) have been shown to be involved in the recognition 
of RNA viruses, namely the membrane-bound Toll-like receptors (TLRs) and the cytosolic RIG-I-
like receptors (RLRs) (65). The primary ligands for the activation of these PRRs are double-stranded 
RNA (dsRNA) and 5’-triphosphorylated RNA, normally absent from uninfected host cells. Activation 
of TLRs or RLRs by these molecules activates a signaling cascade that, via the transcription factors 
,QWHUIHURQ5HJXODWRU\)DFWRU,5)DQG,5)DFWLYDWHVWUDQVFULSWLRQRIW\SH,LQWHUIHURQV,)1ĮDQG
,)1ȕDQGDVHWRIDQWLYLUDOJHQHV)LJ,QWHUIHURQVDUHUHDGLO\VHFUHWHGE\WKHLQIHFWHGFHOODQGDFW
DVZDUQLQJVLJQDOE\ELQGLQJ WR WKHXELTXLWRXVO\H[SUHVVHG,)1UHFHSWRU ,)1$5RQQHLJKERXULQJ
cells. Binding of IFN induces phosphorylation of Janus kinases (JAK and TYK), which in turn, 
phosphorylate STAT1 and STAT2 (Signal Transducers and Activators of Transcription), causing them 
to dimerize and associate with IRF9 to form the interferon-stimulated gene factor 3 (ISGF3) complex. 
6XEVHTXHQW QXFOHDU WUDQVORFDWLRQ DQG ELQGLQJ RI ,6*) WR LQWHUIHURQ VWLPXODWHG UHVSRQVH SURPRWHU
elements (ISRE) activates transcription of antiviral genes known as interferon-stimulated genes (ISGs) 
(66, 67). Hundreds of ISGs have been described (68) and those that have been characterised in more 
detail, such as Mx, MDA5, TLR3, PKR, OAS, ADAR and IRF1 are involved in detection and signaling 
of viral infection and inhibition of viral translation, replication, entry, and budding (69). To provide a 
rapid response against viral infection, transcription of a subset of interferon-stimulated genes (ISGs) is 
also activated upon stimulation of pattern recognition receptors, independently of IFN (70). 
The type I interferon response to RNA viruses in chicken
The interferon response is an evolutionarily conserved defence mechanism against invading pathogens. 
In many respects the chicken interferon system, although not studied in much detail, resembles that of 
humans. Similar to the human genome, the chicken genome encodes for one copy of ,IQȕ and multiple 
paralogs of ,IQĮ. However, differences between the chicken and mammalian interferon system also 
exist (Reviewed in (71)). For example, chickens lack the ssRNA sensor TLR8 and stimulation of 
chicken TLR7 with ssRNA results in expression of ,Oȕ and Il8, but not ,IQĮ or ,IQȕ (72).
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Fig. 4  Schematic overview of the type I interferon response 
Overview explained in paragraph 1.2: The type I interferon response in detail. Dotted lines indicate pathways that 
KDYHEHHQKLJKO\VLPSOL¿HGWRLPSURYHFODULW\
Contrary to chicken TLR7, stimulation of human TLR7 does induce expression of ,IQĮȕ via the 
transcription factor IRF7. This difference between chicken and mammalian TLR7 may be related to the 
fact that chickens encode a transcription factor that resembles both mammalian IRF3 and IRF7 (named 
IRF3/7) (73). The dsRNA-sensor TLR3 is also expressed by chicken cells (74) and like its mammalian 
counterpart, recognizes dsRNA (75), and activates transcription of Ifnɴ probably via IRF3/7 (76). 
Rather unexpectedly, the cytoplasmic RNA sensor RIG-I, which is present in ducks, seems to be absent 
from the chicken genome (77). However, the cytoplasmic dsRNA pattern recognition receptor MDA5 
is present in chickens and responds to dsRNA (78). In line with this, the adaptor protein for both RIG-I 
DQG0'$WHUPHGPLWRFKRQGULDODQWLYLUDOVLJQDOLQJSURWHLQ0$96KDVEHHQLGHQWL¿HGLQFKLFNHQ
FHOOV,QFKLFNHQFHOOVGHWHFWLRQRILQÀXHQ]DYLUXVZDVVKRZQWRGHSHQGRQUHFRJQLWLRQE\0'$
ZKHUHDVLQPDPPDOLDQFHOOVGHWHFWLRQRILQÀXHQ]DLVPHGLDWHGE\5,*,7KHVHREVHUYDWLRQV
indicate that chicken MDA5 may have a broader sensitivity than its mammalian counterpart (78, 82).
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1.3 INTERACTION
Coronaviruses and the type I IFN response 
The IFN response is a powerful mechanism in combating virus infections, including coronaviruses. 
However, our understanding of the power and importance of the IFN response in combating coronaviruses 
in vivo comes primarily from studies on mouse hepatitis virus (MHV) infection in mice. IFN receptor-
GH¿FLHQWPLFH ,)1$5-/-TXLFNO\ VXFFXPE WRDQRUPDOO\ VXEOHWKDO0+9 LQIHFWLRQ LQGLFDWLQJ WKDW
ZLWKRXWDQDFWLYH,)1UHVSRQVHPLFHFDQQRWVXI¿FLHQWO\FRPEDWWKHYLUXVDQGUHFRYHUIURPLQIHFWLRQ
(64, 83, 84). In general, to avoid clearance, coronaviruses have evolved various strategies to interfere 
with the IFN response. 
Coronaviruses prevent activation of the IFN response
Although large amounts of dsRNA accumulate in coronavirus-infected cells (85-87), Alpha- and 
Betacoronaviruses, including human coronavirus 229E (HCoV-229E), severe acute respiratory 
syndrome coronavirus (SARS-CoV) and mouse hepatitis virus (MHV), only mildly activate the type I 
LQWHUIHURQUHVSRQVH,QERWK¿EUREODVWVDQGKHSDWRF\WHV0+9DQG6$56&R9GRQRWLQGXFH
expression of type I interferons. Stimulation of infected cells with dsRNA (poly I:C) however, does 
induce translocation of IRF3 and expression of interferon, indicating that recognition of dsRNA is not 
blocked in coronavirus-infected cells. The fact that coronaviruses induces considerable accumulation 
of dsRNA without triggering the IFN response, suggests that dsRNA is somehow hidden from pattern 
recognition receptors. In fact, almost all (+) stranded RNA viruses induce so-called membrane-bound 
replicative organelles, in which viral RNA synthesis is thought to take place (95). Coronaviruses are 
no exception, and the membrane structures that they induce are associated with the viral replication-
transcription complexes, indicating that these membrane structures indeed form the site of viral RNA 
synthesis (96). As a matter of fact, coronavirus-induced double-membrane vesicles (DMV’s) have 
been shown to contain dsRNA (85) suggesting that DMV’s shield dsRNA from recognition by PRRs 
(85, 97). In addition to hiding dsRNA from PRRs, several coronavirus proteins have been shown to 
‘actively’ interfere with activation of IFN. In overexpression studies, activation of Ifn-reporters was 
prevented by both nsp1 (64, 98, 99) and nsp3 (19, 94) of MHV and SARS-CoV. Using similar assays 
it was shown that the SARS-CoV nucleocapsid as well as accessory proteins ORF3b and ORF6 of 
SARS-CoV (19) and 4a and 4b of Middle East respiratory syndrome coronavirus (MERS-CoV) (100, 
101) inhibited activation the IFN response. Taken together, coronaviruses seem to use a combination of 
hiding and active countermeasures to prevent activation of the IFN response.
Coronaviruses resist the activated IFN response 
Most coronaviruses are relatively resistant to treatment with IFN, compared to other viruses such 
as Sendai virus (family Paramyxoviridae) or vesicular stomatitis virus (family Rhabdoviridae). 
Insensitivity towards IFN could be another mechanism used by coronaviruses to evade the host immune 
response. MHV and feline coronavirus (FCoV) show the highest resistance to IFN (93, 102), followed 
by SARS-CoV (103-105). MERS-CoV on the other hand is 50 to 100 times more sensitive to IFN 
treatment than SARS-CoV (106, 107), a difference that has been ascribed to the ability of SARS-CoV, 
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EXWQRW0(56&R9WRLQKLELWQXFOHDUWUDQVORFDWLRQRI67$73KRVSKRU\ODWLRQDQGVXEVHTXHQW
translocation of STAT1 is an essential step in the activation of ISGs. Accessory protein ORF6 of SARS-
CoV has been shown to inhibit translocation of STAT1 by tethering nuclear import factors at the ER/
Golgi membrane, thus preventing expression of IFN-activated genes (19, 98, 108). Besides blocking 
IFN signaling, coronaviruses also antagonise IFN-activated antiviral proteins. For example, accessory 
protein ns2 of MHV inhibits the IFN-activated OAS-RNase L antiviral pathway (109), the nucleocapsid 
of MHV and the nsp2 protein of IBV seem to antagonise PKR (110, 111), while accessory proteins 5a 
of MHV and 3 and 7a of FCoV confer resistance to IFN treatment via unknown mechanisms (110, 112, 
113).
Coronaviruses inhibit host-translation
Like most viruses, coronaviruses are dependent on host-cell machinery for translation of their proteins. To 
maximise production of viral proteins and limit production of host cytokines and other antiviral proteins, 
some viruses have evolved strategies to favour the production of viral proteins over the production 
of host proteins (114). Betacoronaviruses, such as MHV, SARS-CoV and several Bat coronaviruses 
limit host-translation using their nsp1 protein (115-117), which induces degradation of host, but not 
viral mRNA (116, 118, 119). Nsp1 of the Alphacoronavirus TGEV inhibits host-translation through an 
unknown mechanism that does not seem to involve degradation of host mRNA (117, 120). Strikingly, 
0+9QVSPXWDQWYLUXVHVDUHVWLOOSDWKRJHQLFWRW\SH,,)1UHFHSWRUGH¿FLHQW,)1$5-/-) mice but are 
severely attenuated in IFN competent individuals. This indicates that inhibition of host-translation by 
nsp1 is crucial for coronaviruses such as MHV to interfere with the innate immune response. Contrary 
to Alpha- and Betacoronaviruses, the genomes of Gamma- and Deltacoronaviruses lack an nsp1 
KRPRORJXHUDLVLQJWKHTXHVWLRQZKHWKHUDOVRWKHVHYLUXVHVFRXQWHUDFWKRVWWUDQVODWLRQ
One study on IBV Gammacoronavirus showed that this virus does not reduce host-translation (111). 
The lack of nsp1 coupled to the lack of translational inhibition by Gammacoronaviruses, could indicate 
that Gammacoronaviruses have evolved alternative ways, compared to Alpha- and Betacoronaviruses, 
to counteract the innate immune response of their host.
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1.4 OUTLINE OF THE THESIS
Infectious bronchitis virus (IBV) is an economically-important pathogen of poultry, but little is known 
about how it interacts with the avian innate immune response, neither at the level of the animal, nor at the 
level of individual cells. This lack of knowledge has hindered the understanding of IBV pathology and 
the development of rationally-attenuated vaccines against this disease. The overall aim of this thesis is 
WRXQGHUVWDQGKRZ,%9DYRLGVFOHDUDQFHE\WKHLQQDWHLPPXQHV\VWHPRIWKHFHOODQGPRUHVSHFL¿FDOO\
to investigate the potential role of the accessory proteins herein. In chapter 1 we provide a framework 
for this thesis by describing background information on coronaviruses, the type I IFN response and our 
current knowledge on the antagonism of the IFN response by coronaviruses. In chapter 2 we study if 
and to what extent IBV activates the type I IFN response in chicken cells. In addition to this we test 
ZKHWKHUWKHDFFHVVRU\SURWHLQVRI,%9LQÀXHQFHWKHNLQHWLFVRIDFWLYDWLRQRIWKHW\SH,,)1UHVSRQVH
We also investigate which pattern recognition receptor of the chicken is involved in the detection of 
IBV. In chapter 3ZHTXDQWLI\WKHVHQVLWLYLW\RI,%9WR,)1WUHDWPHQWDQGZHLQYHVWLJDWHZKHWKHU,%9
can inhibit signaling of IFN, as previously reported for some Betacoronaviruses. In addition, we assess 
WKHSRWHQWLDOLQÀXHQFHRIDFFHVVRU\SURWHLQVRQERWK,)1VHQVLWLYLW\DQGVLJQDOLQJRI,)1,Qchapter 
4 we investigate whether IBV, similar to Alpha- and Betacoronaviruses is able to inhibit translation 
of host-cell proteins, and evaluate the potential role of accessory proteins in this process. In chapters 
5 and 6ZHGHVFULEHWKHVSHFL¿FPHWKRGVXVHGLQWKLVWKHVLVIRUTXDQWL¿FDWLRQRI,%9H[SUHVVLRQRI
ISGs and production of interferon by chicken cells. The results described in these chapters answer 
VHYHUDOTXHVWLRQVDERXWWKHDFWLYDWLRQDQGHYDVLRQRIWKHW\SH,LQWHUIHURQUHVSRQVHE\,%9,Qchapter 
7,SODFHWKH¿QGLQJVRIWKLVWKHVLVZLWKLQWKHIUDPHZRUNRINQRZQZRUNRQLQQDWHLPPXQHHYDVLRQ
E\ FRURQDYLUXVHV , DOVR GLVFXVV WKH SRWHQWLDO LPSOLFDWLRQV RIP\¿QGLQJV IRU WKH XQGHUVWDQGLQJ RI
IBV pathology and the development of live rationally-attenuated vaccines against this disease. In 
conclusion, this thesis provides further insight into how IBV avoids and antagonises the innate immune 
V\VWHPDQGLVWKH¿UVWVWXG\WKDWDWWULEXWHVDIXQFWLRQWRWKHDFFHVVRU\SURWHLQVRI,%9
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ABSTRACT
Coronaviruses from both the Alphacoronavirus and Betacoronavirus genera interfere with the type I 
interferon (IFN) response in various ways, ensuring the limited activation of the IFN response in most 
cell types. Of the gammacoronaviruses that mainly infect birds, little is known about the activation of the 
host immune response. We show that the prototypical Gammacoronavirus, infectious bronchitis virus 
(IBV), induces a delayed activation of the IFN response in primary renal cells, tracheal epithelial cells, 
and a chicken cell line. In fact, ,IQȕ expression is delayed with respect to the peak of viral replication 
and the accompanying accumulation of double-stranded RNA (dsRNA). In addition, we demonstrate 
that MDA5 is the primary sensor for Gammacoronavirus infections in chicken cells. Furthermore, we 
provide evidence that accessory proteins 3a and 3b of IBV modulate the response at the transcriptional 
and translational levels. Finally, we show that, despite the lack of activation of the IFN response during 
the early phase of IBV infection, the signaling of nonself dsRNA through both MDA5 and TLR3 
UHPDLQVLQWDFWLQ,%9LQIHFWHGFHOOV7DNHQWRJHWKHUWKLVVWXG\SURYLGHVWKH¿UVWFRPSUHKHQVLYHDQDO\VLV
of host-virus interactions of a Gammacoronavirus with avian innate immune responses.
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INTRODUCTION 
Coronaviruses constitute a large family of positive-stranded RNA viruses and cause a range of human 
and veterinary diseases. Infectious bronchitis virus (IBV) is the prototype avian coronavirus from the 
Gammacoronavirus genus and the causative agent of a highly contagious respiratory disease of major 
economic importance to the poultry industry (38). IBV enters the avian host through the respiratory tract, 
where it causes destruction of the epithelium leading to respiratory distress and initiation of secondary 
bacterial infections. Depending on the strain, IBV can also spread to other epithelial surfaces such as 
the gastrointestinal tract, the kidneys and the oviduct, the latter causing problems in egg production and 
TXDOLW\ &RQWUDU\ WR FRURQDYLUXVHV IURP WKHAlphacoronavirus and Betacoronavirus genera, 
including human coronavirus HCoV-229E, severe acute respiratory syndrome (SARS-CoV), Middle 
East respiratory syndrome (MERS-CoV) and mouse hepatitis virus (MHV), very little is known about 
how Gammacoronaviruses including IBV evade or interfere with innate immune responses of their host. 
    Innate immune responses consist of a network of antimicrobial mechanisms, of which the type 
I interferon (IFN) response is an essential defence mechanism against viruses. Typically, the type 
I IFN response, from hereafter referred to as IFN response, is initiated upon activation of host 
pattern recognition receptors (PRRs), present in all animal cells. Two families of PRRs have been 
shown to be involved in the recognition of RNA viruses namely the membrane-bound Toll-
like receptors (TLRs) and the cytosolic RIG-I-like receptors (RLRs) (65). The primary ligands 
IRU DFWLYDWLRQ RI WKHVH 355V DUH GRXEOHVWUDQGHG 51$ GV51$ DQG ƍ WULSKRVSKDWHFRQWDLQLQJ
RNA, normally absent from uninfected host-cells. Activation of RLRs leads to the transcription 
RI JHQHV HQFRGLQJ W\SH , LQWHUIHURQV ,)1Į DQG ,)1ȕ 7KHVH LQWHUIHURQV DUH VHFUHWHG IURP WKH
infected cell providing a signal for the infected as well as the neighbouring cells that induce the 
transcription of anti-viral effector genes collectively called interferon stimulated genes (ISGs). 
     The ability of a virus to replicate and produce infectious progeny depends for a large part on 
its ability to avoid induction or counteract the IFN response of its host. Indeed, a common feature 
of alpha- and betacoronaviruses, including HCoV-229E, SARS-CoV, and MHV, is their limited 
activation of the IFN response (88-93). This limited activation can be partially explained by 
intracellular membrane rearrangements that might shield dsRNA and other viral components 
from recognition by host PRRs (85, 97). In addition, coronavirus nsp16 displays 2’-O-methylase 
DFWLYLW\ ZKLFK UHVXOWV LQ ƍ2PHWK\ODWLRQ RI D ULERVH PRLHW\ RQ WKH ƍ FDS RI FRURQDYLUXV
mRNAs, making them indistinguishable from host mRNAs (124). Furthermore, many other 
coronavirus proteins, such as nsp1, nsp3, the nucleocapsid and many of the accessory proteins 
have been shown to interfere with the IFN response in various ways (reviewed in (9, 125)). 
          Interaction between gammacoronaviruses and innate immune responses of their avian hosts is poorly 
understood. Early studies on gammacoronaviruses in chicken suggest that IBV-induced IFN production 
is variable and dependent on both virus strain and cell type. (126-129). Further, two transcriptional studies 
on tissues collected after in vivo and in ovo IBV infections, found only limited upregulation of ISGs at 1 
- 3 days post-infection (130-132). Functional studies using IBV Beaudette showed that it induced cell-
cycle arrest and apoptosis (133, 134), that IBV interacts with eIF3f (135) and that IBV inhibits protein 
kinase R activation, thereby maintaining protein synthesis (111). Although these studies did provide a 
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number of details on the interactions between IBV and the host cell, most experiments were carried out 
in Vero cells. This non-avian cell line is one of the very few cell lines in which the IBV-Beaudette strain 
has been adapted to grow, facilitating in vitro experiments. Vero cells, however, lack the ,IQȕ gene, 
preventing them from mounting a type I IFN response (136, 137), reducing the value of Vero cells for 
research on innate immune responses to IBV. In addition, the Beaudette strain is non-pathogenic in vivo 
with limited replication in host tissues (61), reducing the value of these in vitro studies for translation to 
in vivo situations. For these reasons, we used pathogenic isolates of IBV to infect primary chicken cells, 
and a chicken cell line, as these isolates are known to infect, spread and cause clinical disease in vivo. 
,QWKHFXUUHQWVWXG\ZHVKRZWKDW,%9LQIHFWLRQOHDGVWRDVLJQL¿FDQWLQGXFWLRQRI,IQȕtranscription 
through an MDA5-dependent activation of the IFN response, albeit delayed with respect to both virus 
replication and accumulation of dsRNA. This delayed induction of ,IQȕZDVIXUWKHUFRQ¿UPHGWKURXJK
RNA FISH analysis showing that accumulation of Ifnȕ mRNA is restricted to IBV-infected and not 
neighbouring uninfected cells. Although the time lag between accumulation of dsRNA and induction 
of Ifnȕ transcription might suggest that IBV interferes with recognition of dsRNA, we observed that 
sensing of exogenous (non-self) dsRNA remained functional in IBV-infected cells. Using mutant IBV 
viruses we demonstrate that both accessory proteins 3a and 3b are involved in limiting ,IQȕ expression, 
as both 3a and 3b null viruses induced increased ,IQȕ expression. Nevertheless, 3a and 3b seem to have 
a differential effect on IFN protein production, infection with 3a null virus induced lower IFN levels 
whereas a 3b null virus increased IFN production compared to the parental virus. Altogether, our data 
suggest that IBV delays but does not prevent detection by MDA5, and that accessory proteins 3a and 
EPRGXODWHWKH,)1UHVSRQVHLQDYLDQFHOOV7KLV LV WKH¿UVWVWXG\DGGUHVVLQJLPPXQHHYDVLRQDQG
interference strategies of IBV in chicken and not in mammalian cells, providing information essential 
to further understanding of the pathogenesis of Gammacoronaviruses.
18
Activation of the chicken IFN response by IBV
2
MATERIALS AND METHODS
Cells
Chicken embryonic kidneys were aseptically removed from 17-to 19-day-old chicken embryo’s 
(Charles River Laboratories Inc.). A cell suspension was obtained by trypsinisation for 30 min at 37°C 
DQG¿OWHUHGWKURXJKDȝPPHVK7KHUHVXOWLQJFKLFNHQHPEU\RNLGQH\&(.FHOOVZHUHVHHGHGDW
4 x 105 cells/cm2 in 199 medium (Invitrogen) supplemented with 0.5% fetal bovine serum (FBS) and 
1% PenStrep (Gibco, Invitrogen). Chicken tracheal cells were isolated from 8- to 10-week-old chickens 
(white leghorn). Tracheas were collected in ice-cold PBS, washed and stripped from adipose tissue. 
7UDFKHDZHUH¿OOHGZLWKDVROXWLRQRI8POSURWHDVHW\SH;,96LJPD8PO'1DVH,4LDJHQ
and 1% PenStrep in Eagle’s minimum essential medium (EMEM), sealed with clamps, and incubated 
RYHUQLJKWDW&7KHQH[WGD\FHOOVOLQLQJWKHOXPLQDOVLGHRIWKHWUDFKHDZHUHÀXVKHGRXWZLWKFROG
(0(0¿OWHUHGWKURXJKDFHOOVWUDLQHUDQGVHHGHGDW[5 cells/cm2LQ'XOEHFFR¶VPRGL¿HG(DJOH
medium (DMEM) supplemented with 10% FBS and 1% PenStrep. The RIG-Iwt, RIG-IKO, MDA5wt and 
MDA5KOPXULQHHPEU\RQLF¿EUREODVWV0()VZHUHSURYLGHGE\3URI6$NLUD7KH0$96wt 
and MAVSKO MEFs were provided by Z.J. Chen (139). DF-1, CEC-32 and MEF cells were cultured in 
DMEM (Gibco, Invitrogen) supplemented with 10% FBS and 1% PenStrep. All cells were incubated in 
DKXPLGL¿HGLQFXEDWRUDW&DQG&22. 
DF-1 Ifnȕ-luc reporter cell line
DF-1 cells were transfected using Fugene (Promega) according to the manufacturer’s instructions with 
DFRQVWUXFWH[SUHVVLQJ¿UHÀ\OXFLIHUDVHXQGHUWKHFRQWURORIWKHESSUR[LPDOUHJLRQRIWKHKXPDQ
,)1ȕ promotor (140). Stably expressing cells were selected over a period of 3 weeks using geneticin 
JPO'),IQȕOXFVWDEOHFHOOVZHUHFXOWXUHGLQ'0(0VXSSOHPHQWHGZLWK)%6DQG
PenStrep and were not further subcloned.
Viruses 
,%90,%94;DQG,%9,WDO\25LIW9DOOH\)HYHU9LUXVFORQH59)9&ODQG,QIHFWLRXV
Pancreatic Necrosis Virus (IPNV) were obtained from Merck Animal Health, Boxmeer, The 
1HWKHUODQGV 6LQGELVJUHHQ ÀXRUHVFHQW SURWHLQ *)3ZDV D NLQG JLIW IURP - )URV /DERUDWRU\ RI
Virology, Wageningen University). IBV Beaudette, strain Beau-R, as well as the generation of the 
ScAUG3a, ScAUG3b, ScAUG3ab and ScAUG5ab Beau-R null viruses has been published previously 
(13, 14, 141). In these mutant IBV viruses, the start codons of the indicated accessory genes were 
PXWDWHGWRVWRSFRGRQV$OO,%9VWUDLQVZHUHDPSOL¿HGDQGWLWUDWHGRQ&(.FHOOV6LQGELV*)3ZDV
DPSOL¿HGRQEDE\KDPVWHUNLGQH\%+.FHOOVDQGWLWUDWHGRQ&(.FHOOV59)9&OZDVDPSOL¿HG
DQGWLWUDWHGRQ9HURFHOOVDQ$IULFDQJUHHQPRQNH\FHOOOLQH,319ZDVDPSOL¿HGDQGWLWUDWHGRQWKH
&+6(&KLQRRNVDOPRQFHOOOLQH,319ZDVLQDFWLYDWHGE\PLQ89H[SRVXUHRQD:%;7
26-M instrument (Uvitec).
Poly I:C stimulation and RNase treatment
Polyinosinic-poly(C) [p(I:C)] sodium was purchased from Sigma, dissolved in nuclease-free water and 
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stored at -80°C. p(I:C) was either directly added to the medium or transfected using Lipofectamine 
2000 (Invitrogen) as per manufacturer’s instructions. DF-1 cells (3 x 105/well) were cultured in 24 
well plates and transfected with 500 ng p(I:C). RNase treatment of CEK cell culture supernatant was 
SHUIRUPHGE\DGGLWLRQRIȝJPO51DVH$,QYLWURJHQEHIRUH,%9LQIHFWLRQRUEHIRUHVWLPXODWLRQ
ZLWKȝJPOS,&
RNA isolation and cDNA synthesis
Approximately 8 x 105 CEK cells or 3 x 105')FHOOVZHUHO\VHGLQ5/7EXIIHU4LDJHQDWYDULRXV
time points after treatment or infection. RLT cell lysis buffer was spiked with 1 ng/sample of luciferase 
mRNA (Promega) immediately prior to RNA isolation. Luciferase expression will later be used as 
external reference gene for normalization during the gene expression analysis. Total RNA was isolated 
XVLQJ WKH51HDV\0LQL.LW 4LDJHQDFFRUGLQJ WR WKHPDQXIDFWXUHU¶V LQVWUXFWLRQV LQFOXGLQJDQRQ
FROXPQ'1DVHWUHDWPHQWZLWK51DVHIUHH'1DVH4LDJHQ%HIRUHF'1$V\QWKHVLVRI±ȝJWRWDO
51$ D VHFRQG '1DVH WUHDWPHQW ZDV SHUIRUPHG XVLQJ '1DVH , DPSOL¿FDWLRQ JUDGH ,QYLWURJHQ
Synthesis of cDNA was performed using SuperScript III (Invitrogen) using random primers. cDNA 
VDPSOHVZHUHIXUWKHUGLOXWHGLQQXFOHDVHIUHHZDWHUEHIRUHUHDOWLPHTXDQWLWDWLYH3&5DQDO\VLV
Gene expression analysis
5HDOWLPH TXDQWLWDWLYH 3&5 ZDV SHUIRUPHG RQ D 5RWRU*HQH  &RUEHWW 5HVHDUFK XVLQJ
%ULOOLDQW6<%5*UHHQTXDQWLWDWLYH3&56WUDWDJHQHDQGSULPHUVDVOLVWHGLQ7DEOH 
&\FOHWKUHVKROGVDQGDPSOL¿FDWLRQHI¿FLHQFLHVZHUHFDOFXODWHGE\WKH5RWRU*HQHVRIWZDUHYHUVLRQ
7KHUHODWLYHH[SUHVVLRQUDWLRRIWKHWDUJHWJHQHZDVFDOFXODWHGXVLQJWKHDYHUDJHUHDFWLRQHI¿FLHQF\
for each primer set and the cycle threshold (Ct) deviation of sample vs. control at time point 0h, as 
described in (145). For calculation of the fold change of IBV total RNA, Ct deviation was calculated 
versus Ct 30, as no IBV was present in the non-infected cells that were used as control in all the 
experiments. Because expression of various housekeeping genes was unstable during virus infections 
at time points later than 24 hours (data not shown), gene-expression ratios were normalised using an 
external reference gene (luciferase).
Immunohistochemistry
&(.FHOOVZHUHVHHGHGRQ¿EURQHFWLQFRDWHGJODVV%LRFRDWFRYHUVOLSV%'%LRVFLHQFHVDWDGHQVLW\RI
1 x 105 cells/cm2. After incubation at 37°C for 48 hours, cells were infected with IBV strain M41 at an 
02,RIDQG¿[HGDWGLIIHUHQWWLPHSRLQWVZLWKSDUDIRUPDOGHK\GHDQGSHUPHDELOL]HGXVLQJ
7ULWRQ;,QIHFWHGFHOOVZHUHSUREHGZLWKDQWLGV51$DQWLERG\(QJOLVK	6FLHQWL¿F&RQVXOWLQJ
and polyclonal chicken serum raised against IBV M41 was obtained from Merck AH. Detection was 
done performed using Alexa 488 goat anti-mouse antibody (Invitrogen) and FITC labelled goat anti-
chicken antibody (Kirkegaard and Perry laboratories). Nuclei were stained with 4’,6-diamidino-2-
phenylindole (DAPI). Cells were imaged using a Zeiss Primo Vert microscope and Axiovision software. 
Image overlays were made in ImageJ.
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Table 1 siRNAs and primers used in this study
Gene product Category Orientationsa Sequence (5’-3’) Accession no. Reference
Tlr3 siRNA S UCGAAUACUUGGCUUUAAA NM_001011691
  AS UUUAAAGCCAAGUAUUCGA   
ctrl siRNA S AGGUAGUGUAAUCGCCUUG --
  AS CAAGGCGAUUACACUACCU   
Mda5 siRNA S ACACUGGUAUCAAGUUAUU GU570144
  AS AAUAACUUGAUACCAGUGU   
,IQȕ 54SULPHU FW GCTCTCACCACCACCTTCTC NM_001024836
  RV GCTTGCTTCTTGTCCTTGCT   
,IQĮ 54SULPHU FW ATCCTGCTGCTCACGCTCCTTCT ;0B 142
  RV GGTGTTGCTGGTGTCCAGGATG   
Irf3 54SULPHU FW CAGTGCTTCTCCAGCACAAA NM_205372
  RV TGCATGTGGTATTGCTCGAT   
Irf1 54SULPHU FW CAGGAAGTGGAGGTGGAGAA NM_205415
  RV TGGTAGATGTCGTTGGTGCT   
Tlr7 54SULPHU FW TTCTGGCCACAGATGTGACC NM_001011688 142
  RV CCTTCAACTTGGCAGTGCAG   
Tlr3 54SULPHU FW TCAGTACATTTGTAACACCCCGCC NM_001011691 142
  RV GGCGTCATAATCAAACACTCC   
Mda5 54SULPHU FW TGGAGCTGGGCATCTTTCAG GU570144
  RV GTTCCCACGACTCTCAATAACAGT   
Mx 54SULPHU FW TTGTCTGGTGTTGCTCTTCCT *4
  RV GCTGTATTTCTGTGTTGCGGTA   
Oas 54SULPHU FW CACGGCCTCTTCTACGACA NM_205041 143
  RV TGGGCCATACGGTGTAGACT   
Il8 54SULPHU FW TTGGAAGCCACTTCAGTCAGAC NM_205498 143
  RV GGAGCAGGAGGAATTACCAGTT   
Pkr 54SULPHU FW CCTCTGCTGGCCTTACTGTCA NM_204487 144
  RV AAGAGAGGCAGAAGGAATAATTTGCC   
Adar 54SULPHU FW TGTTTGTGATGGCTGTTGAG AF403114
  RV AGATGTGAAGTCCGTGTTG   
Isg12 54SULPHU FW TAAGGGATGGATGGCGAAG NM_001002856
  RV GCAGTATCTTTATTGTTCTCAC   
Mhc-I 54SULPHU FW CTTCATTGCCTTCGACAAAG NM_001031338 143
  RV GCCACTCCACGCAGGT   
Ifnar2 54SULPHU FW GCTTGTGTTCGTCAGCATT AF082665 143
  RV TTCGCAATCTTCCAGTTGT   
IBV-N 54SULPHU FW GAAGAAAACCAGTCCCAGA AY851295
  RV TTACCAGCAACCCACAC   
Luciferase 54SULPHU FW TGTTGGGCGCGTTATTTATC ;
  RV AGGCTGCGAAATGTTCATACT   
a6VHQVH$6DQWLVHQVH):IRUZDUG59UHYHUVH54SULPHUSULPHUXVHGLQUHDOWLPHTXDQWLWDWLYH3&5
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RNA fluorescence in situ hybridization 
51$ ÀXRUHVFHQFH in situ hybridization (FISH) was performed according to previously described 
protocols (146-148). A set of forty RNA FISH probes (20 bp), each labelled with one CAL Fluor 
5HGÀXRURSKRUHDQG WDUJHWLQJFKLFNHQIfnȕ (NM_001024836), was designed using the Stellaris 
SUREHGHVLJQHU%LRVHDUFK7HFKQRORJLHV7KHFRGLQJVHTXHQFHRIFKLFNHQ,IQȕ LVES WKHUHIRUH
WR DFFRPPRGDWH WKHRSWLPXPQXPEHURIÀXRUHVFHQW SUREHV  H[SODLQHG LQ UHIHUHQFH  WKH
3’UTRZDVLQFOXGHGLQWKHSUREHGHVLJQWRRO&(.FHOOVZHUHJURZQRQ¿EURQHFWLQFRDWHGFRYHUVOLSV
(BD Biosciences) at a density of 2 x 105 cells/cm2. After incubation at 37°C for 48 hours, cells were 
LQIHFWHGZLWK,%90DQGDWWKHLQGLFDWHGWLPHSRLQWV¿[HGLQHWKDQRODW&+\EULGLVDWLRQRI
the probes was performed using the manufacturer’s protocol for adherent cells. Imaging was performed 
using a Roper (Evry, France) Spinning Disc Confocal System on a Nikon Eclipse Ti microscope using 
a 100 × Plan Apo oil immersion objective (numeric aperture, 1.4) and a 491 nm laser line. Z-stacks 
ZHUHFROOHFWHGZLWKȝP=LQWHUYDOV)RUHDFKFKDQQHOPD[LPXP=VWDFNSURMHFWLRQVZHUHPDGH
and processed with ImageJ. 
chIFN bioassay. 
%LRDFWLYHFKLFNHQW\SH,LQWHUIHURQFK,)1ZDVPHDVXUHGXVLQJDELRDVVD\EDVHGRQWKH&(&TXDLO
reporter cell line expressing luciferase under the control of the chicken Mx promotor (149) (kindly 
SURYLGHG E\ 3URI 3HWHU 6WDHKHOL %ULHÀ\ &(&ZHUH LQFXEDWHGZLWK VHULDO GLOXWLRQV RI FK,)1
FRQWDLQLQJVDPSOHVIRUKRXUVDIWHUZKLFKOXFLIHUDVHDFWLYLW\ZDVTXDQWL¿HGDQG,)1FRQFHQWUDWLRQV
FDOFXODWHGXVLQJDFK,)1VWDQGDUG7RDYRLGLQÀXHQFHRI,%9RQWKHDVVD\VDPSOHVZHUHKHDWLQDFWLYDWHG
DW&IRUPLQZKLFKGLGQRWLQÀXHQFHW\SH,FK,)1ELRDFWLYLW\
Gene silencing 
siRNAs targeting chicken Tlr3 and Mda5 were designed by and purchased from Microsynth, Switzerland 
VHTXHQFHVDUHLQ7DEOH7UDQVIHFWLRQVZHUHSHUIRUPHGXVLQJVL/HQW)HFW%LRUDGDWD¿QDOVL51$
FRQFHQWUDWLRQRIQ0)RURQHZHOOQJVL51$ZDVFRPELQHGZLWKȝ/VL/HQW)HFWLQȝ/
OptiMEM (Gibco) and incubated for 20 min. The siRNA complexes were added to 2 x 105 DF-1 cells 
JURZQLQȝ/PHGLXPSHUZHOOLQDZHOOSODWHVL51$FRPSOH[HVZHUHOHIWRQWKHFHOOVIRU
hours before further experiments were performed.
Statistics
$OOVWDWLVWLFDODQDO\VHVZHUHSHUIRUPHGLQ*UDSK3DG3ULVP57T3&5IROGFKDQJHV¿UVWZHUHORJ
WUDQVIRUPHGDQGWKHQXVHGIRUVWDWLVWLFDODQDO\VLV)RUDOOWHVWVHTXDOLW\RIYDULDQFHZDVDVVHVVHGXVLQJ
%DUWOHWW¶V WHVW6LJQL¿FDQWGLIIHUHQFHV 3ZHUHGHWHUPLQHGE\DRQHZD\RU WZRZD\$129$
LQGLFDWHGLQWKH¿JXUHOHJHQGIROORZHGE\D%RQIHUURQLpost hoc test. 
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RESULTS
IBV delays the onset of an IFN response during infection of primary chicken cells
To investigate the kinetics of viral replication and IFN induction upon infection with the avian 
Gammacoronavirus IBV, we infected primary CEK cells (131) with the IBV M41 strain. To monitor 
WKHNLQHWLFVRIWKH,)1UHVSRQVHLQUHODWLRQWR,%9UHSOLFDWLRQZHTXDQWL¿HGWUDQVFULSWLRQRI,IQȕ and 
a set of genes involved in innate immunity, extracellular IFN protein production, virus titres and IBV 
RNA in M41-infected CEK cells. In line with previous observations (87), progeny virus was produced 
after 6 hpi and virus titres reached a maximum around 24 hpi (Fig. 1A). Total intracellular IBV RNA 
OHYHOVUHÀHFWHGWKHNLQHWLFVRILQIHFWLRXV,%9YLUXVLQWKHVXSHUQDWDQW)LJ$UHDFKLQJPD[LPXP
levels around 24 hpi. ,IQȕ expression was delayed with respect to the peak of viral replication and 
remained low until 18 hpi, after which it was strongly upregulated, peaking around 36 hpi (Fig. 1B). 
,)1SURWHLQDFWLYLW\ OHYHOVZHUHTXDQWL¿HGXVLQJDFKLFNHQ,)1VSHFL¿FMx-luc cell-based bioassay 
showing accumulation of IFN from 36 hpi onwards (Fig. 1B). Concomitant with ,IQȕ a subset of genes 
involved in innate immunity, including 0[ Oas and ,O were upregulated whereas others, such as 7OU
Adar, ,VJ0+&, and Ifnar2 appeared not, or only marginally affected by IBV infection (Fig. 1C). 
Pattern recognition receptors Mda5 and Tlr3 and the transcription factor Irf3 were also upregulated 
(Fig. 1C), which is of interest given the role of these PRRs in virus recognition.
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Fig. 1  IBV infection delays Ifnȕ upregulation 
Chicken embryo kidney (CEK) cells were infected with IBV M41 at an MOI of 0.1. (A) Replication of IBV was 
TXDQWL¿HGE\WLWUDWLRQLQFHOOFXOWXUHVXSHUQDWDQWVRILQIHFWHGFHOOVLQDSDUDOOHOH[SHULPHQWLQWUDFHOOXODU,%951$
ZDVTXDQWL¿HGXVLQJ57T3&5%,IQȕP51$OHYHOVZHUHGHWHUPLQHGXVLQJ57T3&5DQG,)1SURWHLQOHYHOVXVLQJ
DFKLFNHQ,)1VSHFL¿Fmx-luc cell-based bioassay, respectively. (C) Expression of genes involved in the antiviral 
response. All gene expressions were calculated as fold changes relative to uninfected control cells and normalised 
against an external reference gene (luciferase). For IBV total RNA, fold changes were calculated relative to Ct 30. 
Depicted are the results of a representative experiment out of three independent experiments. 
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The delayed IFN response is independent from the cell type or virus strain
,IQȕ transcription during infection with coronaviruses such as MHV and SARS-CoV is generally 
low (89, 90, 92, 93, 105), and was shown to be dependent on cell type and virus strain (83). The 
delayed induction of ,IQȕ transcription observed in IBV M41-infected CEK cells prompted us to 
investigate whether induction of ,IQȕ would be dependent on the cell type or IBV strain. Epithelial 
FHOOV LVRODWHG IURP WUDFKHD RI ZHHNROG 63) FKLFNHQV DQG ') FKLFNHQ ¿EUREODVW FHOOV ZHUH
infected with IBV M41 or IBV Beaudette (Beau-R, (141)). At several time points after infection, 
,IQȕ OHYHOV ZHUH PRQLWRUHG E\ 57T3&5 )LJ $ DQG % ,Q ERWK FHOO W\SHV ,IQȕ transcription 
followed the same kinetics observed in CEK cells (Fig. 1B), indicating that induction of ,IQȕ by 
IBV is independent of cell type. To study whether induction of ,IQȕ transcription differs between 
GLIIHUHQW VWUDLQV RI ,%9 ZH DOVR LQIHFWHG &(. FHOOV ZLWK WKH 4; DQG ,W2 VWUDLQV RI ,%9 )LJ
2C). Although we observed some differences in absolute levels of ,IQȕ upregulation induced by 
4; ,W2 DQG0 NLQHWLFV RI ,IQȕ transcription were similar, suggesting that delayed induction 
of ,IQȕ transcription could be considered a general feature of IBV infection in chicken cells. 
     To assess whether CEK and DF-1 cells do have the intrinsic ability to express ,IQȕearlier than 
18h, we stimulated these cells with extracellular polyI:C (pI:C), transfected pI:C (t[pI:C]) or with the 
dsRNA virus Infectious Pancreatic Necrosis Virus (IPNV). We found that stimulation of CEK cells 
with pI:C could induce ,IQȕ transcription as early as one hour after stimulation (Fig. 3A). In DF-1 
cells, stimulation with IPNV, and t[pI:C], but not pI:C, induced ,IQȕ already at 4h (Fig. 3B). The 
observation that DF-1 cells do not respond to stimulation with extracellular dsRNA, is in accordance 
ZLWK SUHYLRXV ¿QGLQJV DQG LVPRVW OLNHO\ GXH WR WKH ODFN RI VXUIDFH H[SUHVVLRQ RI7/5  ,Q
addition, a 12h infection of CEK cells with Sindbis, IPNV or Rift Valley Fever Virus clone 13 (RVFV 
Cl13) induced a clear transcription of ,IQȕ (Fig. 3C). These results suggest that delayed expression 
of ,IQȕ LV D VSHFL¿F IHDWXUH RI ,%9 LQIHFWLRQ DQG QRW DQ LQWULQVLF FKDUDFWHULVWLF RI FKLFNHQ FHOOV 
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Fig. 2  Delayed induction of Ifnȕ transcription is independent of cell type or IBV strain 
(A) Epithelial cells from adult chicken trachea were infected with IBV M41 at MOI 0.1. (B) Fibroblast DF-1 cells 
ZHUHLQIHFWHGZLWK,%9%HDX5DW02,&&(.FHOOVZHUHLQIHFWHGZLWK,%9VWUDLQV04;DQG,WDW
an MOI 0.1. Intracellular IBV total RNA (open diamonds) and ,IQȕ mRNA (bars) are depicted as fold changes as 
DVVHVVHGE\57T3&5*HQHH[SUHVVLRQRI,IQȕ was calculated as fold changes relative to uninfected control cells 
and normalised against an external reference gene (luciferase). For IBV total RNA, fold changes were calculated 
relative to Ct 30. Error bars indicate standard deviation.
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Fig. 3  Chicken cells have the intrinsic ability to respond rapidly to dsRNA 
(A) CEK cells were seeded in 24 well plates and 48 hours later stimulated with extracellular poly I:C for the indicated 
times. (B) DF-1 cells were infected with IPNV, a non-replicating dsRNA virus, or stimulated with extracellular pI:C 
or transfected pI:C (t[pI:C]). Four hours later, ,IQȕIROGFKDQJHVZHUHGHWHUPLQHGE\57T3&5%DUVUHSUHVHQWWKH
PHDQSOXVVWDQGDUGGHYLDWLRQRIWULSOLFDWHZHOOVIURPDUHSUHVHQWDWLYHH[SHULPHQW$VWHULVNVLQGLFDWHVLJQL¿FDQW
GLIIHUHQFHV 3ZLWK UHVSHFW WR WKHQRQVWLPXODWHG FRQWURO DV DVVHVVHGE\RQHZD\$129$ IROORZHGE\ D
Bonferroni post-hoc test. (C) CEK cells were infected with IBV M41 (MOI 1), IBV Beau-R, (MOI 1), Sindbis-GFP 
(MOI 1), IPNV (MOI 50) and RVFV Cl13 (MOI 5). Depicted are ,IQȕ fold changes at 12 hpi relative to uninfected 
FRQWUROFHOOVDVDVVHVVHGE\57T3&5
The intracellular pattern recognition receptor MDA5 is the primary sensor of IBV 
In general, dsRNA has been shown to be the canonical inducer of ,IQȕ during infection with Alpha- 
and Betacoronaviruses (83, 124). To determine which pattern recognition receptor (PRR) would be 
involved in sensing (ds)RNA of the Gammacoronavirus,%9OHDGLQJWRVXEVHTXHQW,IQȕ transcription, 
ZH¿UVWH[DPLQHGWKHSRVVLELOLW\WKDW,%9GV51$FRXOGEHVHQVHGH[WUDFHOOXODUO\E\IRUH[DPSOH
cell-surface receptors. To investigate this, CEK cells were infected with IBV M41 in the presence of 
RNase A and ,IQȕ expression was analysed. As a positive control, CEK cells were stimulated with pI:C 
in the presence or absence of RNase A. The IFN response to pI:C was greatly inhibited by addition of 
RNase A, which had no effect on ,IQȕlevels induced by infection with IBV M41 (Fig. 4A). These data 
suggest that,IQȕ upregulation during the late stage (>18 hpi) of IBV infection could be the result of 
sensing of IBV-(ds)RNA by an intracellular rather than an extracellular pattern recognition receptor. 
This is consistent with our observation that IBV infection can be detected by DF-1 cells, which show 
only a marginal upregulation of ,IQȕ transcription in response to extracellular dsRNA (see Fig. 3B). 
In general, dsRNA can be recognised by membrane-bound TLR3 and cytosolic RLRs such as MDA5 
and RIG-I. Genome mining strongly indicates that chickens do not express a RIG-I homologue (77), 
leaving TLR3 and MDA5 as the two PRRs potentially involved in dsRNA sensing. Silencing of Mda5, 
but not Tlr3, in DF-1 cells resulted in a 70% decrease in ,IQȕ transcription (Fig. 4B). Similar results 
were obtained with an ,IQȕ-luc DF-1 reporter cell line in which silencing of Mda5, but not Tlr3, resulted 
in a 70% decrease in luciferase activity by the reporter cells (Fig. 4C). Because no antibody against 
chicken MDA5 is currently available for protein detection, successful knockdown was evaluated using 
A B C
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57T3&5GHPRQVWUDWLQJDVLOHQFLQJHI¿FLHQF\IRUERWKTlr3 and Mda5 of approximately 60% (data not 
shown). Replication of IBV at the investigated time point was not affected by knockdown of neither 
Tlr3 nor Mda5, as measured by both virus titre and intracellular IBV total RNA (Fig. 4D). These results 
indicate that MDA5 is the primary PRR responsible for sensing Gammacoronavirus IBV-(ds)RNA in 
chicken cells.
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Fig. 4  MDA5, and not TLR3, is the prime sensor of IBV 
(A) CEK cells were infected with IBV M41 for 24 hours, in the presence or absence of RNase A. ,IQȕ expression 
ZDVDQDO\VHGE\57T3&56WLPXODWLRQZLWKS,&LQWKHSUHVHQFHRUDEVHQFHRI51DVH$ZDVLQFOXGHGDVDSRVLWLYH
FRQWURO%'')FHOOVDQG&'),IQȕOXFUHSRUWHUFHOOVZHUHWUDQVIHFWHGZLWKVL51$VDJDLQVWTlr3, Mda5 or 
a control siRNA and 48 hours later infected with IBV M41 (MOI 0.1). (B) ,IQȕ mRNA, (C) Ifnȕ-luciferase activity, 
and (D) IBV titres and intracellular RNA were analysed 18 hpi. Bars represent the mean (plus standard deviation) 
RIWULSOLFDWHZHOOVIURPDUHSUHVHQWDWLYHH[SHULPHQW$VWHULVNVLQGLFDWHVLJQL¿FDQWGLIIHUHQFHV3ZLWKUHVSHFW
to the non-RNaseA-treated control (A) or to the siRNA control (B-C), as assessed by one-way ANOVA followed by 
a Bonferroni post-hoc test.
Early accumulation of dsRNA in IBV-infected cells does not result in early induction 
of Ifnȕ 
Having assessed that chicken cells can indeed promptly respond to stimulation with dsRNA (Fig. 3) and 
KDYLQJLGHQWL¿HG0'$DVWKHSULPDU\VHQVRULQYROYHGLQWKHGHWHFWLRQRI,%9)LJZHLQYHVWLJDWHG
whether there would be a temporal difference between IBV-induced accumulation of dsRNA and the 
upregulation of ,IQȕ transcription in CEK cells. Indeed, dsRNA could clearly be detected, even at low 
MOI of 0.01, by 12 hpi (Fig. 5A). In contrast, ,IQȕ levels at this time point remained low (Fig. 5B) 
even in cell cultures infected at higher MOIs of 1 or 10 and despite the increased abundance of dsRNA. 
To further investigate the time lag between early accumulation of dsRNA and late ,IQȕ expression, 
we performed a time course analysis. Foci of dsRNA could be detected as early as 3 hours post-
infection only in IBV-infected cells (Fig. 5C, inset 3hpi) indicating that dsRNA starts accumulating 
very early in IBV-infected cells but apparently only leads to late (>18 hpi) ,IQȕ transcription. 
     Primary CEK cells consist of a heterogeneous mix of cell types. Even at high MOI, IBV M41 
infects only ~70% of the cells, indicating that not all cells are permissive to IBV M41 infection. In 
order to assess whether the time lag between accumulation of dsRNA and ,IQȕ expression could be 
due to the induction of ,IQȕLQE\VWDQGHUUDWKHUWKDQ,%9LQIHFWHGFHOOVZHXVHG51$ÀXRUHVFHQWin 
A B C D
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situ hybridisation to visualise Ifnȕ mRNA in IBV-infected CEK cell cultures (Fig. 5D). At 12 hpi and 
low MOI (0.1), with most cells showing clear foci of dsRNA, none of the IBV-infected cells displayed 
an accumulation of ,IQȕ mRNA. At 12 hpi and a higher MOI, a few cells stained positive for Ifnȕ 
mRNA and only later, at 24 hpi, did most IBV-infected cells also stain positive for Ifnȕ mRNA, the 
kinetics of which closely following that observed in Fig. 5A. In all cases, detection of Ifnȕ mRNA was 
restricted to cells that contained dsRNA. Altogether our data shows that IBV-infected, but not adjacent 
uninfected cells, upregulate ,IQȕ WUDQVFULSWLRQ LQUHVSRQVH WR,%9LQIHFWLRQ7KHVLJQL¿FDQW WLPHODJ
between accumulation of dsRNA and ,IQȕ transcription further suggests the presence of a mechanism 
adopted by IBV to circumvent the onset of an IFN response. 
Accessory proteins 3a and 3b regulate IFN transcription and protein production
To investigate whether the accessory proteins of IBV might play a role in the observed delay in ,IQȕ 
transcription, we infected CEK cells with IBV scAUG3ab and scAUG5ab null viruses and the parental 
Beau-R virus (scAUG viruses possess a scrambled AUG start codon resulting in transcription but not 
translation of either ORFs 3a and 3b or 5a and 5b (13, 14)). Infection with the scAUG3ab, but not a 
scAUG5ab null virus resulted by 24 hpi in increased upregulation of ,IQȕ expression (Fig. 6A). Indicating 
that either one, or a combination of, accessory proteins 3a and 3b play a role in down regulating ,IQȕ 
transcription. The difference in ,IQȕ transcription between the scAUG3ab and the parental (Beau-R) 
virus could not be ascribed to differences in kinetics of virus replication, as all viruses displayed similar 
growth kinetics until 24 hpi (Fig. 6B). To determine whether 3a, 3b or both accessory proteins are 
LQYROYHGLQWKHREVHUYHGGRZQUHJXODWLRQRIWKH,)1UHVSRQVHZHTXDQWL¿HG,IQȕ transcription and IFN 
protein production in CEK cells infected with scAUG3a, scAUG3b and scAUG3ab mutant viruses, and 
compared the values observed in cells infected with Beau-R (Fig. 6C and 6D). Infection with all mutant 
viruses led to an increased transcription of ,IQȕ when compared to the Beau-R (Fig. 6C), indicating 
WKDWWKHSUHVHQFHRIHLWKHURQHRIWKHWZRDFFHVVRU\SURWHLQVLVVXI¿FLHQWWROLPLW,IQȕ transcription. The 
kinetics of ,IQȕ transcription in response to AUG3a/b differs between Fig. 6A and Fig. 6C. In Fig 6C there 
LVDVLJQL¿FDQWGLIIHUHQFHLQ,IQȕ transcription between AUG3a/b and Beau-R, which is absent in Fig 
6A. This difference can probably be attributed to variation in the kinetics of ,IQȕ transcription between 
SULPDU\&(.FHOOVLVRODWHGIURPHPEU\RVRULJLQDWLQJIURPGLIIHUHQWÀRFNV1RQHWKHOHVVWKLVGLIIHUHQFH
does not affect the conclusion that knockout of 3a and 3b leads to an increase in transcription of ,IQȕ. 
1RVLJQL¿FDQWGLIIHUHQFHVLQ,)1SURWHLQSURGXFWLRQZHUHREVHUYHGEHWZHHQFHOOVLQIHFWHGZLWKWKH
Beau-R and the scAUG3ab double null virus, except at 36 hpi. However, infection with scAUG3b virus 
led to an increase in IFN protein levels, whereas infection with the scAUG3a virus led to a decrease in 
IFN when compared to both Beau-R and scAUG3ab double null virus (Fig. 6D). Taken together, these 
results indicate that accessory proteins 3a and 3b both play a role in the inhibition of ,IQȕ transcription 
but have distinct and opposing effects on protein production. Accessory protein 3b seems to be involved 
in limiting IFN protein activity whereas 3a is involved in promoting it.
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_ Fig. 5  Early accumulation of dsRNA in IBV-infected cells does not result in early induction of Ifnȕ 
CEK cells were infected with IBV M41 or IBV Beau-R at the indicated MOIs. At time point 12 hpi (A) dsRNA was 
visualised in M41-infected cells using an antibody against dsRNA. (B) Expression of ,IQȕ mRNA was analysed by 
57T3&5&&(.FHOOVZHUHLQIHFWHGZLWK,%90DQGDFFXPXODWLRQRIGV51$ZDVYLVXDOLVHGDWWKHLQGLFDWHG
WLPHSRVWLQIHFWLRQ'51$ÀXRUHVFHQWin situ hybridisation of ,IQȕ mRNA in IBV M41-infected CEK cells. Open 
DUURZKHDGVLQGLFDWHFHOOVWKDWFRQWDLQGV51$DQGQR,IQȕP51$6ROLGZKLWHDUURZKHDGVLQGLFDWHFHOOVWKDWFRQWDLQ
both dsRNA and ,IQȕ mRNA.
Signaling of non-self dsRNA remains intact in IBV-infected cells
Since IBV showed the intrinsic ability to delay ,IQȕ transcription in several cell types (Fig. 1 and Fig. 
2) even in the presence of high levels of intracellular dsRNA (Fig. 5), we investigated the ability of 
IBV to interfere with sensing of non-self dsRNA by TLR3 or MDA5. We infected CEK cells with IBV 
0DQGVXEVHTXHQWO\XVHGH[WUDFHOOXODUSRO\,&WRWULJJHU7/5VLJQDOLQJ)LJ$6WLPXODWLRQZLWK
S,&DORQHOHGWRDVLJQL¿FDQWLQFUHDVHLQ,IQȕ transcription whereas stimulation with pI:C following 
an infection with IBV led to an enhanced increase in ,IQȕ transcription in an MOI-dependent manner. 
These results indicated that IBV infection does not interfere with TLR3-mediated ,IQȕ transcription, on 
the contrary IBV infection appears to result in a synergistic activation of the TLR3 pathway triggered by 
pI:C. Next, we investigated whether IBV infection could interfere with MDA5-mediated transcription 
of ,IQȕ. Although transfection of pI:C into the intracellular compartment is a commonly used ligand 
of MDA5, this method induced very little transcription of ,IQȕ in primary CEK cells, because of low 
WUDQVIHFWLRQHI¿FLHQF\GDWDQRWVKRZQ$VDQDOWHUQDWLYHURXWHWRVWLPXODWH0'$LQSULPDU\FKLFNHQ
cells, we investigated the use of either RVFV Cl13 or IPNV, that induce Ifnȕ transcription in CEK 
cells (Fig 3C). RVFV Cl13 is a (-) ssRNA virus with a truncated IFN antagonist (151), for which 
RIG-I, but not by MDA5 or TLR3, was previously shown to be the most likely PRR in mammalian 
cells (152, 153). Since chickens, as opposed to most mammals, do not have a RIG-I homologue, 
the most likely PRR for RVFV in CEK cells would be MDA5. IPNV is a birnavirus with a dsRNA 
genome that naturally infects salmonids but has been shown to enter but not replicate in cells of warm-
blooded animals (154). To date, the PRR responsible for sensing IPNV dsRNA has not been described. 
Knockdown experiments in DF-1 Ifnȕ-luc reporter cells, using siRNAs against chicken MDA5 or 
7/5 UHYHDOHG WKDW0'$ EXW QRW7/5 LV WKH SULPH 355 IRU ,319 )LJ %7KHVH ¿QGLQJV
ZHUHFRQ¿UPHGXVLQJ0()VPRXVHHPEU\R¿EUREODVWVIURPNQRFNRXWPLFHGH¿FLHQWLQH[SUHVVLRQ
of either MDA5, RIG-I or the downstream adaptor protein MAVS. Here, knockout of either MDA5 
or MAVS abrogated sensing of IPNV as shown by a strong reduction of ,IQȕ transcription, whereas 
NQRFNRXWRI5,*,GLGQRW)LJ&%RWK,319DQG59)9&OZHUHVXEVHTXHQWO\XVHGWRLQYHVWLJDWH
whether IBV infection could interfere with MDA5-mediated transcription of ,IQȕ in CEK cells. 
    8VLQJ TXDQWL¿FDWLRQ RI ,IQȕ WUDQVFULSWLRQ E\ 57T3&5 DV UHDG RXW ZH FRXOG VKRZ WKDW ,%9
infection does not interfere with MDA5-mediated signaling of IPNV (Fig. 7D) or RVFV Cl13 (Fig. 
7E), in fact it had a synergistic effect on ,IQȕ transcription as previously observed for TLR3-mediated 
signaling (Fig. 7A). Similar results were obtained when stimulating IBV-infected DF-1 cells with 
,319RUW>S,&@)LJ)LQGLFDWLQJWKDWWKHREVHUYHGV\QHUJLVWLFHIIHFWLVQRWVSHFL¿FWR&(.FHOOV 
7DNHQWRJHWKHU,%9LQIHFWLRQYHU\HI¿FLHQWO\SUHYHQWVVHQVLQJRI,%9GV51$EXWRXUUHVXOWVLQGLFDWH
that it does not interfere with sensing and downstream signaling of other non-self (ds)RNA ligands.
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Fig. 6  Accessory proteins 3a and 3b are involved in regulation of IFN transcription and protein production
(A) CEK cells were infected with IBV Beau-R 3a/3b (scAUG3ab) or 5a/5b (scAUG5ab) null viruses (MOI 0.1). ,IQȕ 
OHYHOVZHUHGHWHUPLQHGXVLQJ57T3&5%'&(.FHOOVZHUHLQIHFWHGZLWKVF$8*DVF$8*ERUVF$8*DE
null IBV viruses (MOI 0.1). In the same cultures (B) ,IQȕ mRNA, (C) virus titres and (D) type I IFN protein were 
TXDQWL¿HG%DUVUHSUHVHQWWKHPHDQSOXVVWDQGDUGGHYLDWLRQRIWULSOLFDWHZHOOVIURPDUHSUHVHQWDWLYHH[SHULPHQW
6LJQL¿FDQWGLIIHUHQFHV3UHODWLYHWRWKH%HDX5YLUXVDWWKHVDPHWLPHSRLQWRUEHWZHHQWKHLQGLFDWHGEDUV
(#) as assessed by a two-way ANOVA followed by a Bonferroni post-hoc test.
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DISCUSSION
In this study we performed a comprehensive analysis of the kinetics of IBV infection in avian cells and 
studied the mechanisms by which IBV interferes with the onset of the type I IFN response. We show that 
infection with the Gammacoronavirus IBV leads to a considerable activation of the type I IFN response, 
albeit delayed with respect to the peak of viral replication and accumulation of viral dsRNA. Using an 
siRNA knockdown approach we show that MDA5 is the main receptor involved in the induction of 
,IQȕ expression during IBV infection. We present evidence that IBV accessory proteins 3a and 3b play 
a role in the modulation of the delayed IFN response, by regulating interferon production both at the 
transcriptional as well as translational level. In addition, we show that although IBV alone effectively 
prevents ,IQȕ induction in IBV-infected cells, it does not block ,IQȕ induction upon stimulation of IBV-
infected cells with other RIG-I, MDA5 or TLR3 ligands. To our knowledge, this study provides the most 
comprehensive analysis of the interplay between a Gammacoronavirus and the avian type I IFN response. 
   Much of our current knowledge about the interaction of coronaviruses with the innate immune 
response (reviewed in (155)) comes from studies in mice and mouse cells using mouse hepatitis 
YLUXV 0+9 0+9 DFWLYDWHG ,)1 SURGXFWLRQ RQO\ LQ VSHFL¿F FHOO W\SHV DQG DQ HI¿FLHQW ,)1
response was only mounted by plasmacytoid dendritic cells (156), bone marrow derived 
macrophages (90, 157) and oligodendrocytes (90). In a recent study on SARS-CoV and MERS-
CoV in an epithelial lung cell line, ISGs started to be upregulated at 12 hpi (158), when virus 
titres were already reaching their maximum. The kinetics of IFN response observed in our study 
are in line with aforementioned studies, however it must be noted that in most cell types, infection 
with Alpha or Betacoronaviruses induced very little, if any, Ifnȕ transcription (88-93, 105). 
This suggests that all coronaviruses are able to modulate the activation of the type I IFN response. 
    We found that IBV infection is detected by various chicken cell types, but until now it was 
unknown which PRR was involved. MHV has been shown to be detected by MDA5 and not RIG-I 
or TLR3 in brain macrophages (83), by both MDA5 and RIG-I in an oligodendrocyte derived 
cell line (90) and by TLR7 in plasmacytoid dendritic cells (156). Analysis of the chicken genome 
suggests that chicken lack a RIG-I homologue (77), and basal expression of Tlr7 was found 
to be very low in CEK cells (data not shown). We therefore silenced the remaining candidate 
RNA sensors MDA5 and TLR3, and were able to show that MDA5, but not TLR3, is involved 
in the sensing of IBV. Silencing of Mda5 did not lead to an increase in replication of IBV, 
suggesting that IBV might have developed strategies to counteract the activated IFN response. 
       We recently reported membrane rearrangements in chicken cells infected with IBV (87), similar 
to those found in cells infected with Betacoronaviruses. In theory, the formation of intracellular 
membrane rearrangements might partly explain the discrepancy observed in the kinetics of dsRNA 
accumulation and ,IQȕ upregulation. Indeed, for SARS-CoV it has been shown that virus-induced 
double membrane vesicles (DMVs) contain dsRNA (85), suggesting that coronaviruses might exploit 
membrane structures to shield dsRNA from recognition by host PRRs (86). However, the kinetics 
of ,IQȕ transcription were not investigated in these studies. The presence of coronavirus-induced 
DMVs has been demonstrated as early as 2 hpi in SARS-CoV-infected cells (85). Although we did 
not demonstrate the presence of DMVs in IBV-infected chicken cells at time points earlier than 
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7 hpi (87), it is likely that DMVs could also be present at earlier time points. As such, the timing 
of DMV formation in coronavirus-infected cells could suggest that membrane rearrangements 
play a role in the delayed activation of the IFN response by shielding dsRNA from cellular PRRs. 
    In addition to membrane rearrangements, coronavirus-encoded proteins, including numerous 
accessory genes, have been shown to interfere with the type I IFN response pathway (reviewed in (9, 
125). To investigate the possible role of IBV accessory proteins in the regulation of the IFN response 
we made use of our previously constructed mutant IBV Beau-R viruses that do not express either one or 
more of the four accessory proteins 3a, 3b, 5a and 5b. Previously we have demonstrated the accessory 
genes of IBV are not essential for replication (13, 14). 
Fig. 7  Signaling of non-self RNA remains intact in IBV-infected cells
(A) CEK cells were infected with IBV M41 for 3 hours and stimulated with extracellular poly I:C (50µg/ml) for an 
additional 3 hours after which ,IQȕWUDQVFULSWLRQZDVDQDO\VHGE\57T3&5%'),IQȕOXFUHSRUWHUFHOOVZHUH
transfected with siRNAs against Tlr3, Mda5 or a control siRNA and 48 hours later infected with IPNV (MOI 50); 
DWKSLOXFLIHUDVHDFWLYLW\ZDVTXDQWL¿HG&.QRFNRXW.2DQGZLOGW\SHZW0()VZHUHLQIHFWHGZLWK,319
(MOI 50) for 8 hours. (D) CEK cells were infected with IBV M41 (MOI 10) for 6h and super-infected with IPNV or 
UV-inactivated IPNV (MOI 50) for an additional 6 h. (E) CEK cells were co-infected with IBV M41 (MOI 5) and 
RVFV clone 13 (MOI 5) and sampled at 6 hpi. (F) DF-1 cells were infected with IBV Beau-R (MOI 1) for 3 h and 
super-infected with IPNV (MOI 50) or transfected with pI:C (t[pI:C], 500 ng/well) for an additional 4 h. (C-F) ,IQȕ
OHYHOVZHUHTXDQWL¿HGE\57T3&5%DUVUHSUHVHQWWKHPHDQSOXVVWDQGDUGGHYLDWLRQRIWULSOLFDWHZHOOV6LJQL¿FDQW
GLIIHUHQFHV3DUHLQGLFDWHGE\DVDVVHVVHGE\RQHZD\$129$IROORZHGE\D%RQIHUURQLSRVWKRFWHVW
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In addition to membrane rearrangements, coronavirus-encoded proteins, including numerous accessory 
genes, have been shown to interfere with the type I IFN response pathway (reviewed in (9, 125). 
To investigate the possible role of IBV accessory proteins in the regulation of the IFN response 
we made use of our previously constructed mutant IBV Beau-R viruses that do not express either 
one or more of the four accessory proteins 3a, 3b, 5a and 5b. Previously we have demonstrated the 
accessory genes of IBV are not essential for replication (13, 14). In the present study we show that 
infection of CEK cells with 3a or 3b null viruses as well as a 3a/3b double null virus led to increased 
Ifnȕ transcription compared to Beau-R. Because the kinetics of Ifnȕ transcription of 3a, 3b and 
3a/3b null viruses are comparable to the parental virus, we conclude that, 3a and 3b are probably 
not responsible for the delay in Ifnȕ transcription, suggesting that IBV utilises additional strategies 
to delay transcription of Ifnȕ. Apart from their effect on Ifnȕ transcription, 3a and 3b seem to have 
opposing effects on IFN protein production by IBV infected cells. Infection with the 3b null virus 
resulted in increased IFN production whereas infection with the 3a null virus resulted in reduced IFN 
levels compared to the Beau-R virus. Together with the observation that IFN production induced by 
the 3a/3b double null virus is comparable to that induced by Beau-R virus, our data suggests that 
accessory proteins 3a and 3b antagonise each other to tightly regulate IFN production (Fig. 6B). 
8VLQJWKHHXNDU\RWLFOLQHDUPRWLIVHUYHUZHLGHQWL¿HGD3URWHLQSKRVSKDWDVH33ELQGLQJ
17KISF20 GRPDLQ LQ WKH ,%9ESURWHLQ VHTXHQFH7KH FDQRQLFDO33ELQGLQJPRWLI LV >5.@>9,/@
;>):@LQZKLFK[FDQEHDQ\DPLQRDFLGH[FHSWSUROLQH,QWHUHVWLQJO\Alphacoronavirus TGEV 
accessory protein 7 (TGEV-7) has been shown to bind PP1 via a binding motif similar to that found in 
,%9E6LPLODUWR,%9VF$8*ELQIHFWLRQZLWK7*(9¨OHGWRLQFUHDVHGP51$DQGSURWHLQ
OHYHOVRI,)1ȕ7KHIDFWWKDWERWK7*(9DQG,%9EFRQWDLQD33ELQGLQJGRPDLQLQGLFDWHVWKDW
interaction with PP1 could be a common strategy of coronaviruses to inhibit the host innate immune 
response. The mechanism by which interaction of coronavirus accessory proteins with PP1 counteracts 
the innate immune response still needs to be determined. One clue might come from the PP1-binding 
domain of Measles virus V, which was recently shown to be essential for inhibition of MDA5 signaling 
0HDVOHV9SURWHLQELQGV33DQGLQKLELWVGHSKRVSKRU\ODWLRQRI0'$ZKLFKLVUHTXLUHG
IRUDFWLYDWLRQDQGVXEVHTXHQWVLJQDOLQJE\0'$0RWLIDQDO\VLVIRU,%9DSURWHLQGLGQRWUHYHDOWKH
presence of relevant motives that might explain the observed activity of 3a on IFN regulation. We conclude 
that both accessory proteins 3a and 3b limit ,IQȕ transcription but have distinct and opposing effects on 
protein production. Whereas 3a seems to promote IFN production, 3b seems to be involved in limiting 
IFN protein production, possibly through a similar mechanism as described for protein 7 of TGEV. The 
fact that IBV 3a and 3b have opposing roles in regulating IFN production, indicates that CoV’s tightly 
regulate IFN production to balance their own survival with that of the host. This hypothesis is supported 
E\WKHREVHUYDWLRQWKDW¿HOGLVRODWHVODFNLQJDDQGEGLVSOD\UHGXFHGYLUXOHQFHin vitro as well as in vivo 
(34). Elucidation of the exact mechanisms of action of 3a and 3b will be the subject of further investigation. 
      To investigate whether IBV interferes with a general sensing of (ds)RNA ligands or downstream 
signaling that leads to ,IQȕ transcription, we stimulated IBV-infected cells with TLR3, RIG-I, and 
MDA5 ligands. Surprisingly, we found that infection with IBV did not reduce ,IQȕ transcription 
but rather increased ,IQȕ levels upon stimulation with these PRR ligands. Similar to IBV, MHV 
has been shown unable to inhibit expression of ,IQȕ induced by either t[pI:C] or Sendai virus (163, 
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164), but in these studies no synergistic effect was observed. Currently, we can only speculate about 
the cause of this synergistic effect. It appears that IBV infection ‘arms’ the ,IQȕ induction pathway, 
without actually triggering it, possibly by enhancing the activity of one or more components of 
the pathway leading to Ifnȕ upregulation. One possibility is that IBV-proteins interact with host-
SURWHLQV WKDW UHJXODWH WKLVSDWKZD\ WKURXJKXELTXLWLQDWLRQDQGSKRVSKRU\ODWLRQ UHYLHZHG LQ 
The fact that stimulation with either TLR3 or MDA5 ligands resulted in exacerbated transcription 
of ,IQȕ LQGLFDWHV WKDW ,%9LQÀXHQFHVDFRPSRQHQWZKLFK LVGRZQVWUHDPRIERWK0'$DQG7/5 
7DNHQWRJHWKHURXUVWXG\SURYLGHVWKH¿UVWFRPSUHKHQVLYHDQDO\VLVRIKRVWYLUXVLQWHUDFWLRQVRID
Gammacoronavirus with the avian innate immune response. We show that the Gammacoronavirus IBV, 
induces activation of the type I IFN response in primary chicken renal cells, tracheal epithelial cells 
and in a chicken cell line. We show that activation of the IFN response is dependent on MDA5 but is 
delayed with respect to the peak of virus replication. We demonstrate that ,IQȕ transcription is restricted 
to IBV-infected, dsRNA-containing cells and provide evidence that accessory proteins 3a and 3b of 
IBV are involved in regulating transcription as well as protein production of type I IFN.
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ABSTRACT
7KHLQQDWHLPPXQHUHVSRQVHLVWKH¿UVWOLQHRIGHIHQFHDJDLQVWYLUXVHVDQGWKHW\SH,LQWHUIHURQ,)1
response is a critical component of this response. Similar to other viruses, the Gammacoronavirus 
infectious bronchitis virus (IBV) has evolved under evolutionary pressure to evade and counteract the 
IFN response to enable its survival. Previously, we reported that IBV induces a delayed activation of 
the IFN response and that accessory proteins 3a and 3b modulate the IFN response. In the present work, 
we describe the resistance of IBV to IFN and the potential role of accessory proteins herein. We identify 
that accessory proteins 3a and 3b are involved in resistance to IFN, as their absence renders IBV less 
UHVLVWDQWWR,)1WUHDWPHQW,QDGGLWLRQWRWKLVZH¿QGWKDWLQGHSHQGHQWRIWKHSUHVHQFHRIDFFHVVRU\
proteins, IBV inhibits IFN-mediated phosphorylation and translocation of STAT1. In summary, we 
show that IBV uses multiple strategies to counteract the IFN response.
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INTRODUCTION
Infectious bronchitis virus (IBV) is a member of the genus Gammacoronavirus, a group of viruses from 
the order of Nidovirales characterised by a large positive-stranded RNA genome (1). IBV is the causative 
agent of infectious bronchitis, which is one of the most important viral diseases in chickens, causing a 
highly contagious respiratory disease that can spread to the gastrointestinal or the urogenital tract (38, 
166). Despite widespread application of inactivated and live-attenuated vaccines, IBV remains one of the 
most reported diseases in poultry farms worldwide. Notwithstanding the widespread nature and economic 
importance of this virus, interactions between IBV and the host immune response remain poorly understood. 
    During the immune response to viruses, the type I interferon response plays a pivotal role. 
Recently, we have shown that IBV induces delayed activation of the interferon response (167) 
in a manner similar to several members of the genus Betacoronavirus, including mouse hepatitis 
virus (MHV), severe acute respiratory syndrome-associated coronavirus (SARS-CoV) and Middle 
East respiratory syndrome coronavirus (MERS-CoV) (88, 89, 157, 158). The observation that 
coronaviruses delay activation of the IFN response and limit production of IFN, suggests that IFN 
has the ability to hinder their propagation. In apparent contrast, most coronaviruses are relatively 
resistant to treatment with IFN in vitro (93, 113), one exception being MERS-CoV, which was 
shown to be highly sensitive to IFNȕ in vitro (101, 107). Although previous studies suggest that 
WUHDWPHQW ZLWK ,)1 FRXOG KLQGHU SURSDJDWLRQ RI ,%9 EDVHG RQ UHGXFHG SODTXH IRUPDWLRQ 
DQGUHGXFHGV\QF\WLD IRUPDWLRQ TXDQWLWDWLYHGDWDRQ WKH UHVLVWDQFHRI ,%9WR ,)1LV ODFNLQJ 
      It is unknown which of the IBV proteins confer resistance to IFN, if any. Various studies have 
demonstrated that accessory proteins of coronaviruses play an important role in the resistance to the IFN-
induced antiviral response (15, 19, 32, 100, 101, 109, 112, 113). Accessory proteins are a group of small 
±DDSURWHLQVWKDWDUHQRWHVVHQWLDOIRUYLUXVUHSOLFDWLRQin vitro. The number of accessory proteins 
YDULHVEHWZHHQFRURQDYLUXVHVDQGDPLQRDFLGVHTXHQFHVRIDFFHVVRU\SURWHLQVIURPGLIIHUHQWJHQHUD
VKRZYHU\OLPLWHGVLPLODULW\VXJJHVWLQJWKDWWKHLUIXQFWLRQLVYLUXVRUKRVWVSHFL¿F,%9KDVEHHQVKRZQ
to express at least four accessory proteins, 3a, 3b, 5a and 5b, which are translated from two polycistronic 
mRNAs. Recently, we showed that both 3a and 3b limit transcription of ,IQȕ and that 3b limits production 
of IFN protein in vitro (167). Additional roles of IBV accessory proteins have remained elusive. 
,QWKHSUHVHQWVWXG\ZHVKRZWKDW,%9LVUHODWLYHO\UHVLVWDQWWRWUHDWPHQWZLWKHLWKHU,)1ĮRU,)1ȕ
but that simultaneous knockout of 3a and 3b makes IBV less resistant to treatment with type I IFN. In 
addition, we show that IBV inhibits phosphorylation and translocation of the IFN-activated transcription 
IDFWRU67$7DQGLQKLELWVVXEVHTXHQW,)1PHGLDWHGDFWLYDWLRQRIDQ,6*SURPRWHUDWOHDVWGXULQJODWH
stages of the infection. However, using mutant viruses we demonstrate that the presence of accessory 
SURWHLQVDEDDQGELVQRWUHTXLUHGIRUHLWKHULQKLELWLRQRI67$7WUDQVORFDWLRQRUDFWLYDWLRQRI
an ISG promoter. We discuss two strategies by which IBV counteracts the type I IFN response: one 
based on counteracting the IFN-mediated antiviral response using accessory proteins 3a and 3b and 
another based on blocking of IFN-mediated activation of antiviral genes through inhibition of STAT1 
translocation. This study demonstrates that the Gammacoronavirus IBV has evolved multiple strategies 
to counteract activation of, and clearance by the type I IFN response.
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MATERIALS AND METHODS
Cells 
Chicken embryonic kidneys (CEK) were aseptically removed from 17- to 19-day-old chicken embryos 
(Charles River, SPAFAS). A cell suspension was obtained by trypsinisation for 30 min at 37 °C and 
¿OWHUHGWKURXJKDȝPPHVK7KHUHVXOWLQJ&(.FHOOVZHUHVHHGHGDW[5 cells/cm2 in a 1:1 mix of 
199 and F10 medium (Invitrogen) supplemented with 0.5% foetal bovine serum (FBS, SAFC) and 1% 
SHQLFLOOLQVWUHSWRP\FLQ3HQ6WUHS*LEFR,QYLWURJHQ')FKLFNHQ¿EUREODVWFHOOVWKH$IULFDQJUHHQ
monkey Vero cells and baby hamster kidney (BHK) cells were cultured in DMEM (Gibco, Invitrogen) 
supplemented with 10% fetal bovine serum (FBS) and 1% PenStrep. All cells were incubated in a 
KXPLGL¿HGLQFXEDWRUDW&DQG&22. 
Viruses 
Sindbis virus (SinV) was a kind gift from Dr. G. Pijlman, (Laboratory of Virology, Wageningen 
University). IBV Beaudette, strain Beau-R, as well as the generation of the ScAUG3a, ScAUG3b, 
ScAUG3ab and ScAUG5ab Beau-R null viruses were described previously (13, 14, 141). In the null 
IBV viruses, the start codons of the indicated accessory genes were mutated to stop codons. All IBV 
VWUDLQVZHUHDPSOL¿HGDQGWLWUDWHGRQ&(.FHOOV6LQ9ZDVDPSOL¿HGRQ%+.FHOOVDQGWLWUDWHGRQ&(.
cells.
Immunohistochemistry
Vero cells were cultured on 8 well Lab-Tek #1.0 borosilicate coverglasses (Sigma-Aldrich) whereas 
&(.FHOOVZHUHFXOWXUHGLQZHOOFXOWXUHSODWHV%ULHÀ\FHOOVZHUH¿[HGZLWKSDUDIRUPDOGHK\GH
DQGSHUPHDELOL]HGXVLQJ7ULWRQ;LQSKRVSKDWHEXIIHUHGVDOLQH3%66LQ9LQIHFWLRQZDV
GHWHFWHGXVLQJDPRXVHPRQRFORQDODQWLERG\DJDLQVWGV51$(QJOLVK	6FLHQWL¿F&RQVXOWLQJDQG,%9
infection using antibodies against the IBV-nucleocapsid (N) protein (Prionics). Tyr701-phosphorylated 
67$7S67$7ZDVGHWHFWHGXVLQJWKHUDEELWPRQRFORQDO0$7KHUPR6FLHQWL¿FDQGWRWDO
STAT1 was detected using the rabbit polyclonal sc-346 (Santa Cruz Biotechnology). Visualization was 
performed using Alexa-488 or -568 labelled goat-anti-mouse or goat-anti-rabbit antibodies (Invitrogen). 
Antibodies were diluted 1:1000 in PBS supplemented with 5% FBS, except the anti-pSTAT1 which 
was diluted 1:500. Nuclei were stained with 4’,6-diamidino-2-phenylindole (DAPI, 0.5 µg/ml; Sigma). 
Cells were imaged using a Zeiss Primo Vert microscope and Axiovision software. Image overlays and 
cross-sections were made in ImageJ.
Interferon sensitivity assay
&(.')RU9HURFHOOVDWFRQÀXHQF\ZHUHSUHWUHDWHGIRUKRXUVZLWKGLIIHUHQWFRQFHQWUDWLRQV
RIUHFRPELQDQWFKLFNHQ,)1ĮRU,)1ȕSURGXFHGLQ+(.FHOOVRUUHFRPELQDQWKXPDQ,)1ȕ
(CalBioChem). Infection was carried out using different viruses at MOI 0.01 for two hours, after 
which cells were washed and new medium containing the same concentration of interferon was added. 
Supernatants were collected for titration at 18 hours post infection (hpi) (CEK) or 24 hpi (DF-1). 
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ISG54-luciferase reporter assays
9HURRU')FHOOVZHUHVHHGHGDWFRQÀXHQFHLQZHOOSODWHVDQGWUDQVIHFWHGXVLQJ)X*(1(
+'3URPHJDDWDUDWLRRI'1$)X*(1(+'DFFRUGLQJWRPDQXIDFWXUHUV¶VSHFL¿FDWLRQV3HU
well, 100 ng of ISG54-luciferase reporter plasmid (kind gift from David E. Levy (171)) was transfected, 
together with 2 ng pRL-SV40 Renilla plasmid (Promega) to correct for differences in transfection 
HI¿FLHQF\DQGWUDQVFULSWLRQ$WOHDVWKRXUVODWHUFHOOVZHUHLQIHFWHGDQGKSLVWLPXODWHGZLWK
8PO,)1IRUDQDGGLWLRQDOKRXUV)LUHÀ\DQG5HQLOODOXFLIHUDVHDFWLYLWLHVZHUHTXDQWL¿HGXVLQJWKH
Dual-Glo Luciferase Assay (Promega) and a Filtermax F5 luminometer (Molecular Devices). 
Western Blot
9HURFHOOVLQZHOOSODWHVDWFRQÀXHQF\ZHUHLQIHFWHGZLWK,%9%HDX5DW02,$WKSLFHOOV
ZHUHVWLPXODWHGZLWKKXPDQ,)1ȕ8POIRUPLQDQGVXEVHTXHQWO\O\VHGLQO\VLVEXIIHU
P07ULVP01D&/P0('7$7ULWRQ;DQGP0306)S+6DPSOHVZHUH
ERLOHGIRUPLQXWHVLQ/DHPPOLORDGLQJEXIIHUFODUL¿HGE\FHQWULIXJDWLRQDW[g for 5 min and 
separated on a 10% SDS-PAGE gel. Proteins were transferred onto a Whatman Protran nitrocellulose 
membrane (GE Healthcare) by semi-dry blotting (Trans-Blot SD Semi-Dry Transfer Cell, Bio-Rad). 
Blotted membranes were blocked overnight in 5% non-fat dry milk (w/v) in TBS/Tween (20 mM Tris, 
500 mM NaCl, 0.05% Tween-20 (v/v), pH 8.0) at 4 °C. The blotted membranes were incubated with 
primary antibodies (rabbit anti-STAT1 sc-346, Santa Cruz Biotechnology 1:1000; rabbit anti-pSTAT1 
0$7KHUPR6FLHQWL¿F UDEELWDQWLȕWXEXOLQ$EFDP$E LQQRQIDW
dry milk in TBS/Tween for 1 h at 37 °C followed by incubation with a goat-anti-rabbit-HRP antibody 
(Bio-Rad) at a 1:1000 dilution in the same buffer for 1 h at 37 °C. Chemiluminescence of bound anti-
rabbit-HRP antibody was detected with WesternBright ECL (Advansta) and visualized using Lumni-
¿OP5RFKH
Statistics
6WDWLVWLFDODQDO\VHVZHUHSHUIRUPHGLQ*UDSK3DG3ULVPRU,%06366(TXDOLW\RIYDULDQFHZDV
DVVHVVHGXVLQJ%DUWOHWW¶VWHVW6LJQL¿FDQWGLIIHUHQFHVZHUHGHWHUPLQHGE\DRQHZD\$129$IROORZHG
by a Bonferroni post-hoc test or by a two-way ANOVA when indicated. 
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RESULTS
IBV is relatively resistant to treatment with type I IFN 
To test resistance of IBV to type I IFN, we treated primary chicken embryo kidney cells with recombinant 
FKLFNHQ ,)1 DQG VXEVHTXHQWO\ LQIHFWHG WKHPZLWK ,%9%HDX5 RU ZLWK WKH ,)1VHQVLWLYH 6LQGELV
YLUXV DV FRQWURO ,PPXQRÀXRUHVFHQFH VWDLQLQJ LQGLFDWHG WKDW SURSDJDWLRQ RI ,%9ZDV OHVV DIIHFWHG
by treatment with IFNĮ and IFNȕ than propagation of the IFN-sensitive Sindbis virus (Fig. 1A). To 
investigate the kinetics of IBV resistance to IFN, we treated CEK cells with increasing concentrations 
RI,)1ĮDQG,)1ȕDQGGHWHUPLQHGWKHHIIHFWRQSURSDJDWLRQE\WLWUDWLRQRI%HDX5)LJ%7KHWLWUH
of Beau-R decreased in a dose-dependent manner and the effect of IFNȕ on the titre of Beau-R was 
PRUHSURQRXQFHGWKDQWKDWRI,)1Į6LPLODUWRRWKHUFRURQDYLUXVHVUHODWLYHO\KLJKFRQFHQWUDWLRQVRI
,)1!8POZHUHUHTXLUHGWRKLQGHUSURSDJDWLRQRI,%9%HDX5ZKLFKVXJJHVWHGWKDW,%9OLNH
other coronaviruses, is relatively resistant to IFN and raised the possibility that IBV actively counteracts 
the type I IFN response.
Accessory proteins 3a and 3b contribute to IFN resistance 
For coronaviruses other than IBV, the accessory proteins have been implicated in counteracting the type 
I IFN response. To investigate whether the accessory proteins of IBV contribute to resistance to IFN, 
we stimulated CEK cells with a high concentration of IFN, and infected them with 3a/3b and 5a/5b null 
viruses (scAUG3a/3b and scAUG5a/5b). These viruses do not express the indicated accessory proteins 
owing to a mutation in the AUG start codon. IFN treatment reduced titres of scAUG3a/3b more than 
either scAUG5a/5b or the parental Beau-R virus (Fig. 1C), suggesting that 3a/3b null virus is more 
sensitive to treatment with IFN. To further investigate IFN-sensitivity of 3a/3b null virus, we stimulated 
') FHOOV ZLWK LQFUHDVLQJ FRQFHQWUDWLRQV RI ,)1Į RU ,)1ȕ )LJ ' DQG ($JDLQ VF$8*DE
ZDVPRUHVHQVLWLYHWRWUHDWPHQWZLWKHLWKHU,)1ĮRU,)1ȕWKDQVF$8*DERUWKHSDUHQWDO%HDX5
indicating that accessory proteins 3a and 3b could play an important role in conferring resistance of 
IBV to treatment with type I IFN.
Fig. 1  Accessory proteins 3a/3b confer resistance to treatment of IBV with type I IFN `
&HOOVZHUHSUHVWLPXODWHGZLWK WKH LQGLFDWHG FRQFHQWUDWLRQRI ,)1ĮRU ,)1ȕ IRUK DQG VXEVHTXHQWO\ LQIHFWHG
with the indicated viruses at MOI 0.01. At 2 hpi cells were washed and IFN-containing medium was added. 
(A &(. FHOOV ZHUH LQIHFWHG ZLWK 6LQGELV YLUXV 6LQ9 RU ,%9 %HDX5$W  KSL FHOOV ZHUH ¿[HG DQG
stained for dsRNA (red) or IBV-N (green). (B) CEK cells were infected with Beau-R in the presence of 
the indicated concentrations of IFN. Virus titers at 18 hpi are expressed relative to the titres measured 
in mock-treated, IBV-infected cells. Symbols indicate the means of triplicate measurements from two 
LQGHSHQGHQW H[SHULPHQWV DQG HUURU EDUV LQGLFDWH VWDQGDUG HUURU RI WKH PHDQ 6(0 $VWHULVN  LQGLFDWHV
VLJQL¿FDQW GLIIHUHQFHV 3   EHWZHHQ ,)1Į DQG ,)1ȕ WUHDWPHQW DV DVVHVVHG E\ D WZRZD\ $129$ 
(C) CEK cells were IFN-treated, virus-infected and sampled as described in (B), using Beau-R and accessory 
protein-null viruses in the presence of 10,000 U/ml of IFN. Symbols indicate the means (± SEM) of triplicate 
PHDVXUHPHQWV IURP WZR LQGHSHQGHQW H[SHULPHQWV $VWHULVN  LQGLFDWHV VLJQL¿FDQW GLIIHUHQFH 3  
compared to the parental virus as assessed by one-way ANOVA followed by a Bonferroni post-hoc test. 
(D and E) DF-1 cells were IFN-treated and virus-infected as described in (B). Virus titers at 24 hpi are expressed 
relative to titres measured in mock-treated, IBV-infected cells. Symbols indicate the mean (± SEM) of triplicate 
ZHOOVIURPDUHSUHVHQWDWLYHH[SHULPHQWRIWZRELRORJLFDOUHSOLFDWHV$VWHULVNLQGLFDWHVVLJQL¿FDQWGLIIHUHQFH3
0.01) between the 3a/b null virus and the other viruses as assessed by two-way ANOVA. 
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Fig. 2  IBV prevents translocation of STAT1 and IFN signaling at late stages of infection
(A) Vero cells were infected with IBV-Beau-R (MOI 1 for 6 h and MOI 0.1 for 18h) and at 6 or 18 hpi cells were 
VWLPXODWHGZLWK8PO,)1ȕIRUPLQEHIRUH¿[DWLRQDQGVWDLQLQJIRU,%91DQG67$7:KLWHDUURZKHDGV
indicate nuclear accumulation of STAT1, black arrowheads indicate absence of STAT1 accumulation in the nucleus. 
(B ,Q ,)1ȕWUHDWHG ZHOOV WKH SHUFHQWDJH RI QXFOHL VKRZLQJ WUDQVORFDWLRQ RI 67$7 ZDV GHWHUPLQHG LQ QRQ
infected (non-inf.) cells and in IBV-infected cells at the indicated time-points. Each bar indicates the mean 
percentage of nuclei showing translocation of STAT1 as determined in 50 - 400 cells from multiple images 
of a representative experiment of two biological replicates. Error bars indicate standard deviation (SD). 
(C')FHOOVZHUHWUDQVIHFWHGZLWKDQ,6*)LUHÀ\OXFLIHUDVHFRQVWUXFWDQGKRXUVODWHULQIHFWHGZLWK%HDX5
RU6LQ902,DQGUHVSHFWLYHO\DWRUKSLFHOOVZHUHVWLPXODWHGZLWK8PO,)1ȕIRUDQDGGLWLRQDO
K)LUHÀ\DQG5HQLOODOXFLIHUDVHDFWLYLW\ZDVTXDQWL¿HGDQG,6*SURPRWRUDFWLYLW\DWDQGKSLZDVFDOFXODWHG
DVSHUFHQWDJHUHODWLYHWRGXSOLFDWHZHOOVQRWWUHDWHGZLWK,)1ȕ)LUHÀ\OXFLIHUDVHYDOXHVZHUHQRUPDOLVHGWR69
5HQLOOD OXFLIHUDVH WR FRUUHFW IRU GLIIHUHQFHV LQ WUDQVIHFWLRQ HI¿FLHQF\ DQG SURWHLQ WUDQVODWLRQ %DUV LQGLFDWH WKH
PHDQ6'RIWULSOLFDWHZHOOVIURPDUHSUHVHQWDWLYHH[DPSOHRIWKUHHELRORJLFDOUHSOLFDWHV$VWHULVNVLQGLFDWH
VLJQL¿FDQWGLIIHUHQFHV3ZLWKUHVSHFWWRQRQLQIHFWHGFHOOVDVDVVHVVHGE\RQHZD\$129$IROORZHGE\
a Bonferroni post-hoc test.
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IBV prevents IFN signaling late during infection
Next, we wanted to investigate how accessory proteins 3a and 3b contribute to IFN resistance. One 
possibility is that IBV 3a/3b interfere with signaling of IFN, in a similar way to accessory protein ORF6 
of SARS-CoV which was shown to block IFN signaling through inhibition of nuclear translocation of 
STAT1 (108). To investigate whether also IBV is able to inhibit nuclear translocation of STAT1, we 
used Vero cells, as commercially available STAT1 antibodies did not detect chicken STAT1. Vero cells 
were infected with IBV and translocation of STAT1 was induced at 6 and 18 hpi by stimulation with 
,)1ȕ/RFDOLVDWLRQRI67$7LQWKHQXFOHXVRI,%9LQIHFWHGFHOOVZDVYLVXDOLVHGE\LPPXQRVWDLQLQJ
DJDLQVW,%91UHGDQG67$7JUHHQ)LJ$,QPRFNWUHDWHGFHOOVQRVWLPXODWLRQZLWK,)1ȕ
nuclear translocation of STAT1 was not visible, neither in infected nor in non-infected cells (black 
arrowheads), indicating that IBV infection alone does not induce translocation of STAT1. At 6 hpi IBV 
GLGQRWSUHYHQW,)1ȕLQGXFHGWUDQVORFDWLRQRI67$7ZKLWHDUURZKHDGV$WKSLKRZHYHU,)1ȕ
induced translocation of STAT1 was strongly reduced in IBV-infected cells (Fig 2A, bottom row of 
images). This indicated that IBV-mediated inhibition of STAT1 translocation is a time-dependent event. 
        To substantiate the observed time-dependency of IBV-mediated inhibition of STAT1 translocation, 
ZHTXDQWL¿HG WUDQVORFDWLRQRI67$7 LQERWK LQIHFWHGDQGQRQLQIHFWHG ,)1ȕWUHDWHGFHOOV ,QQRQ
LQIHFWHGFHOOVWUHDWPHQWZLWK,)1ȕOHGWRWUDQVORFDWLRQRI67$7LQPRUHWKDQRIWKHFHOOV)LJ
2B, striped bar), regardless of time point (6-24 hpi) or presence of neighbouring cells infected with 
IBV (not shown). Translocation of STAT1 in mock-treated cells was comparable between IBV-infected 
DQGQRQLQIHFWHGFHOOVGDWDQRWVKRZQLQGLFDWLQJWKDW,%9DORQHGLGQRWLQGXFHWUDQVORFDWLRQ
RI67$7,QFRQWUDVWLQ,%9LQIHFWHGFHOOVWUHDWPHQWZLWK,)1ȕGLGQRWDOZD\VOHDGWRWUDQVORFDWLRQ
of STAT1. The inhibition seen in IBV-infected cells was time-dependent: at time points between 6 
and 12 hpi translocation of STAT1 was not different from non-infected cells, whereas at later time 
points, between 12-18 hpi onwards, STAT1 translocation was strongly inhibited (Fig. 2B, black bars). 
          To verify whether the observed time-dependency of IBV-mediated inhibition of STAT1 translocation 
would correlate with an inhibition of transcription of ISGs, we used an IFN reporter assay based on 
the human ISG54 promotor, which contains multiple copies of the STAT1-binding interferon-regulated 
regulatory element (ISRE) (171). Indeed, at early time points (12 hpi) we observed only a marginal 
inhibition of luciferase production, whereas at later time points (24 hpi) IBV strongly inhibited the 
IFN-mediated production of luciferase to the same extent as Sindbis virus, a well-known inhibitor of 
STAT signaling (Fig. 2C). We interpret inhibition of luciferase activity as the result of a reduction in 
IFN-mediated ISG54 promoter activity and thus conclude that IBV inhibited the transcription of ISGs 
by inhibiting translocation of STAT1, but only during later stages of infection.
IBV inhibits phosphorylation of STAT1
A crucial step in IFN-induced translocation of STAT1 is its phosphorylation. Only phosphorylated 
STAT1 (pSTAT1) can associate with STAT2 and IRF9 to form the transcription factor ISGF3, which 
binds to ISRE promoter elements. To investigate whether IBV is able to block phosphorylation of 
67$7ZHYLVXDOLVHG,)1ȕLQGXFHGSKRVSKRU\ODWLRQRI67$7LQ,%9LQIHFWHGFHOOVKSLXVLQJ
DS67$7VSHFL¿FDQWLERG\S67$7FRXOGQRWEHGHWHFWHGLQPRFNWUHDWHGFHOOVHYHQZKHQLQIHFWHG
ZLWK,%9)LJ$XSSHUSDQHOOHIW&HOOVWUHDWHGZLWK,)1ȕKRZHYHU)LJ$ORZHUSDQHOVKRZHG
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nuclear translocation of pSTAT1, but only in cells not infected with IBV. In IBV-infected cells, in 
contrast, translocation of pSTAT1 was severely reduced. In addition to reduced levels of nuclear 
pSTAT1 (i.e. reduced translocation), we also observed reduced levels of cytoplasmic pSTAT1 in 
,)1ȕVWLPXODWHGFHOOV LQIHFWHGZLWK,%9)LJ%GHOLQHDWHGDUHD$FURVVVHFWLRQRI,%9LQIHFWHG
DUHDV YHUVXV QRQLQIHFWHG DUHDV FRQ¿UPHG WKH JHQHUDO ODFN RI S67$7 VLJQDO LQ ,%9LQIHFWHG FHOOV
(Fig 3B). To determine whether IBV selectively inhibits phosphorylation of STAT1 rather than 
affecting total STAT1 protein levels, we performed a western blot analysis (Fig. 3C). Levels of total 
STAT1 were comparable between IBV-infected and non-infected monolayers, whereas IFN-mediated 
SKRVSKRU\ODWLRQRI67$7ZDVUHGXFHGLQLQIHFWHGFRPSDUHGWRQRQLQIHFWHGPRQROD\HUVFRQ¿UPLQJ
that IBV prevents phosphorylation of STAT1. In the western blot, we observed a residual signal for 
S67$7LQ,)1ȕVWLPXODWHG,%9LQIHFWHGPRQROD\HUVPRVWOLNHO\GXHWRWKHSUHVHQFHRIQRQLQIHFWHG
cells. Taken together, our data suggest that IBV prevents IFN-induced phosphorylation of STAT1.
IBV accessory proteins are not responsible for inhibition of phosphorylation and 
translocation of STAT1.
The Betacoronavirus SARS-CoV mediates inhibition of STAT1 translocation by its accessory protein 
ORF6 (106, 108). To test whether the IBV accessory proteins are also involved in inhibition of 
phosphorylation and translocation of STAT1, we used 3a/3b and 5a/5b null viruses (scAUG3a/3b and 
scAUG5a/5b) that do not express the indicated accessory proteins owing to a mutation in the AUG 
start codon. First, we investigated nuclear translocation of pSTAT1 in cells infected with 3a/3b and 
5a/5b null virus under circumstances similar to those shown before (see Fig. 3) for the parental Beau-R 
virus. We found that translocation of pSTAT1 was inhibited by both 3a/3b and 5a/5b null viruses in a 
PDQQHUVLPLODUWRWKDWREVHUYHGIRUWKHSDUHQWDOYLUXV)LJ$4XDQWL¿FDWLRQRIWKHSHUFHQWDJHRI
cells showing pSTAT1 in the nucleus substantiated that translocation of pSTAT1 to the nucleus was 
inhibited to the same extent by 3a/3b null, 5a/5b null and the parental IBV Beau-R virus (Fig. 4B). 
     Second, we investigated whether the accessory proteins of IBV are involved in inhibition of STAT1 
phosphorylation. Western blot analysis indicated that wild-type Beau-R had a more pronounced 
inhibitory effect on STAT1 phosphorylation than the 5a/5b null virus, whereas the inhibitory effect on 
pSTAT1 of the 3a/3b null virus was intermediate (Fig. 4C). To verify the results of the western blot 
analysis, we performed immunostaining which indicated that the parental Beau-R virus and the 3a/3b 
and 5a/5b null viruses, all reduced STAT1 phophorylation to the same extent (Fig. 4D). To examine 
the apparent discrepancy between the western blot analysis and the immunostaining, we investigated 
WKHHI¿FLHQF\RIUHSOLFDWLRQRI%HDX5YHUVXVDEDQGDEQXOOYLUXVHVLQ9HURFHOOV7RGRVRZH
TXDQWL¿HGWKHSHUFHQWDJHRILQIHFWHGFHOOVLQPLFURVFRSLFLPDJHV)LJ(LQSDUDOOHOWRTXDQWL¿FDWLRQ
of virus titre in supernatants of infected cells (Fig 4F). These experiments indicated that replication of 
the 5a/5b null virus was lower than that of either Beau-R or 3a/3b null, which is in agreement with a 
previous report showing that replication of 5a/5b null is reduced in Vero, but not in CEK cells (172). 
Reduced replication of 5a/5b null virus in Vero cells provides an explanation for its reduced inhibitory 
effect on IFN-mediated phosphorylation of STAT1 in the western blot analysis. In short, we conclude 
that it is likely that phosporylation of pSTAT1 is inhibited to the same extent by 3a/3b null, 5a/5b null 
and the parental Beau-R virus.
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Fig. 3  IBV prevents translocation and phosphorylation of STAT1
9HURFHOOVZHUHLQIHFWHGIRUKZLWK,%9%HDX502,DQGVXEVHTXHQWO\VWLPXODWHGZLWK8PO,)1ȕ
IRUPLQEHIRUH¿[DWLRQDQGVWDLQLQJIRU,%91DQGS67$7:KLWHDUURZKHDGVLQGLFDWHWUDQVORFDWLRQRIS67$7
black arrowheads indicate absence of pSTAT1 from the nucleus. (B) to verify the overal decrease of pSTAT1, an 
DUHDFRQWDLQLQJ,%9LQIHFWHGFHOOVZLWKLQDQ,)1ȕVWLPXODWHGPRQROD\HULVGHOLQHDWHGE\DGRWWHGOLQHLQWKHWRS
OHIWSDQHODQGRYHUOD\HGRQWKHERWWRPOHIWSDQHO&URVVVHFWLRQÀXRUHVFHQFHLQWHQVLW\SORWRIS67$7DQG,%91
along the yellow line indicated in the top right panel of (B). (C) westernblot analysis of non-infected (non-inf.) and 
,%9LQIHFWHGPRQROD\HUVWKDWZHUHHLWKHUPRFNRU,)1ȕWUHDWHGDVGHVFULEHGLQ$6WDLQLQJZDVSHUIRUPHGXVLQJ
DQWLERGLHVDJDLQVW67$7DQG7\USKRVSKRU\ODWHG67$76WDLQLQJDJDLQVWȕ7XEXOLQZDVLQFOXGHGDVDORDGLQJ
control.
      Third, we investigated to which extent the null viruses would inhibit IFN-mediated activation of 
the ISG54 promoter and found no differences between the null viruses and wild-type Beau-R, in both 
Vero and DF-1 cells (Fig. 4G). Taken together, our data indicate that the inhibition of phosphorylation 
and translocation of STAT1 and activation of ISG54 promoter, observed after infection with IBV, is 
independent of the accessory proteins 3a, 3b, 5a and 5b.
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Fig. 4  IBV accessory proteins are not required for inhibition of translocation of pSTAT1 and ISG promotor 
activation
(A) Vero cells were infected with Beau-R, 3a/3b or 5a/5b null viruses (MOI of 0.1) and at 18 hpi, stimulated 
ZLWK8PO ,)1ȕIRUPLQDQGVWDLQHGIRU ,%91DQGS67$7:KLWHDUURZKHDGV LQGLFDWH WUDQVORFDWLRQ
of pSTAT1, black arrowheads indicate absence of accumulation of pSTAT1 in the nucleus. (B) In parallel, we 
determined the percentage of nuclei showing translocation of pSTAT1 in the wells treated as described in (A). Each 
bar indicates the mean (+ SD) percentage of nuclei showing translocation based on 100 - 300 cells from multiple 
LPDJHVRIDUHSUHVHQWDWLYHH[SHULPHQWRIWZRELRORJLFDOUHSOLFDWHV$VWHULVNVLQGLFDWHVLJQL¿FDQWGLIIHUHQFHV3
0.01) with respect to non-infected cells, as assessed by one-way ANOVA followed by a Bonferroni post-hoc test. (C) 
:HVWHUQEORWDQDO\VLVRI,%9LQIHFWHGDQGQRQLQIHFWHG9HURFHOOVWKDWZHUHHLWKHUPRFNRU,)1ȕWUHDWHG6WDLQLQJ
ZDVSHUIRUPHGXVLQJDQDQWLERG\DJDLQVW7\USKRVSKRU\ODWHG67$7DQGDQDQWLERG\DJDLQVWȕWXEXOLQZDV
used as loading control. (D) Vero cells were infected with the indicated viruses (MOI 0.1) and at 18 hpi, stimulated 
ZLWK8PO,)1ȕIRUPLQDQGVWDLQHGIRU,%91DQGS67$77KHDUHDGHOLQHDWHGE\WKH\HOORZGRWWHGOLQH
indicates the overall decrease in pSTAT1 staining in IBV-infected cells. (E4XDQWL¿FDWLRQRIWKHSHUFHQWDJHRI,%9
infected cells in microscopic images of cells infected with the indicated viruses at MOI 0.1 and stained using IBV-
1VSHFL¿FDQWLERG\DWKSL)RUHDFKYLUXVDWOHDVWFHOOVGHYLGHGRYHUPLFURVFRSLF¿HOGVZHUHDQDO\VHG
(F) Virus titres in supernatants from Vero cells infected for 18 h with the indicated viruses at MOI 0.01. (G) Vero 
DQG')FHOOVZHUHWUDQVIHFWHGZLWKDQ,6*)LUHÀ\OXFLIHUDVHFRQVWUXFWDQGKODWHULQIHFWHGZLWK%HDX5
DERUDEQXOOYLUXVHVDWYDULRXV02,$WKSLFHOOVZHUHVWLPXODWHGZLWK8PO,)1ȕIRU
DQDGGLWLRQDOK$IWHUDWRWDORIK)LUHÀ\DQG5HQLOODOXFLIHUDVHDFWLYLW\ZDVTXDQWL¿HGDQG,6*SURPRWRU
DFWLYLW\FDOFXODWHGDVSHUFHQWDJHUHODWLYHWRGXSOLFDWHZHOOVQRW WUHDWHGZLWK,)1ȕ)LUHÀ\OXFLIHUDVHYDOXHVZHUH
QRUPDOLVHGWR695HQLOODOXFLIHUDVHWRFRUUHFWIRUGLIIHUHQFHVLQWUDQVIHFWLRQHI¿FLHQF\DQGSURWHLQWUDQVODWLRQ
Bars indicate the mean (+ SD) of triplicate wells of a representative example of n=3 biological replicates.
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DISCUSSION
In this study we investigated the in vitro sensitivity of the Gammacoronavirus IBV to treatment with IFN, 
and the potential role of IBV accessory proteins in conferring resistance to the host’s type I IFN response. 
We found IBV to be relatively resistant to treatment with IFN and showed that simultaneous knockout of 
the accessory proteins 3a and 3b decreased resistance of IBV to treatment with IFN. Independent of the 
counteracting activity of 3a and 3b on the IFN response we found that IBV interferes with IFN signaling by 
inhibition of phosphorylation and nuclear translocation of STAT1. In summary, this study demonstrates 
that the Gammacoronavirus IBV has evolved multiple strategies to antagonise the innate immune response. 
    The coronaviruses MHV, SARS-CoV, MERS-CoV and IBV have all been shown to induce 
modest and delayed transcription of ,IQȕ (91, 158). Alpha- and Betacoronaviruses (not Gamma- 
and Deltacoronaviruses) encode the nsp1 protein that decreases transcription of ,IQȕ and inhibits 
synthesis of host proteins thereby further reducing production of IFN (64, 119, 120, 167, 173). The 
observation that coronaviruses employ multiple strategies to limit production of IFN seems to suggest 
that IFN could be detrimental to the propagation of coronaviruses. However, treatment of both MHV 
and Feline coronavirus (FcoV) with IFN (1000 U) reduces their propagation by approximately 
1 log only, indicating that these viruses are relatively resistant to IFN (93, 102). In comparison, 
SARS-CoV is at least 10 times more sensitive (103-105), and MERS-CoV even 1000 times more 
sensitive to IFN treatment than MHV (106, 107). We found that propagation of IBV was reduced 
by 0.5-2.5 log upon treatment with IFN (1000 U) suggesting that IBV is relatively resistant to IFN. 
      Compared to MHV and FCoV, SARS-CoV is relatively sensitive to IFN treatment. However, 
MERS-CoV is 50 to 100 times more sensitive than SARS-CoV (106, 107). The difference in sensitivity 
between the latter two viruses has been ascribed to the ability of SARS-CoV to inhibit nuclear 
translocation of pSTAT1 (106). Considering the relative resistance of IBV to treatment with IFN we 
investigated whether IBV, similar to SARS-CoV, would inhibit nuclear translocation of pSTAT1. We 
observed that at time points earlier than 18 hpi, IBV did not inhibit nuclear translocation of pSTAT1 or 
activation of a STAT1-responsive promoter (ISG54). In contrast, from 18 hpi onwards, IBV inhibited 
both IFN-mediated pSTAT1 translocation and activation of the ISG54-promoter. Of interest, SARS-
CoV has been shown to inhibit STAT1 translocation as early as 8 hpi, whereas MERS-CoV did not 
inhibit STAT1 translocation (106). In another study, MHV did not inhibit IFN-mediated translocation 
of STAT1-GFP at 9 hpi, but inhibited IFN-mediated ISG expression at 11 hpi and rescued Sendai 
YLUXV 6H9 IURP WKH DQWLYLUDO HIIHFWV RI ,)1ȕZKHQ0+9ZDV SUHVHQW SULRU WR6H9 LQIHFWLRQ DQG
for a total period of 16 h (88). Our data indicate a time-dependent inhibition of IFN signaling by 
IBV, a phenomenon that has not been reported for other coronaviruses, although it cannot be excluded 
that for the Betacoronaviruses MHV and possibly MERS-CoV, inhibition of pSTAT1 translocation 
could be a relatively late event similar to what we observed for the Gammacoronavirus IBV. 
    For SARS-CoV, it has been shown that accessory protein ORF6 is responsible for blocking 
nuclear translocation of STAT1 by tethering nuclear import factors at the ER/Golgi membrane, 
inhibiting expression of STAT1-activated genes (19, 98, 108). In the present study we showed 
that IBV inhibits phosphorylation of STAT1 and that, in contrast to SARS-CoV, the presence of 
DFFHVVRU\ SURWHLQV RI ,%9ZDV QRW UHTXLUHG IRU LQKLELWLRQ RI 67$7PHGLDWHG VLJQDOLQJ 2XU GDWD
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suggest that IBV and SARS-CoV may exploit different strategies to inhibit translocation of STAT1. 
7DNLQJWRJHWKHUWKHDELOLW\RI,%9WRVLJQL¿FDQWO\GHOD\WUDQVFULSWLRQRI,IQȕ up until 12-18 hpi and 
GHOD\VXEVHTXHQWWUDQVODWLRQRI,)1XQWLOKSLDQGWKHLQKLELWLRQRIS67$7WUDQVORFDWLRQDW
times points >18 hpi, we suggest there could be a correlation between the timing of ,IQȕ transcription 
by the host cell and inhibition of IFN signaling induced by IBV. Although there is no proof of causality, 
we hypothesize that changes in the host cell trigger the relocation of, or conformational changes in IBV 
proteins, which in turn activate their anti-IFN activity. Further research is needed to verify this hypothesis. 
     In general, coronavirus accessory proteins can antagonise the IFN response at various steps. For 
example, proteins 4a and 4b of MERS and 3b of SARS inhibit activation of ,IQȕ (19, 100, 101), 
whereas protein 7 of TGEV and 3b of IBV inhibit transcription and translation of Ifnȕ (15, 16, 167). 
Notwithstanding these and other steps to counteract and/or avoid activation of the IFN response (reviewed 
in (155)). Accessory proteins not only inhibit activation of the IFN response, but they also antagonise 
the antiviral effect of IFN. ORF6 of SARS-CoV inhibits IFN-signaling by blocking translocation of 
STAT1 (108), ns2 of MHV inhibits the IFN-activated OAS-RNase L antiviral pathway (109) and 5a of 
MHV and 7a of FCoV also confer resistance to IFN treatment but via presently unknown mechanisms 
(112, 113). Using IBV accessory protein null viruses, here we showed that simultaneous knockout of 
protein 3a and 3b rendered IBV more sensitive to IFN treatment. In a previous study we found that 3a 
and 3b decrease transcription of ,IQȕ and modulate production of IFN protein (167). The mechanism 
by which accessory proteins 3a and 3b confer resistance to IFN treatment remains unclear although, 
in the present study, we could show that 3a and 3b do not interfere with STAT1-mediated signaling. 
              To explain the role of 3a and 3b in counteracting the type I IFN response, we hypothesise that 
these two accessory proteins interact with host-proteins involved in both the induction of ,IQȕ and the 
IFN-induced antiviral response. Host proteins that meet these criteria are, for example, the dsRNA-
activated antiviral proteins PKR and OAS, the latter of which was also shown to be involved in the 
antiviral response against MHV
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ABSTRACT
We previously showed that infectious bronchitis virus (IBV, genus Gammacoronavirus) induces 
both ,IQȕ transcription and IFN protein production in chicken cells albeit substantially delayed with 
respect to the peak of viral replication. Other studies have proven the intrinsic ability of chicken cells 
WRUHVSRQGZLWKSURGXFWLRQRIKLJKOHYHOVRI,)1SURWHLQWRGV51$RULQÀXHQ]DYLUXVLQIHFWLRQEXW
we consistently observed low-to-negligible amounts of IFN upon IBV infection. We also previously 
VKRZHGWKDWYHU\KLJKGRVHVRI,)1DUHUHTXLUHGWRHIIHFWLYHO\KLQGHU,%9UHSOLFDWLRQ$OO WRJHWKHU
the late kinetics of IFN production, the low amount of IFN produced in response to IBV and the 
KLJKGRVHVRI,)1UHTXLUHGWRKLQGHUYLUDO UHSOLFDWLRQVXJJHVW WKDW,%9KDVGHYLVHGPHFKDQLVPVWR
inhibit IFN production by chicken cells. In the present study we investigate whether the ability of 
IBV to delay transcription and limit protein production is restricted to type I IFN only, or whether 
IBV, similarly to Alpha- and Betacoronaviruses, adopted a strategy based on a more general inhibition 
of translation of host-cell proteins. Many viruses in fact, inhibit translation of host-cell proteins, a 
process commonly referred to as “host shutoff”. In Alpha- and Betacoronaviruses, non-structural 
protein 1 (nsp1) is responsible for virus-induced host shutoff. Gamma- and Deltacoronaviruses, 
however, lack nsp1 and it has remained unclear whether and how these viruses inhibit translation of 
KRVWFHOOSURWHLQV+HUHZHFRQ¿UPWKDWDOVR,%9LQGXFHVKRVWVKXWRIIDQGXVLQJYLUXVHVPXWDQWIRUWKH
accessory proteins of IBV, we show that accessory protein 5b contributes to this process by inhibiting 
translation of host proteins, including translation of type I IFN. Taken together, our data identify the 
accessory protein 5b of IBV GammacoronavirusDVWKHSRWHQWLDOIXQFWLRQDOHTXLYDOHQWRIQVSIRXQGLQ
Alpha- and Betacoronaviruses2XU¿QGLQJVVXJJHVWWKDWLQKLELWLRQRIWUDQVODWLRQRIKRVWFHOOSURWHLQV
is an evolutionarily conserved defense mechanism found in most if not all coronaviruses. This study 
increases our understanding of innate immune evasion by IBV and provides a novel target for the 
development of improved vaccines against this important pathogen.
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INTRODUCTION
The type I IFN (IFN) response is essential for clearance of coronavirus infections in vivo (64, 83, 
84), whereas coronaviruses have evolved multiple mechanisms to delay and antagonise the antiviral 
response (114). Previously (Chapter 2, this thesis), we demonstrated that in chicken cells infected 
with the Gammacoronavirus IBV, transcription of Ifnȕ mRNA and translation of IFN is substantially 
delayed with respect to the peak of viral replication (176). In the same study we reported that the 
accessory proteins 3a and 3b both play a role in the inhibition of ,IQȕ transcription while having 
opposing effect on ,IQȕ translation; infection with a 3b null virus resulted in increased IFN production 
whereas infection with a 3a null virus resulted in reduced IFN levels compared to the wild type virus, 
suggesting that accessory proteins 3a and 3b antagonise each other’s effects to tightly regulate IFN 
production. In other studies where researchers used the same reporter assay as used by us in our studies 
WR TXDQWLI\ ,)1SURWHLQ SURGXFWLRQ SURGXFWLRQRI KLJK OHYHOV XS WR XQLWVPO RI ,)1ZHUH
reported for chicken cells when stimulated in vitro with dsRNA analogues (79) or in vivo when infected 
ZLWK KLJKO\ SDWKRJHQLF DYLDQ LQÀXHQ]D YLUXVHV  7KH REVHUYDWLRQ WKDW ,%9 GHOD\V DFWLYDWLRQ
of the IFN response and limits production of IFN, prompted us to investigate to what extent IBV is 
affected by treatment with IFN. We showed that IBV, compared to the IFN-sensitive Sindbis virus, is 
UHODWLYHO\UHVLVWDQWWRWUHDWPHQWZLWKHLWKHU,)1ĮRU,)1ȕFKDSWHUWKLVWKHVLV,QIDFWKLJKGRVHV
RI,)1SURWHLQWRXQLWVPOZHUHUHTXLUHGWRUHGXFHUHSOLFDWLRQRI,%9E\ORJV7KH
discrepancy between the amount of IFN protein produced during IBV infection (150-1000 units/ml, 
DQGWKHDPRXQWRI,)1UHTXLUHGWRLQKLELWYLUDOUHSOLFDWLRQFRPELQHGZLWKWKHGHOD\HGNLQHWLFVRI
IFN production, suggests that IBV must have developed mechanisms to limit IFN protein production. 
     Whether the effects observed on gene transcription and translation during IBV infection are 
restricted to the regulation of type I IFN only, or whether IBV has adopted a broader strategy based 
on general inhibition of host-protein translation is currently unknown. For example, Alpha- and 
Betacoronaviruses antagonise the overall antiviral response of their host cells through inhibition of 
host-protein translation, including that of type I IFN, a mechanism mediated by their nsp1 protein and 
best known as “host shutoff”. For example, Betacoronaviruses such as mouse hepatitis virus (MHV), 
severe acute respiratory syndrome coronavirus (SARS-CoV) and several bat coronaviruses all inhibit 
translation of host-cell proteins via a mechanism mediated by nsp1 (115-117); inducing degradation of 
host, but not viral mRNA (116, 118, 119). In contrast, transmissible gastroenteritis coronavirus (TGEV, 
genus Alphacoronavirus) and several bat Betacoronaviruses inhibit translation of host-cell proteins via 
a mechanism mediated by nsp1, that does not seem to involve degradation of host mRNA (117, 120). 
In contrast to Alpha- and Betacoronaviruses, the genome of Gamma- and Deltacoronaviruses is devoid 
RIDQVSKRPRORJXHUDLVLQJWKHTXHVWLRQZKHWKHUWKHVHYLUXVHVKDYHHYROYHGDOWHUQDWLYH
strategies to inhibit translation of host mRNA, including inhibition of type I IFN. The few studies 
performed on IBV have remained inconclusive; Wang et al.VXJJHVWHGWKDW,%9GRHVQRWVLJQL¿FDQWO\
inhibit translation of host proteins as assessed by metabolic labelling (111), but also reported that the 
VSLNHSURWHLQRI,%9GHFUHDVHVKRVWWUDQVODWLRQWKURXJKLQWHUDFWLRQZLWKH,))7KHVHFRQÀLFWLQJ
data, combined with our previous work on the kinetics of IBV infection and type I IFN response, left 
XQDQVZHUHGWKHTXHVWLRQZKHWKHURUQRW,%9LQKLELWVWUDQVODWLRQRIKRVWFHOOSURWHLQVLQJHQHUDORURI
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IFN in particular. In the present study, we show that IBV does indeed inhibit translation of host-cell 
proteins in general, including type I interferon, and we present evidence that accessory protein 5b is, 
at least partly, responsible for this process of IBV-induced host shutoff. Taken together, our results 
VXJJHVW WKDW*DPPDFRURQDYLUXVDFFHVVRU\SURWHLQEPD\EH IXQFWLRQDOO\HTXLYDOHQW WR$OSKDDQG
Betacoronaviruses nsp1. As such, this study closes a gap in the understanding of Gammacoronaviruses 
and shows that evolutionarily-distant coronaviruses use similar strategies to ensure their survival.
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MATERIALS AND METHODS
Cells 
Chicken embryonic kidneys (CEK) were aseptically removed from 17- to 19-day-old chicken 
embryos (Charles River, SPAFAS). A cell suspension was obtained by trypsinisation for 30 min at 
 & DQG¿OWHUHG WKURXJK D ȝPPHVK7KH UHVXOWLQJ&(.FHOOVZHUH VHHGHG DW  [ 5 cells/
cm2 in a 1:1 mix of 199 and F10 medium (Invitrogen) supplemented with 0.5% fetal bovine serum 
(FBS, SAFC) and 1% penicillin-streptomycin (PenStrep; Gibco, Invitrogen). DF-1 chicken 
¿EUREODVW FHOOV WKH$IULFDQ JUHHQ PRQNH\ 9HUR FHOOV EDE\ KDPVWHU NLGQH\ %+. FHOOV DQG WKH
chIFN-reporter CEC-32 cells were cultured in DMEM (Gibco, Invitrogen) supplemented with 10% 
)%6 DQG 3HQ6WUHS$OO FHOOVZHUH LQFXEDWHG LQ D KXPLGL¿HG LQFXEDWRU DW  & DQG &2 
Viruses 
,%90,%94;DQG,%9,WDO\25LIW9DOOH\)HYHU9LUXVFORQH59)9&OZHUHREWDLQHG
IURP0HUFN$QLPDO+HDOWK%R[PHHU7KH1HWKHUODQGV,%90,%94;DQG,%9,WDO\2ZHUH
adapted to propagation in CEK-cells by serial passaging. Sindbis virus (SinV) was a kind gift from dr 
G. Pijlman, (Laboratory of Virology, Wageningen University). IBV Beaudette, strain Beau-R, as well as 
the generation of the ScAUG3a, ScAUG3b, ScAUG3ab and ScAUG5ab Beau-R null viruses has been 
described previously (21-23). In these mutant IBV viruses, the start codon of the indicated accessory 
JHQHVZDVPXWDWHGWRDVWRSFRGRQ$OO,%9VWUDLQVZHUHDPSOL¿HGDQGWLWUDWHGRQ&(.FHOOV6LQ9ZDV
DPSOL¿HGRQ%+.FHOOVDQGWLWUDWHGRQ&(.FHOOV59)9&OZDVDPSOL¿HGDQGWLWUDWHGRQ9HURFHOOV
cDNA synthesis, RNA isolation and gene expression analysis
Approximately 8 x 105&(.FHOOVZHUHO\VHGLQ5/7EXIIHU4LDJHQDWYDULRXVWLPHSRLQWVDIWHULQIHFWLRQ
RLT cell lysis buffer was spiked with 1 ng/sample of luciferase mRNA (Promega) immediately prior to 
RNA isolation as external reference gene for normalization during the gene expression analysis. Total 
51$ZDVLVRODWHGXVLQJWKH51HDV\0LQL.LW4LDJHQDFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV
LQFOXGLQJDQRQFROXPQ'1DVHWUHDWPHQW4LDJHQ3ULRUWRF'1$V\QWKHVLVDVHFRQG'1DVHWUHDWPHQW
ZDVSHUIRUPHGXVLQJDPSOL¿FDWLRQJUDGH'1DVH,,QYLWURJHQDQGVXEVHTXHQWO\J51$
was used for cDNA synthesis using SuperScript III (Invitrogen) and random hexamer primers. cDNA 
VDPSOHV ZHUH GLOXWHG  LQ QXFOHDVHIUHH ZDWHU EHIRUH UHDOWLPH TXDQWLWDWLYH 3&5 DQDO\VLV RQ D
5RWRU*HQH&RUEHWW5HVHDUFKXVLQJ%ULOOLDQW6<%5*UHHQTXDQWLWDWLYH3&56WUDWDJHQHDQG
SULPHUVDVOLVWHGLQ7DEOH&\FOHWKUHVKROGVDQGDPSOL¿FDWLRQHI¿FLHQFLHVZHUH
calculated using the Rotor-Gene software (version 1.7). The relative expression ratio of the target gene 
ZDVFDOFXODWHGXVLQJWKHDYHUDJHUHDFWLRQHI¿FLHQF\IRUHDFKSULPHUVHWDQGWKHF\FOHWKUHVKROG&t) 
deviation of sample vs. control at time point 0h, as previously described (145). Because expression 
of various housekeeping genes was unstable during virus infections at time points later than 24 hours 
(data not shown), gene-expression ratios were normalised using an external reference gene (luciferase). 
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Table 1 Primers used in this study
Gene product Orientationa Sequence (5’-3’) Accession no. Reference
,IQȕ FW GCTCTCACCACCACCTTCTC NM_001024836
 RV GCTTGCTTCTTGTCCTTGCT   
,IQĮ FW ATCCTGCTGCTCACGCTCCTTCT ;0B 142
 RV GGTGTTGCTGGTGTCCAGGATG   
Irf3 FW CAGTGCTTCTCCAGCACAAA NM_205372
 RV TGCATGTGGTATTGCTCGAT   
Tlr3 FW TCAGTACATTTGTAACACCCCGCC NM_001011691 142
 RV GGCGTCATAATCAAACACTCC   
Mda5 FW TGGAGCTGGGCATCTTTCAG GU570144
 RV GTTCCCACGACTCTCAATAACAGT   
Mx FW TTGTCTGGTGTTGCTCTTCCT *4
 RV GCTGTATTTCTGTGTTGCGGTA   
Oas FW CACGGCCTCTTCTACGACA NM_205041 143
 RV TGGGCCATACGGTGTAGACT   
Il8 FW TTGGAAGCCACTTCAGTCAGAC NM_205498 143
 RV GGAGCAGGAGGAATTACCAGTT   
Pkr FW CCTCTGCTGGCCTTACTGTCA NM_204487 144
 RV AAGAGAGGCAGAAGGAATAATTTGCC   
Adar FW TGTTTGTGATGGCTGTTGAG AF403114
 RV AGATGTGAAGTCCGTGTTG   
Mhc-I FW CTTCATTGCCTTCGACAAAG NM_001031338 143
 RV GCCACTCCACGCAGGT   
Isg20 FW TCTGGAAAGGTGGTGGTT EU602349
RV AAGGGGATTTTGGATGTGT
Caspase 3 FW GTTAGAAACGCAAACCTGA NM_204725
RV TGAAGATACGAAACCAAACCA  
Rpl17 FW TGGATTCTCTGGTGATTGAG ;0B
RV CTTCTTCCTCTGGCTTGG
Gapdh FW CATCACAGCCACACAGAAG NM_204305
RV GGTCAGGTCAACAACAGAGA
(HIĮ FW CTGATTGTGCTGTCCTGATT NM_204157
RV TTCGTATCTCTTCTGGCTGT  
ASFV FW AAAGGAACAATGGACTCTGGTCA AF134508 178
RV CACTTCTTACTACCATGTCCTCCAAT
SinV FW CCCAGGAACCCGCAAGTATG GM893992 179
RV CGTGAGGAAGATTGCGGTTC
IBV-N FW GAAGAAAACCAGTCCCAGA AY851295
 RV TTACCAGCAACCCACAC  
Luciferase S TGTTGGGCGCGTTATTTATC ;
AS AGGCTGCGAAATGTTCATACT   
a FW, forward; RV, reverse
58
IBV 5b inhibits synthesis of host proteins 
4
Chicken type I IFN bioassay. 
Bioactive chicken type I interferon (chIFN) was measured as described previously (180) using a bioassay 
EDVHGRQWKH&(&TXDLOUHSRUWHUFHOOOLQHH[SUHVVLQJOXFLIHUDVHXQGHUWKHFRQWURORIWKHFKLFNHQmx 
SURPRWHUNLQGO\SURYLGHGE\3URI3HWHU6WDHKHOL%ULHÀ\&(&FHOOVZHUHLQFXEDWHGZLWK
VHULDOGLOXWLRQVRIFK,)1FRQWDLQLQJVDPSOHVIRUKRXUVDIWHUZKLFKOXFLIHUDVHDFWLYLW\ZDVTXDQWL¿HG
DQG,)1FRQFHQWUDWLRQVFDOFXODWHGXVLQJDFK,)1VWDQGDUG7RDYRLGLQÀXHQFHRIYLUXVRQWKHDVVD\
VDPSOHVZHUHKHDWLQDFWLYDWHGDW&IRUPLQZKLFKGLGQRWLQÀXHQFHELRDFWLYLW\RIFK,)1
Luciferase activity 
CEK cells (4 x 106) were electroporated using the Amaxa nucleofector II (solution V, program W001), 
DSSO\LQJ  J S*/)LUHÀ\ OXFLIHUDVH UHSRUWHU SODVPLG S*/))OXF 3URPHJD DQG VXEVHTXHQWO\
VHHGHGDWFHOOVZHOOLQZHOOSODWHV9HURDQG')FHOOVDWFRQÀXHQFHLQZHOO
plates were transfected with 100 ng pGL3-FFluc per well using FuGENE HD (Promega) at a 1:3.5 
UDWLRRI'1$)X*(1(DFFRUGLQJWRPDQXIDFWXUHUV¶VSHFL¿FDWLRQV$WKRXUVSRVWWUDQVIHFWLRQFHOOV
were infected at an MOI 10 with IBV-M41 (CEK) or Beau-R (DF-1 and Vero), and 22 hours later 
OXFLIHUDVHDFWLYLW\ZDVTXDQWL¿HGXVLQJWKH%ULJKW*OR/XFLIHUDVH$VVD\3URPHJDDQGD)LOWHUPD[)
luminometer (Molecular Devices). 
Transfection of accessory proteins and cytotoxicity assay
The constructs used for the overexpression of accessory proteins of IBV were generated as 
GHVFULEHG SUHYLRXVO\  %ULHÀ\ WKH RSHQ UHDGLQJ IUDPH 25) RI WKH %HDX5 D E
5a and 5b proteins were cloned in the EcoRI site of the pFLAG-CMV-2 vector (Sigma-
$OGULFK LQ IUDPH ZLWK WKH 1WHUPLQDO )/$* WDJ VHTXHQFH HQFRGHG E\ WKH YHFWRU 
9HURDQG')FHOOVDWFRQÀXHQFHZHUHWUDQVIHFWHGLQZHOOSODWHVDVGHVFULEHGDERYH
using 10 ng pRL-SV40 Renilla luciferase plasmid (Promega) and 90 ng pFLAG-Beau-R 3a/3b/5a/5b or 
S(*)30+9QVSSHUZHOO$WKRXUVSRVWWUDQVIHFWLRQOXFLIHUDVHDFWLYLW\ZDVTXDQWL¿HGXVLQJWKH
Renilla Luciferase Assay (Promega) and a Filtermax F5 luminometer (Molecular Devices). In parallel 
ZHOOVF\WRWR[LFLW\RIDFFHVVRU\SURWHLQVZDVTXDQWL¿HGXVLQJWKH&HOO7LWHUFHOOSUROLIHUDWLRQDVVD\
3URPHJD%ULHÀ\DWKRXUVSRVWWUDQVIHFWLRQȝO$TXHRXVRQHVROXWLRQZDVDGGHGWRHDFKZHOODQG
incubated at 37 °C for 4 hours. Absorbance at 485 nm was measured using a FilterMax F5 luminometer. 
The absorbance value for 0% cell viability was established by incubating non-transfected cells for 15 
PLQXWHVLQ7ULWRQ;%LR5DGLQPHGLXPSULRUWRDGGLWLRQRIWKH$TXHRXVRQHVROXWLRQ7R
visualise expression of Beau-R accessory proteins, the above mentioned Fugene transfection method 
was used to transfect Vero cells, cultured on 8-well Lab-Tek #1.0 borosilicate coverglasses (Sigma-
$OGULFKDWFRQÀXHQFH$WKRXUVSRVWWUDQVIHFWLRQFHOOVZHUH¿[HGZLWKSDUDIRUPDOGHK\GH
DQGSHUPHDELOL]HGXVLQJ7ULWRQ;LQ3%6)/$*WDJJHGDFFHVVRU\SURWHLQVZHUHGHWHFWHG
using anti-FLAG M2 antibody (Sigma-Aldrich) and visualization was performed using Alexa-488 
labelled goat-anti mouse antibody (Invitrogen). Antibodies were diluted 1:1000 in phosphate-buffered 
saline (PBS) supplemented with 5% FBS. Nuclei were stained with 4’,6-diamidino-2-phenylindole 
(DAPI, 0.5 µg/ml, Sigma). Cells were imaged using a Zeiss Primo Vert microscope and Axiovision 
software. Image overlays were obtained in ImageJ.
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RNA stability assay
6WDELOLW\RIKRVWP51$VZDVTXDQWL¿HGE\FRPSDULQJ WKH IROGFKDQJH LQJHQHH[SUHVVLRQEHWZHHQ
LQIHFWHGDQGQRQLQIHFWHGFHOOVDIWHUWUHDWPHQWZLWKȝJPO$FWLQRP\FLQ'$FW'7RWKLVH[WHQW
CEK cells (8 x 105) were seeded in 24-well plates and infected with Beau-R at MOI 10 or mock treated; 
5 hours later ActD was added to all cells and incubation was continued for an additional 6 hours. Before 
(IBV-5h; ActD-0h) and after ActD treatment (IBV-11h; ActD-6h), samples were collected for RNA 
LVRODWLRQF'1$V\QWKHVLVDQG57T3&5)ROGFKDQJHVZHUHFDOFXODWHGUHODWLYHWRWKHVDPSOHVWDNHQ
prior to ActD addition (ActD-0h) and normalised to an external reference gene (luciferase, Promega) 
which was added as mRNA to the RLT cell-lysis buffer.
Radioactive labelling of de-novo translated proteins
Approximately 2 x 105 Vero cells were seeded in 6-well plates and 24 hours later infected with either 
Beau-R or scAUG-3ab, scAUG-5ab, scAUG-5a, scAUG-5b Beau-R null viruses at a MOI of 20. Cell 
O\VDWHVZHUHFROOHFWHGDWDQGKRXUVSRVWLQIHFWLRQ)RUW\¿YHPLQXWHVSULRUWRWKHLQGLFDWHG
WLPH SRLQWV FHOOV ZHUH VWDUYHG LQ 0HW&\V GH¿FLHQW PHGLXP IRU  PLQXWHV DQG LQFXEDWHG ZLWK
35S-trans-label (Amersham) for 15 minutes. Cells were washed three times in phosphate-buffered saline 
(PBS) to wash away free label. Cells were released using trypsin, suspended in complete medium, spun 
down 5 minutes at 300 x g, washed once with PBS and lysed in TEN-L buffer (40 mM Tris-HCl pH 
7.4, 150 mM NaCl, 10 mM EDTA, 1% NP40 and protease inhibitor cocktail [Roche]). Lysates were 
FOHDUHGIRUPLQXWHVDW[JDQGLQFRUSRUDWLRQRIODEHOZDVTXDQWL¿HGXVLQJWKHVFLQWLOODWLRQ
FRXQWHU%HFNPDQ(TXDODPRXQWRIODEHOOHGSURWHLQVEDVHGRQVFLQWLOODWLRQFRXQWVZHUHVHSDUDWHGRQ
DVRGLXPGRGHF\OVXOSKDWHSRO\DFU\ODPLGHJHOHOHFWURSKRUHVLV6'63$*(DQGVXEVHTXHQWO\XVHGIRU
ÀXRURJUDSK\DVSUHYLRXVO\GHVFULEHG)RUTXDQWL¿FDWLRQRISURWHLQWUDQVODWLRQOHYHOVWKHJHOZDV
LPDJHGXVLQJD6WRUP3KRVSKRU,PDJHU0ROHFXODU'\QDPLFVDQGTXDQWL¿FDWLRQZDVSHUIRUPHG
using ImageJ software.
Statistics
6WDWLVWLFDODQDO\VHVZHUHSHUIRUPHGLQ*UDSK3DG3ULVP6LJQL¿FDQWGLIIHUHQFHVZHUHGHWHUPLQHG
using an unpaired t test or a one-way ANOVA followed by a Bonferroni post-hoc test when indicated.
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RESULTS
IBV inhibits production of type I IFN
Although chicken cells are able to produce high levels of IFN protein both in vitro (79) and in vivo (177), 
we showed that infection with IBV, despite the transcription of a considerable amount of ,IQȕ mRNA, 
leads to the production of only low concentrations of IFN (176). Furthermore, we showed (chapter 3, 
WKLVWKHVLVWKDWKLJKFRQFHQWUDWLRQVRI,)1DUHQHHGHGWRVLJQL¿FDQWO\LQKLELW,%9UHSOLFDWLRQLQFKLFNHQ
FHOOV7RDGGUHVVWKHTXHVWLRQDVWRZKHWKHU,%9LQIHFWLRQLQGHHGOLPLWVSURGXFWLRQRI,)1SURWHLQZH
infected chicken cells with IBV and compared ,IQȕ transcription and IFN protein production with that 
of different RNA viruses known to either trigger IFN protein production or actively inhibit host-protein 
translation: as a positive control for IFN production, we used rift valley fever virus clone 13 (RVFV 
Cl13), which has a truncated IFN antagonist (the NSs protein) (182), and was previously shown to 
induce transcription of Ifnȕ in chicken embryo kidney (CEK) cells (176). As a positive control for 
inhibition of host translation, we used Sindbis virus (SinV) (183) that was also previously shown to 
propagate in chicken cells and induce transcription of Ifnȕ (176). To examine the effect of IBV on ,IQȕ 
transcription and IFN protein production, we used a pathogenic IBV-M41 strain adapted to CEK cells. 
9LUXVUHSOLFDWLRQLQ&(.FHOOVZDVH[DPLQHGE\57T3&5XVLQJYLUXVVSHFL¿FSULPHUVGHWHFWLQJ
large amounts of total viral RNA in both SinV- and IBV-infected cells, but much less in RVFV Cl13-
LQIHFWHGFHOOV)LJ$7KHVHGDWDFRQ¿UPHGSUHYLRXVREVHUYDWLRQVWKDW6LQ9DQG,%9SURSDJDWHZHOO
LQFKLFNHQFHOOVZKHUHDVWKH59)9&OPXWDQWVWUDLQGRHVQRW'HVSLWHWKHTXDQWLWDWLYH
GLIIHUHQFHVLQYLUXVUHSOLFDWLRQTXDQWL¿FDWLRQRIIfnȕ mRNA in the same samples showed that all three 
viruses triggered considerable transcription of Ifnȕ (Fig. 1B). In contrast to Ifnȕ, transcription of ,IQĮ 
was not upregulated in chicken cells by IBV (176), RVFV Cl13 or Sindbis at any of the time points 
VWXGLHGGDWDQRWVKRZQ,QSDUDOOHOWRWKHTXDQWL¿FDWLRQRIIfnȕP51$ZHTXDQWL¿HG,)1SURWHLQ
and found that in both SinV- and RVFV Cl13-infected cells, accumulation of IFN in the supernatant 
correlated to transcription of Ifnȕ. In contrast, in the supernatant of IBV-infected cells, only negligible 
amounts of IFN could be detected (Fig. 1C). As predicted based on the observation that SinV strongly 
inhibits translation of host-cell proteins (183), production of IFN by SinV-infected cells was markedly 
lower than IFN production by RVFV-infected cells. The observation that IBV-infected cells produce 
VLJQL¿FDQWDPRXQWVRI Ifnȕ mRNA, but only negligible amounts of IFN protein, indicated that IBV 
limits IFN production by inhibiting translation of Ifnȕ mRNA. 
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Fig. 1  IBV induces transcription, but limits production of type I IFN
Chicken embryo kidney (CEK) cells were infected with IBV-M41, RVFV Cl13 (MOI 5) or Sindbis (MOI 1). At the 
indicated time points (A) total viral RNA, (B) ,IQȕ mRNA were determined and (C) IFN protein in the cell culture 
VXSHUQDWDQWZDVTXDQWL¿HG9DOXHVUHSUHVHQWUHVXOWVRIRQHUHSUHVHQWDWLYHH[SHULPHQWZKLFKZDVSHUIRUPHGWZLFH
with comparable results. Error bars indicate standard deviation of triplicate wells. (D - F) CEK cells were infected 
with the indicated strains of IBV (MOI 1). (D) Virus titres, (E) ,IQȕ mRNA and (F) IFN protein were determined at 
24 and 48 hpi.
7RDVVHVVZKHWKHUWKHREVHUYHGLQKLELWLRQRI,)1SURGXFWLRQFRXOGEHDVSHFL¿FWUDLWRIWKH,%90
VWUDLQ RU D JHQHUDO IHDWXUH RI ,%9ZH TXDQWL¿HG ERWK Ifnȕ mRNA and IFN protein concentrations 
LQ VXSHUQDWDQWV RI&(. FHOOV LQIHFWHGZLWK ¿YH GLIIHUHQW VWUDLQV RI ,%9$OO VWUDLQV KDG SUHYLRXVO\
EHHQDGDSWHG WRJURZ LQ&(.FHOOV DVDOVRFRQ¿UPHGE\ WLWUDWLRQ (Fig. 1D)6XEVHTXHQW57T3&5
DQDO\VLVFRQ¿UPHGWKDWDOO¿YHVWUDLQVRI,%9LQGXFHGWUDQVFULSWLRQRIIfnȕ mRNA, although with some 
A D
B E
C F
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differences between strains (Fig. 1E)$JDLQRQO\YHU\ORZFRQFHQWUDWLRQV8PORI,)1SURWHLQ
were detected in culture supernatants, with the exception of supernatants from Beau-R-infected CEK 
cells collected at 48 hpi (Fig. 1F). The higher concentration of IFN protein in Beau-R supernatants 
could be attributed to the ability of this particular strain to infect almost 100% of the cells as it is very 
well-adapted to growth in CEK cells. Despite the difference between strains, the results clearly indicate 
that inhibition of translation of Ifnȕ mRNA is a general feature of IBV viruses.
IBV inhibits translation but not transcription of host mRNA
Many viruses, including Alpha- and Betacoronaviruses inhibit translation of host-mRNA (114). The 
observation that IBV inhibited translation of Ifnȕ mRNA could be the result of a general inhibition 
of translation by IBV, leading to a general inhibition of protein expression. To study whether 
besides IFN, IBV infection would also inhibit expression of other proteins we investigated the effect 
RI ,%9RQH[SUHVVLRQRI)LUHÀ\ OXFLIHUDVH LQ WKUHHGLIIHUHQW FHOO W\SHV to this end CEK, DF-1 and 
Vero cells were transfected with a luciferase plasmid. The results showed that infection with IBV 
reduces luciferase expression by ± in all three cell types (Fig. 2A). Although the reduction 
in luciferase activity was not complete, this clearly indicated that besides IFN, IBV also inhibits the 
H[SUHVVLRQRIRWKHUSURWHLQV&RQVLGHULQJ WKDW WUDQVIHFWHGFHOOVDUH UHODWLYHO\GLI¿FXOW WR LQIHFWZLWK
IBV and that IBV-M41 only infects a subset of CEK cells which typically consist of a mixed cell 
population, to further investigate whether IBV inhibits general host-cell translation, we visualised de 
novo protein synthesis in IBV-infected cells using 35S metabolic labelling (Fig. 2B). Results indicated 
that at 6 hpi, both host and viral proteins were translated, whereas at 12 hpi translation of host 
proteins was severely reduced compared to mock-infected cells, while translation of viral proteins 
was unaffected. At 24 hpi, however, both translation of host and viral proteins was markedly reduced 
compared to mock-infected cells, which probably can be attributed to the extensive cytopathic effect 
(CPE) observed at this time point. Taken together, these data indicate that the inhibitory effect of 
IBV is not limited to synthesis of IFN only, but extends to a more general host translational shut off. 
     After having established that IBV inhibits general synthesis of host proteins, we investigated the 
underlying mechanisms. For the Betacoronaviruses SARS-CoV and MHV it was shown that inhibition 
of protein synthesis is accompanied by degradation of host mRNA (116, 118, 119). To investigate 
whether also IBV would negatively affect stability of host mRNA we restricted de novo transcription 
in IBV-infected cells and compared mRNA levels of a number of genes before and after treatment 
with actinomycin D (ActD) (Fig. 2C). Indeed, inhibition of de novo transcription by ActD induced 
DGHFUHDVHLQP51$OHYHOVRIDOOJHQHVVWXGLHG$OWKRXJKVWDWLVWLFDODQDO\VLVLQGLFDWHGQRVLJQL¿FDQW
(P=0.12) difference between the change in mRNA levels in infected (black bars) versus mock-treated 
cells (white bars), the rate of degradation of most mRNAs was lower in IBV-infected cells than in mock-
treated cells, clearly suggesting that IBV does not increase host mRNA degradation. Interestingly, of 
all genes studied, Ifnȕ mRNA was least degraded in IBV-infected cells indicating a stabilising effect of 
IBV on Ifnȕ mRNA. Taken together, our results indicate that the mechanism by which IBV decreases 
host translation is not based on degradation of host mRNA and it therefore appears different from the 
mechanisms adopted by some Betacoronaviruses.
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Fig. 2  IBV-induced host-protein shutoff does not require degradation of host mRNA
(A&(.FHOOVZHUHWUDQVIHFWHGZLWKS*/69)LUHÀ\OXFLIHUDVHSODVPLGDQGKUVODWHUFHOOVZHUHLQIHFWHGZLWK
IBV-M41 (MOI 10). DF-1 and Vero cells were transfected with the same plasmid and 24 hrs later infected with 
%HDX502,$WKSLOXFLIHUDVHDFWLYLW\ZDVTXDQWL¿HG%DUVUHSUHVHQWPHDQOXFLIHUDVHDFWLYLW\RIWULSOLFDWH
PHDVXUHPHQWVIURPWZRLQGHSHQGHQWH[SHULPHQWV(UURUEDUVLQGLFDWHVWDQGDUGGHYLDWLRQDQGDVWHULVNVLQGLFDWH
VWDWLVWLFDOO\VLJQL¿FDQWGLIIHUHQFHV3FRPSDUHGWRWKHUHVSHFWLYHPRFNLQIHFWHGFHOOVDVGHWHUPLQHGXVLQJ
an unpaired Student’s t-test. (B) Vero cells were infected with Beau-R (MOI 20), and at the indicated time after 
infection, newly synthesised proteins were radioactively labelled using 35S methionine. Cells were lysed, total protein 
FRQWHQWTXDQWL¿HGEDVHGRQVFLQWLOODWLRQFRXQWVDQGVHSDUDWHGXVLQJ6'63$*(DIWHUZKLFK35S was visualised using 
a phosphoimager. (C&(.FHOOVZHUHLQIHFWHGZLWK%HDX502,DQG¿YHKRXUVODWHUde novo transcription was 
LQKLELWHGXVLQJ$FWLQRP\FLQ'$FW'IRUDQDGGLWLRQDOVL[KRXUVDIWHUZKLFKP51$OHYHOVZHUHTXDQWL¿HGE\57
T3&57KHGRWWHGOLQHLQGLFDWHVWKHUHODWLYHJHQHOHYHOEHIRUH$FW'WUHDWPHQW%DUVLQGLFDWHWKHIROGFKDQJHRIWKH
gene induced by actinomycin D treatment, compared to before treatment. Bars indicate the mean of triplicate wells 
from a representative experiment out of two biological replicates. Error bars indicate standard deviation. Asterisk 
LQGLFDWHVVLJQL¿FDQWGLIIHUHQFH3EHWZHHQ,%9LQIHFWHGDQGPRFNWUHDWHGFHOOVDVDVVHVVHGE\RQHZD\
ANOVA followed by a Bonferroni post-hoc test.
A B
C
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Accessory protein 5b inhibits translation of host-cell proteins 
Alpha- and Betacoronaviruses mediate host shutoff via their nsp1, but IBV, like other Gamma- and 
DeltacoronavirusesGRHVQRWHQFRGHDQQVSKRPRORJXH OHDYLQJXQUHVROYHGWKHTXHVWLRQRIZKLFK
IBV protein could be responsible for the observed inhibition of translation of host-cell proteins. 
Besides genes that encode for structural and non-structural proteins, all coronaviruses have genes 
that encode a variable number of accessory proteins that are dispensable for virus replication in 
vitro, but may play a role in virulence in vivo (10, 11, 186). Gammacoronaviruses possess at least 
four accessory proteins, namely 3a, 3b, 5a, and 5b. To examine whether one or more of the IBV 
accessory proteins could be involved in inhibition of translation of host-cell proteins, we investigated 
whether individual IBV accessory proteins could inhibit expression of luciferase protein in cell 
culture. To this end, we overexpressed all four IBV accessory proteins as Flag-tagged constructs 
(Fig. 3A) together with a construct expressing Renilla luciferase, in both DF-1 and Vero cells. As a 
positive control for inhibition of translation we included a MHV nsp1 construct. Our results show 
that accessory protein 5b in particular, substantially inhibited luciferase activity in both cell types 
(Fig. 3B). Inhibition of luciferase activity could not be ascribed to direct cytotoxicity since no 
difference in cell viability could be observed upon transfection of any of the constructs (Fig. 3B). 
In contrast to the clear effect of 5b, expression of accessory protein 3a only moderately inhibited 
luciferase activity and only in DF-1 cells, whereas accessory protein 3b induced a slight increase in 
luciferase activity in both cell types. In conclusion, these results suggest that accessory protein 5b 
of IBV, similar to nsp1 of MHV, might be involved in inhibition of translation of host-cell proteins. 
      To verify whether accessory protein 5b indeed would be the best candidate to investigate the 
DELOLW\RI,%9WRLQKLELWJHQHUDOWUDQVODWLRQRIKRVWFHOOSURWHLQVZH¿UVWFRPSDUHGWKHOHYHOVRI,)1
protein produced by chicken cells infected with 3a, 3b, 3a/3b, 5a, 5b, and 5a/5b null viruses. These 
mutantviruses do not express the indicated accessory proteins owing to a mutation in the AUG start 
codon of the respective ORFs (13, 14). CEK cells were infected with Beau-R wild type virus or mutant 
viruses and at various time points after infection, IFN protein in the cell culture supernatants was 
TXDQWL¿HG)LJ&,QWHUHVWLQJO\DWDQGKSLRQO\FHOOVLQIHFWHGZLWKWKHEQXOOYLUXVSURGXFHG
elevated levels of IFN protein whereas only at 36 hpi, cells infected with the 3b null virus also began 
WRH[SUHVVVLJQL¿FDQWO\PRUH,)1SURWHLQ$OWRJHWKHUWKHVHUHVXOWVFRQ¿UPWKHLPSRUWDQFHRIDFFHVVRU\
protein 5b in mediating inhibition of translation of host-cell proteins. 
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Fig. 3  Accessory protein 5b plays a role in limiting IFN production
(A) Detection of IBV accessory proteins. Vero cells were transfected with plasmids expressing Flag-tagged accessory 
SURWHLQVDQGKUVODWHUSURWHLQVZHUHGHWHFWHGXVLQJD)ODJVSHFL¿FDQWLERG\B) DF-1 and Vero cells were seeded 
in 96-well plates and transfected with 10 ng Renilla luciferase expressing plasmid plus 90 ng of plasmid expressing 
the indicated accessory protein of Beau-R, MHV nsp1 or empty plasmid (ctrl). At 18 hours post transfection, 
OXFLIHUDVHDFWLYLW\ZDVTXDQWL¿HGDQGSORWWHGRQWKHOHIW<D[LV,QSDUDOOHOZHOOVF\WRWR[LFLW\RIHDFKFRQVWUXFWZDV
investigated using the cell titer 96 cytotoxicity assay. Results are plotted on the right Y-axis. For both luciferase and 
F\WRWR[LFLW\YDOXHVUHSUHVHQWWKHPHDQRITXDGUXSOLFDWHPHDVXUHPHQWVIURPWZRLQGHSHQGHQWH[SHULPHQWV(UURU
EDUVLQGLFDWHVWDQGDUGGHYLDWLRQDQGDVWHULVNVLQGLFDWHVLJQL¿FDQWGLIIHUHQFHV3FRPSDUHGWRWKHFRQWURODV
assessed by a one-way ANOVA followed by a Bonferroni post-hoc test. (C) CEK cells were infected with Beau-R 
or Beau-R-null viruses not expressing the indicated accessory proteins (MOI 0.1). The concentration of type I IFN 
protein was determined in the supernatant at the indicated time points. Values represent the mean of one experiment 
SHUIRUPHG LQ WULSOLFDWH DQGHUURUEDUV LQGLFDWH VWDQGDUGGHYLDWLRQ$VWHULVNV LQGLFDWH VLJQL¿FDQWGLIIHUHQFHV 3
0.01) compared to the parental Beau-R virus at the same time point, as assessed by a one-way ANOVA followed by 
a Bonferroni post-hoc test. 
A
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C
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        Considering the kinetics of IFN protein production observed in cells infected with the 5b null virus 
(Fig. 3B) and the kinetics of host-cell protein shutoff (Fig. 2B), we used mutant viruses to verify whether, 
besides inhibition of IFN protein, accessory protein 5b would also inhibit general translation of host-
cell proteins. We again visualised de novo protein synthesis by repeating the 35S metabolic labelling 
H[SHULPHQWXVLQJDEDEDQGDEQXOOYLUXVHV)LJ$3URWHLQV\QWKHVLVZDVVLJQL¿FDQWO\
inhibited at 12 hpi in cells infected with wild-type Beau-R, and in cells infected with 3a/3b and 5a null 
viruses but not in cells infected with 5a/5b- and 5b-null viruses (Fig. 4B). At 24 hpi, also the 5a/5b null 
YLUXVVLJQL¿FDQWO\LQKLELWHGSURWHLQV\QWKHVLVEXWQRWWRWKHVDPHH[WHQWDVWKHRWKHUYLUXVHVZKHUHDVWKH
5b null virus remained unable to inhibit de novo protein synthesis (Fig. 4C). Differently from the effect 
on translation of host proteins, at 12 hpi the translation of viral proteins remained unaffected (Fig. 4D). 
Nevertheless, under the conditions studied, infection with 5a/5b and 5b null viruses did not strongly 
inhibit de novo protein synthesis, supporting the observation that 5b inhibits general translation of host-
cell proteins, including that of type I IFN. Taken together, our results indicate that accessory protein 5b 
of IBV is at least partly responsible for the IBV-induced host shut off.
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Fig. 4  Accessory protein 5b inhibits host-protein translation
(A) Vero cells were mock treated or infected with the indicated mutant viruses not expressing one or two accessory 
proteins (MOI 20). At the indicated time points after infection, de novo synthesized proteins were labelled with 
356PHWKLRQLQH IRU RQHKRXU6XEVHTXHQWO\ FHOOVZHUH O\VHG DQGSURWHLQVZHUH VHSDUDWHGXVLQJ6'63$*(DQG
35S-labelled proteins were visualized using a phosphoimager. Areas containing host proteins are indicated with 1, 
2 and 3. Virus proteins are indicated with S, N and M. (B) Synthesis of host-proteins at 12 hpi and (C) at 24 hpi 
in mock- and virus-infected cells expressed as ratio relative to mock-infected cells at 6 hpi (dotted line). Host 
WUDQVODWLRQZDVDSSUR[LPDWHGE\TXDQWL¿FDWLRQRI35S signal intensity in the areas that contain mostly host-proteins, 
indicated with 1, 2 and 3 on the right side of Fig. 4A. (D) Synthesis of IBV-proteins at 12 hpi relative to Beau-R 
LQIHFWHGFHOOVDWKSL,%9WUDQVODWLRQZDVDSSUR[LPDWHGE\TXDQWL¿FDWLRQRI35S signal intensity of IBV-S, -N and 
-M proteins, as indicated on the right side of Fig. 4A. Bars indicate the mean of the three values determined for either 
YLUXVRUKRVWSURWHLQVDWWKHLQGLFDWHGWLPHSRLQWDQGHUURUEDUVLQGLFDWHVWDQGDUGGHYLDWLRQ$VWHULVNVLQGLFDWH
VLJQL¿FDQWGLIIHUHQFHV3FRPSDUHGWRPRFNDVDVVHVVHGE\RQHZD\$129$IROORZHGE\D%RQIHUURQL
post-hoc test.
A
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DISCUSSION
In this study we investigated the ability of the Gammacoronavirus IBV to interfere with the host 
antiviral response through inhibition of translation of host-cell proteins and studied the role of 
accessory proteins in this process. Previously, we demonstrated that IBV is relatively resistant 
to treatment with IFN and that very high doses (1000 to 10.000 U/ml) of IFN are necessary to 
VLJQL¿FDQWO\LQKLELWYLUDOJURZWKE\ORJVFKDSWHUWKLVWKHVLV,QDQRWKHUVWXG\ZHLQYHVWLJDWHG
the kinetics of ,IQȕ transcription and showed that IBV infection elicits delayed, but substantial 
transcription of Ifnȕ mRNA in avian cells (176). Despite the substantial ,IQȕ transcription, only low 
levels (100 - 150 U/ml) of IFN protein could be detected in supernatants from IBV-infected chicken 
cells. In the current study, using as positive controls RVFV clone 13, a virus with a defective IFN 
DQWDJRQLVW DQG 6LQGELV D YLUXV NQRZQ WR FDXVH KRVW VKXWRII ZH ZHUH DEOH WR FRQ¿UP WKDW ,%9
effectively limits production of IFN protein in chicken cells, independently of the IBV strain used. 
    The ability of a virus to delay and antagonise the antiviral response determines its ability to 
avoid clearance by the host and coronaviruses have evolved multiple mechanisms to this purpose. 
One mechanism used by Alpha- and Betacoronaviruses is inhibition of host-protein translation, 
including that of type I IFN, a mechanism which is mediated by viral nsp1 protein. Gamma- and 
Deltacoronaviruses lack nsp1 and it has remained unclear whether and how these viruses inhibit 
host-protein translation. Only few studies have been performed on IBV by Wang et al. but produced 
apparently inconsistent data; LW DSSHDUHG WKDW ,%9 GRHV QRW VLJQL¿FDQWO\ LQKLELW WUDQVODWLRQ RI KRVW
proteins as assessed by metabolic labelling (111), but also that the spike protein of IBV decreases host-
translation through interaction with eIF3F (135). Considering the lack of IFN protein production during 
,%9LQIHFWLRQREVHUYHGLQRXUVWXG\ZHLQYHVWLJDWHGZKHWKHU,%9VSHFL¿FDOO\OLPLWHGSURGXFWLRQRI
IFN only or whether IBV induced a more general inhibitory mechanism based on host-cell protein 
shutoff. Using the same cell line and the same IBV strain used by Wang et al. (18), we could show 
WKDW ,%9 LQGXFHV DQ HI¿FLHQW KRVW VKXWRII7KH DSSDUHQWGLVFUHSDQF\EHWZHHQRXU DQG WKHSUHYLRXV
study by Wang et al. is probably due to the difference in MOI used. To achieve host shutoff measured 
by 35S metabolic labelling it is crucial to infect all cells simultaneously, for which reason we have 
used an MOI of 20, which is 10-fold higher than the MOI used by Wang et al. Based on our results, 
we conclude that IBV does indeed induce a general host shutoff, indicating that such a defense 
mechanism is evolutionary conserved between Gammacoronaviruses and Alpha- or Betacoronaviruses. 
      During infection with Beta-, but not Alphacoronaviruses, host shutoff is accompanied by 
degradation of host mRNAs (118, 119). To investigate whether IBV infection induces degradation 
of mRNA, we inhibited de novo WUDQVFULSWLRQ DQG TXDQWL¿HG WKH GHFUHDVH LQ KRVWP51$ OHYHOV
in IBV-infected and non-infected cells. In contrast to what is known for MHV and SARS-CoV 
(118, 119), we did not observe a degradation of host mRNAs. The observation that IBV does not 
degrade host mRNAs may suggest that IBV induces host shutoff via a mechanism similar to 
Alphacoronaviruses, which also do not induce degradation of host mRNA (120). Interestingly, 
some mRNAs, such as ,IQȕ, Isg20 and Tlr3 showed increased rather than decreased stability in 
IBV-infected cells. The increased mRNA stability of these particular mRNAs could be the result of 
stress granule (SG) formation as it has been observed for MHV (115). Although formation of SGs 
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has been associated with increased mRNA stability, activation of this stress pathway has thus far 
not been studied for IBV and awaits further investigation before a clear conclusion can be drawn. 
        Because the genome of Gamma- and Deltacoronaviruses does not encode for an nsp1 homologue, it has 
remained unclear which IBV protein could play a role in the above-described IBV-induced host protein 
shutoff. Based on the hypothesis that one of the four canonical accessory proteins might be involved in 
this process, we overexpressed the IBV-accessory proteins and found that only 5b consistently inhibited 
WKHDFWLYLW\RIDFRQVWLWXWLYHO\H[SUHVVHGKRVWSURWHLQ$OWKRXJKPD\EHGLI¿FXOWWRFRPSDUHLQTXDQWLWDWLYH
terms, inhibition by IBV 5b seemed less pronounced than inhibition by MHV-nsp1. Also, similar 
GLIIHUHQFHVLQLQKLELWLRQHI¿FLHQF\KDYHEHHQUHSRUWHGIRUQVSSURWHLQVIURPYDULRXVBetacoronaviruses 
(117). Next, we investigated the role of IBV accessory proteins on IFN protein production using mutant 
viruses that do not express one or more of the accessory proteins. We found that both 5a/5b- and 
5b-null viruses induced up to 90 times more type I IFN in chicken cells than the parental Beau-R virus. 
The difference in induction of type I IFN between the IBV 5b-null virus and Beau-R-infected cells is 
comparable to the difference observed between a SARS-CoV-nsp1 mutant virus and the parental virus 
(187). We previously showed that infection with accessory protein 3b null viruses leads to increased IFN 
production but only late (>36hpi) after IBV infection (176). Here, metabolic labelling analysis indicated 
that inhibition of translation of host-proteins by IBV occurs early, already at 12 hpi. The observation that 
infection with null virus for accessory protein 5b, but not 3b, led to increased IFN protein production 
DOUHDG\DWKSLWRJHWKHUZLWKWKHREVHUYDWLRQWKDWERYHUH[SUHVVLRQHI¿FLHQWO\LQKLELWHGOXFLIHUDVH
activity, suggests that accessory protein 5b in particular, might play a role in IBV-induced host shutoff. 
      Using radioactive labelling of de novo protein synthesis, we found that both 5a/5b- and 5b-null 
YLUXVHVZHUHOHVVHI¿FLHQWDWLQKLELWLQJKRVWWUDQVODWLRQWKDQWKHSDUHQWDOYLUXV)LJ7KHGLIIHUHQFH
LQLQKLELWLRQHI¿FLHQF\EHWZHHQWKHEQXOOYLUXVDQGWKHSDUHQWDOYLUXVUHVHPEOHVWKHGLIIHUHQFHLQ
IFN production between an nsp1-mutant and the parental SARS-CoV (187). Taken together, these 
REVHUYDWLRQVVXJJHVWWKDW,%9EPD\EHWKHIXQFWLRQDOHTXLYDOHQWRIAlpha- and Betacoronavirus nsp1. 
      The conclusion that IBV 5b and accessory protein nsp1 of Alpha- and Betacoronavirus share a functional 
UHVHPEODQFHZRXOGDQVZHUDORQJVWDQGLQJTXHVWLRQRQWKHDEVHQFHRIQVSLQGammacoronaviruses and 
ZKHWKHUWKLVDEVHQFHLVFRPSHQVDWHGIRUE\DQRWKHUYLUDOSURWHLQ$VVXFKWKLVVWXG\PDUNVDVLJQL¿FDQW
step forward in the understanding of coronavirus biology and demonstrates that mechanisms aimed at 
altering host antiviral responses may have been functionally conserved during evolution. Although the 
exact mechanism by which 5b inhibits host-translation remains to be elucidated, our in vitro results 
indicate that accessory protein 5b may be an important virulence factor of Gammacoronaviruses and a 
potential target for the design of rationally-attenuated vaccines against IBV. 
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ABSTRACT
4XDQWL¿FDWLRQ RI WKH QXPEHU RI LQIHFWLRXV YLUXVHV LQ D VDPSOH LV D EDVLF YLURORJLFDO WHFKQLTXH ,Q
WKLV FKDSWHUZHSURYLGHDGHWDLOHGGHVFULSWLRQRI WKUHH WHFKQLTXHV WR HVWLPDWH WKHQXPEHURIYLDEOH
LQIHFWLRXVDYLDQFRURQDYLUXVHVLQDVDPSOH$OOWKUHHWHFKQLTXHVDUHVHULDOGLOXWLRQDVVD\VEHWWHUNQRZQ
as titrations. 
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1. INTRODUCTION
7HFKQRORJLFDO DGYDQFHV LQ SDUWLFOH DQDO\VLV KDYHPDGH LW SRVVLEOH WR TXDQWLI\ WKH QXPEHU RI YLUXV
SDUWLFOHVLQDVDPSOHZLWKLQFUHDVLQJDFFXUDF\7HFKQLTXHVVXFKDVVSHFLDOL]HGÀRZF\WRPHWU\
G\QDPLFOLJKWVFDWWHULQJTXDQWLWDWLYHFDSLOODU\HOHFWURSKRUHVLVDQGÀXRUHVFHQFHFRUUHODWLRQ
spectroscopy (191) can determine the number of particles in a sample within hours. The choice of 
WHFKQLTXHGHSHQGVRQ WKHVRUWRIYLUXVDQG WKHPDWUL[ LQZKLFK LW LVVXVSHQGHG$OODIRUHPHQWLRQHG
WHFKQLTXHVGLIIHUHQWLDWHSDUWLFOHVRQWKHEDVLVRISK\VLFDOSURSHUWLHVVXFKDVVL]HRUDQWLERG\DI¿QLW\
$VDFRQVHTXHQFHSDUWLFOHDQDO\VLVFDQQRWGLIIHUHQWLDWHLQIHFWLRXVIURPQRQLQIHFWLRXVYLUXVSDUWLFOHV 
        7KHUHLVRQO\RQHWHFKQLTXHDYDLODEOHWKDWFDQUHOLDEO\TXDQWLI\WKHQXPEHURILQIHFWLRXVSDUWLFOHVLQ
DVDPSOH7KLVWHFKQLTXHGHYHORSHGPDQ\GHFDGHVDJRH[SORLWVWKHIDFWWKDWYLUXVFDQSURSDJDWH
in biological systems such as embryonated eggs or cell cultures. Propagation of a virus is generally 
accompanied by changes in cell morphology (referred to as cytopathic effect or CPE), which can be 
visualised using a microscope, or even by eye. Some viruses do not induce CPE, in which case an 
DQWLERG\EDVHGDVVD\LPPXQRÀXRUHVFHQFHRU(/,6$LVQHHGHGWRGHWHUPLQHSUHVHQFHRUDEVHQFHRI
virus. During a titration assay, tissue cultures or embryonated eggs are incubated with tenfold serial 
dilutions of a virus containing sample and several days later the cytopathic effect is scored. From these 
scores, the virus titre is calculated using the methods described by Spearman and Kaerber (193, 194) 
RU5HHGDQG0XHQFK7KHYLUXVWLWUHLVGH¿QHGDVWKHUHFLSURFDORIWKHGLOXWLRQDWZKLFKRI
the inoculated embryos or tissue cultures show CPE. In this chapter we use the method of Spearman 
DQG.DHUEHU WR FDOFXODWH WKH WLWUH DV WKLV FDOFXODWLRQ FDQ FRSHZLWK XQHTXDO JURXS VL]HV 8QHTXDO
JURXSVL]HVIUHTXHQWO\DULVHZKHQHJJVDUHORVWWRDVSHFL¿FGHDWKRIWKHHPEU\RRUEDFWHULDOLQIHFWLRQ 
     Coronaviruses in general have a narrow host range and many clinical isolates only replicate in 
SULPDU\ FHOOV 5HSOLFDWLRQ RI PRVW ¿HOG LVRODWHV RI LQIHFWLRXV EURQFKLWLV FRURQDYLUXV LV UHVWULFWHG
to embryonated eggs or tracheal organ culture. Most isolates however, can be adapted to 
SURSDJDWLRQ LQ SULPDU\ FKLFNHQ NLGQH\ &. FHOOV$GDSWDWLRQ W\SLFDOO\ UHTXLUHV VHYHUDO SDVVDJHV
and selects for viral subpopulations and can induce mutations (185). Passaging of IBV in either 
embryonated eggs or primary cell cultures leads to attenuation of the virus in vivo (196-198). The 
most striking example is the IBV Beaudette strain, which has been passaged hundreds of times in 
eggs and primary chicken kidney cells (199, 200). Although IBV Beaudette propagates very well 
on eggs, CK cells and even in Vero cells, the virus is highly attenuated in vivo and vaccination 
using Beaudette provides little protection against infection with pathogenic strains of IBV (61). 
)RUTXDQWL¿FDWLRQRI,%9¿HOGLVRODWHVHPEU\RQDWHGFKLFNHQHJJVDUHWKHPRVWVXLWDEOHVXEVWUDWH
$SURWRFRORQWLWUDWLRQRI,%9RQHPEU\RQDWHGFKLFNHQHJJVLVSURYLGHGLQWKH¿UVWSDUWRIWKLVSURWRFRO
IBV strains which have been adapted to grow in cultures of primary chicken cells can be titrated on 
these cells using either the TCID50PHWKRGRUSODTXHWLWUDWLRQ3URWRFROVIRUERWKPHWKRGVDUHSURYLGHG
LQWKLVFKDSWHU3ODTXHIRUPLQJXQLW3)8WLWUDWLRQ\LHOGVPRUHDFFXUDWHDQGUHSURGXFLEOHUHVXOWVWKHQ
the TCID50 method, it is however more labour intensive. Both methods are presented in this chapter. 
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2. MATERIALS
2.1 Titration of Avian Infectious Bronchitis virus in fertilized eggs by EID50.
1. )HUWLOL]HGVSHFL¿FSDWKRJHQIUHH63)HJJVWR±GD\ROGsee Note 1)
2. Diluent: Tryptose 2.5% w/v supplemented with 1000 IU/ml of Penicillin and 1000µg/ml of 
Streptomycin
3. Disinfectant: 70% alcohol in water
4. Egg shell drill or punch
5. Sterile 1 ml syringes
6. Needles, preferably 25 G; 16 mm
7. Hobby glue or melted wax to seal the inoculation site
8. Egg candling light
9. Egg incubator with rocking
10. Positive control sample with known titre
2.2 Tissue culture infective dose (TCID50) titration.
1. ZHOOSODWHVFRQWDLQLQJFRQÀXHQW&.FHOOV
2. Titration medium: 1:1 mix of medium M199 and Ham’s F-10 nutrient mixture supplemented 
with 0.5% fetal calf serum (FCS), 0.1% w/v tryptose phosphate broth, 0.1% w/v sodium 
bicarbonate, 0.1% w/v HEPES, 100 U/mL penicillin, 100 µg/mL streptomycin.
3. 0XOWLVWHSSHUSLSHWWH6RFRUH[RUHTXLYDOHQW
4. Inverted microscope.
5. Positive control sample with known titre.
2.3 Plaque forming unit titration.
1. 6L[ZHOOSODWHVFRQWDLQLQJFRQÀXHQW&.FHOOV
2. 1x BES cell culture medium: EMEM, 10% w/v tryptose phosphate broth, 0.2% w/v BSA, 
20 mM N,N bis(2-hydroxethyl)-2-aminoethanesulfonic acid (BES), 0.4% w/v sodium 
bicarbonate, 2 mM L-glutamine, 250 U/mL nystatin, 100 U/mL penicillin, 100 µg/mL 
streptomycin. 
3. 2x BES cell culture medium: 2x EMEM, 20% w/v tryptose phosphate broth, 0.4% w/v 
BSA, 40 mM N,N bis(2-hydroxethyl)-2-aminoethanesulfonic acid (BES), 0.8% w/v sodium 
bicarbonate, 4 mM L-glutamine, 500 U/mL nystatin, 100 U/mL penicillin and 100 µg/mL of 
streptomycin.
4. Sterile phosphate buffered saline (PBS).
5. 2% w/v agarose in water (autoclaved)
6. 10% w/v formaldehyde in PBS
7. 0.1% w/v crystal violet in water 
8. Microwave
9. Water bath
10. Small spatula
11. Positive control sample with known titre.
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3. METHODS 
3.1 Titration of Avian Infectious Bronchitis virus in fertilized eggs.
1. Candle the eggs using the candling light and draw a line on the shell marking the edge of the 
DLUVDF'UDZDQ;DSSUR[LPDWHO\PPDERYHWKLVOLQHZKLFKPDUNVWKHLQRFXODWLRQVLWH
2. Assign 10 eggs per dilution and select those dilutions (at least three) that include the 50% 
end point of the sample.
3. Prepare tenfold serial dilutions in diluent.
4. Disinfect the eggs by spraying them with disinfectant
5. After the eggs have dried drill or pierce a hole in the egg shell at the marked inoculation site.
6. Inoculate ten eggs per dilution each with a 0.2 ml volume via the allantoic cavity by 
holding the syringe and needle vertically and by inserting the needle approximately 16 mm 
into the egg (see Fig. 1A, B). 
 
 
 
Fig. 1  Egg inoculation into the allantoic cavity.  
(A) Drill or pierce a hole in the egg 5 mm above the edge of the air sac. (B) Inoculate each egg with 
a 0.2 ml volume by inserting the needle approximately 16 mm into the egg. (C) Typical IBV induced 
malformations 2 days post infection with strain 4/91. Plus signs indicate infected embryos with IBV, 
minus indicates non-infected embryos
A B
C
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7. After inoculation, the hole in each egg is sealed with hobby glue or melted wax.
8. Incubate the eggs in an egg incubator with rocking at 37.8°C and 60-65% humidity.
9. Candle the eggs after 24 h of incubation. Embryo mortality occurring up till 24 h post 
LQRFXODWLRQLVFRQVLGHUHGQRQVSHFL¿FDQGWKHUHIRUHWKHVHHJJVDUHGLVFDUGHG
10. Incubate the eggs for 6 more days in an egg incubator with rocking at 37.8 °C and 60-
65% humidity. Candle the eggs at the end of the incubation period to identify embryos that 
KDYHGLHG6XEVHTXHQWO\PDFURVFRSLFDOO\HYDOXDWHDOOVXUYLYLQJHPEU\RVIRU WKHSUHVHQFH
of lesions characteristic for IBV infection (stunting and curling; Fig. 1C). Embryos that died 
and embryos that exhibit lesions characteristic for IBV infection are considered positive. (see 
Note 2)
11. Virus titers in the original sample, expressed as 
10log EID50/ml are calculated using the 
method described by Spearman and Kaerber (193, 194), using the following formula: 
 
                                        
In which: 
x0:  logarithm of the inverse value of the lowest dilution at which all embryos are   
                positive. 
d: logarithm of the dilution factor (d = 1 when using tenfold serial dilutions). 
n: number of eggs used per dilution. 
r: number of positive eggs at that dilution.
12. Example of calculation of virus titre  
Using the result of the titration depicted in Fig. 2 , the virus titre is calculated as follows: 
Fig. 2  Schematic result of an egg titration 
Each circle represents one egg and crossesLQGLFDWHDVSHFL¿FGHDWKPlus signs LQGLFDWHHPEU\RVZLWK,%9VSHFL¿F
malformations
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3.2 Tissue culture infective dose (TCID50) titration.
1. CK cells are seeded in 96-well plates at 7.5 x 104 cells/well, one or two days before the 
titration. One plate is needed per sample. At the time of titration, the monolayer should be 
QHDUO\FRQÀXHQW
2. Prepare tenfold serial dilutions of the samples in titration medium. (see Note 3). 
3. Empty the medium from the 96-well plate containing CK cells in a waste container, and 
gently tap the plate dry on a stack of tissues.
4. Fill the wells of column 1 and 12 of the 96w-plate with 100 µl/well titration medium. These 
are the negative control wells (Fig. 3A).
5. Starting with the highest dilution, dispense 100 µl/well in row H using the multi stepper 
SLSHWWH3URFHHGZLWK¿OOLQJWKHDVFHQGLQJGLOXWLRQVLQURZV*WLOO$
6. Incubate the infected CK cell monolayers  for 3-4 days at 37 °C and 5% CO2.
7. $IWHUGD\VLQFXEDWLRQVFRUHWKH&.FHOOPRQROD\HULQDOOZHOOVIRU,%9VSHFL¿F&3(
using a microscope. Although the CPE may vary per IBV strain, it is generally characterized 
by clusters of rounded cells on top of the monolayer. At low dilutions the monolayer may be 
SDUWO\GHVWUR\HGH[HPSOL¿HGE\WKH,%9%HDXGHWWHVWUDLQ)LJ%
8. Titers are calculated using the method described by Spearman and Kaerber (subheading 3.1, 
step 11) and are expressed in 10log (TCID50)/ml. 
3.3 Plaque forming unit titration.
                Infection of cells
1. CK cells are seeded into 6-well plates one or two days before the titration. When performing 
WKHWLWUDWLRQWKHPRQROD\HUVKRXOGFRQÀXHQW
2. Prepare tenfold serial dilutions of virus in 1x BES. 
3. Remove media from cells and wash once with sterile PBS.
4. Remove PBS from the cells and add 500 ʅl of diluted virus to each well. Duplicate wells 
should be inoculated for each dilution.
5. Incubate cells at 37 oC for 1 hour to allow virus attachment.
6. Melt 2% agar in a microwave and then transfer to a 42 oC water bath. Allow the agar to 
HTXLOLEUDWHLQWHPSHUDWXUH
7. Mix the partially cooled agar with 2x BES pre-warmed to 37 oC to generate 1x BES + 1% 
agar. Keep at 42 oC until needed to prevent premature setting (see Note 4).
8. Remove virus inoculum and overlay cells with 2.5 ml of the 1x BES/agar mix.
9. /HDYHFHOOVDWURRPWHPSHUDWXUHIRUDSSUR[LPDWHO\PLQXWHVXQWLODJDUKDVVROLGL¿HG
10. Incubate at 37 oC and 5% CO2 IRUGD\VIRUSODTXHVWRGHYHORS
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                Staining cells and determining titre
1. Overlay agar with 1 ml per well 10% formaldehyde in PBS.
2. Incubate at room temperature for 1 hour.
3. Remove formaldehyde and ensure disposal according to local regulations.
4. 8VLQJDVPDOOVSDWXODÀLFNRIIWKHDJDUIURPWKHFHOOVVHH1RWH
5. Wash cells by shaking the plate upside down in a sink containing water.
6. Add 0.5 ml 0.1% crystal violet to each well.
7. Incubate at room temperature for 10 minutes.
8. Remove crystal violet and dispose of according to local regulations.
9. Wash plate by shaking upside down in a sink of water.
10. Pat plate dry and leave upside down at room temperature to fully dry.
11. 3ODTXHVVKRXOGEHFOHDUO\YLVLEOHDVKROHVLQWKHPRQROD\HU)LJ&RXQWWKHQXPEHURI
SODTXHVSHUZHOODWWKHGLOXWLRQZLWKFOHDUO\GH¿QHGLQGLYLGXDOQRWRYHUODSSLQJSODTXHV
W\SLFDOO\SODTXHVZHOO(QVXUHGXSOLFDWHZHOOVDUHFRXQWHGDQGDQDYHUDJHWDNHQ
12. 'HWHUPLQHWLWUHXVLQJWKHIROORZLQJHTXDWLRQ 
 
              
13. )RUPRVWDFFXUDWHUHVXOWVWKHSODTXHDVVD\VKRXOGEHUHSHDWHGWKUHHWLPHVDQGWKHDYHUDJH
titre determined.
 
4. Notes
1. 63)HJJVVKRXOGEHXVHG IRU WLWUDWLRQRI ,%9DVQRQ63)HJJVPD\FRQWDLQ ,%9VSHFL¿F
antibodies that can interfere with the replication of IBV.
2. 1RQHJJ DGDSWHG ,%9 LVRODWHV PD\ LQGXFH YHU\ OLWWOH ,%9 VSHFL¿F DEHUUDWLRQV RI WKH
embryos When titrating such viruses the eggs are incubated for an additional 2-3 days after 
inoculation. Candle the eggs at the end of the incubation period to identify embryos that have 
GLHG6XEVHTXHQWO\FROOHFWDOODQWRLFÀXLGRIHDFKRI WKHVXUYLYLQJHPEU\RVDQG WHVW WKHP
in a monoclonal based antigen capture ELISA as described in (201, 202). Dead embryos 
DQGWKRVHRIZKLFKWKHDOODQWRLFÀXLGFRQWDLQV,%9DVHVWDEOLVKHGE\(/,6$DUHFRQVLGHUHG
positive.
3. IBV titres usually do not exceed 108,8 TCID50/ml, therefor 10
-8VKRXOGEHDGHTXDWHDVKLJKHVW
dilution. When the virus titre of the sample is known, select a number of tenfold dilutions (at 
least 3) that include the 50% end-point dilution. If the titre is unknown select a broader range 
of tenfold dilutions that most likely include the 50% end-point dilution. For a TCID50 titration 
typically all the wells of the 96-well plate are used 
4. Alternative methods also exist for mixing media and agar. If there is concern regarding the 
RYHUOD\VHWWLQJ WRRTXLFNO\RU ULVNRIFRQWDPLQDWLRQ IURP WKHZDWHUEDWKKRWDJDUFDQEH
mixed directly with cold media (4 oC). Once the mixture feels warm to the touch, rather than 
hot, it can be added to the cells.
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5. The simplest method for removing agar from the cells is to hold the plate upside down with 
the lid removed. The small spatula is inserted between the agar and the wall of the well. Once 
the base of the well is reached, a small amount of pressure is applied to remove the agar being 
careful not to scrape off the cells. The whole agar plug should then fall out easily.
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ABSTRACT
Activation of the type I interferon (IFN) response is an essential defense mechanism against invading 
SDWKRJHQVVXFKDVYLUXVHV7KLVFKDSWHUGHVFULEHVWZRSURWRFROVWRTXDQWLI\DFWLYDWLRQRIWKHFKLFNHQ
,)1UHVSRQVHWKURXJKDQDO\VLVRIJHQHH[SUHVVLRQE\UHDOWLPHTXDQWLWDWLYH3&5DQGE\TXDQWL¿FDWLRQ
of bioactive IFN protein using a bioassay.
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INTRODUCTION
The type I interferon response (IFN response) is an important part of the immune reaction against viruses. 
Interferon alpha and beta (IFNĮ and IFNȕ) are the prototypical type I interferons and can be produced by 
most animal cells. Production of IFNĮȕ is triggered upon stimulation of pattern recognition receptors, 
such as Toll like receptors (TLRs) or Rig-I like receptors (RLRs). Upon production, IFNĮ and IFNȕ are 
UDSLGO\VHFUHWHGWRWKHH[WUDFHOOXODUFRPSDUWPHQWZKHUHWKH\FDQELQGWRWKHXELTXLWRXVO\H[SUHVVHG
IFN receptor. Binding of IFN to the receptor activates the JAK/STAT signaling pathway, leading to the 
formation of the ISGF3 transcription complex consisting of a STAT1, STAT2 and IRF9. In the nucleus, 
the ISGF3 complex induces transcription of hundreds of IFN-stimulated genes (ISGs)(203). Many of 
these genes encode proteins that interfere with the replicative cycle of viruses at various stages (reviewed 
in ref. (204)). The IFN response is a potent antiviral mechanism, therefore most viruses have been 
evolutionarily selected to counteract it and coronaviruses are no exception (reviewed by Zhong et al. (125)). 
,QWKLVFKDSWHUZHGHVFULEHWZRSURWRFROVWRTXDQWLI\DFWLYDWLRQRIWKH,)1UHVSRQVH:HKDYHIRXQG
these protocols useful to study if and how viruses counteract the IFN response in chicken cells. The 
¿UVWSURWRFROGHVFULEHVKRZWRTXDQWLI\DFWLYDWLRQRIWKH,)1UHVSRQVHDWWKHWUDQVFULSWLRQDOOHYHOXVLQJ
UHDOWLPHTXDQWLWDWLYH3&557T3&5RQIfn and IFN-stimulated genes. The second protocol describes 
TXDQWL¿FDWLRQRIELRDFWLYHW\SH,,)1SURWHLQERWK,)1Į and IFNȕ) by the use of a reporter cell line. 
7KLVELRDVVD\FDQEHXVHGWRTXDQWLI\,)1VHFUHWHGLQUHVSRQVHWRYLUXVLQIHFWLRQDQGZKHQFRPELQHG
with transcription analysis of ,IQĮ and ,IQȕ these assays can provide an integral picture of activation of 
the chicken IFN response.
1.1 Quantitation of transcription of chicken Ifn-related genes.
Similar to most mammalian cell lines, activation of the interferon response in most chicken cells is 
characterised by upregulation of Ifnȕ. Like the human genome, the chicken genome encodes only 
one copy of the Ifnȕ gene, whereas at least ten isoforms of ,IQĮ are present (205, 206). Similar to 
mammals, production of chicken IFNĮ is mainly mediated by monocytes, other cells mainly 
SURGXFH ,)1ȕ LQ UHVSRQVH WR YLUDO LQIHFWLRQ  %HFDXVH DYLDQ FRURQDYLUXVHV UHSOLFDWH PDLQO\
LQHSLWKHOLDOFHOOVZHPRQLWRUDFWLYDWLRQRI WKH W\SH , LQWHUIHURQ UHVSRQVHE\TXDQWL¿FDWLRQRI Ifnȕ. 
Similar to mammalian cells, Ifnȕ is upregulated upon activation of either TLR or Rig-I like receptors 
(RLRs), but not in response to stimulation with IFN. Concomitant with Ifnȕ, many ISGs are also 
upregulated, indicating that the term interferon stimulated genes is somewhat misleading (208). 
6WXG\LQJWKHH[SUHVVLRQRI,6*VFDQEHXVHIXOWKHUHIRUHZHKDYHSURYLGHGDOLVWRIDYLDQVSHFL¿F
SULPHUV IRU XVH LQ UHDOWLPH TXDQWLWDWLYH 3&5 57T3&5 7DEOH   3URWRFROV IRU 51$
isolation, cDNA synthesis and real-time PCR are plenty and every lab has its own protocols. In this 
FKDSWHUZHGHVFULEHEULHÀ\WKHPHWKRGVXVHGLQRXUODE)RUDGHWDLOHGRYHUYLHZRI57T3&5WHFKQLTXHV
and theoretical background, please refer to Forlenza et al. (145). 
1.2 Quantitation of chicken type I IFN protein using a bioassay.
The chicken interferon bioassay was developed in the laboratory of Prof. P. Staeheli (149). It is based 
RQDTXDLOFHOOOLQH&(&WKDWFRQWDLQVWKHOXFLIHUDVHJHQHGRZQVWUHDPRIDSDUWRIWKHLQGXFLEOH
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chicken mx promotor. Stimulation of these cells with type I interferon readily induces activation of the 
mxSURPRWRUDQGVXEVHTXHQWSURGXFWLRQRIWKH¿UHÀ\OXFLIHUDVHHQ]\PH)LUHÀ\OXFLIHUDVHFDQEHHDVLO\
TXDQWL¿HGXVLQJFRPPHUFLDOO\DYDLODEOHOXFLIHUDVHDVVD\NLWV+HUHZHSURYLGHDVWHSE\VWHSSURWRFRO
for measuring IFN concentrations using this bioassay.
 
Table 1 Chicken-specific real-time qPCR primers, including accession numbers of the sequences used to 
design the primers
Gene product Orientationa Sequence (5’-3’) Accession no. Reference
,IQȕ FW GCTCTCACCACCACCTTCTC NM_001024836
 RV GCTTGCTTCTTGTCCTTGCT   
,IQĮ FW ATCCTGCTGCTCACGCTCCTTCT ;0B 142
 RV GGTGTTGCTGGTGTCCAGGATG   
Irf3 FW CAGTGCTTCTCCAGCACAAA NM_205372
 RV TGCATGTGGTATTGCTCGAT   
Irf1 FW CAGGAAGTGGAGGTGGAGAA NM_205415
 RV TGGTAGATGTCGTTGGTGCT   
Tlr7 FW TTCTGGCCACAGATGTGACC NM_001011688 142
 RV CCTTCAACTTGGCAGTGCAG   
Tlr3 FW TCAGTACATTTGTAACACCCCGCC NM_001011691 142
 RV GGCGTCATAATCAAACACTCC   
Mda5 FW TGGAGCTGGGCATCTTTCAG GU570144
 RV GTTCCCACGACTCTCAATAACAGT   
Mx FW TTGTCTGGTGTTGCTCTTCCT *4
 RV GCTGTATTTCTGTGTTGCGGTA   
Oas FW CACGGCCTCTTCTACGACA NM_205041 143
 RV TGGGCCATACGGTGTAGACT   
Il8 FW TTGGAAGCCACTTCAGTCAGAC NM_205498 143
 RV GGAGCAGGAGGAATTACCAGTT   
Pkr FW CCTCTGCTGGCCTTACTGTCA NM_204487 144
 RV AAGAGAGGCAGAAGGAATAATTTGCC   
Adar FW TGTTTGTGATGGCTGTTGAG AF403114
 RV AGATGTGAAGTCCGTGTTG   
Isg12 FW TAAGGGATGGATGGCGAAG NM_001002856
 RV GCAGTATCTTTATTGTTCTCAC   
Mhc-I FW CTTCATTGCCTTCGACAAAG NM_001031338 143
 RV GCCACTCCACGCAGGT   
Ifnar2 FW GCTTGTGTTCGTCAGCATT NP_990189 143
RV TTCGCAATCTTCCAGTTGT
Luciferase FW TGTTGGGCGCGTTATTTATC ;
RV AGGCTGCGAAATGTTCATACT  
a FW, forward; RV, reverse
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MATERIALS
2.1 RNA isolation, cDNA synthesis and RT-qPCR on avian cells.
1. Cells and virus, as per experiment
2. 51HDV\0LQL.LW4,$JHQ
3. 51DVHIUHH'1DVHVHW4,$JHQ
4. %LRDQDO\VHU$JLOHQW7HFKQRORJLHVRUDJDURVHJHOHOHFWURSKRUHVLVHTXLSPHQW
5. 6SHFWURSKRWRPHWHU1DQR'URSRUHTXLYDOHQW
6. '1DVH,$PSOL¿FDWLRQ*UDGH
7. 5HYHUVH7UDQVFULSWDVH,QYLWURJHQ6XSHU6FULSW,,,RUHTXLYDOHQW
8. PCR machine (for cDNA synthesis)
9. Nuclease-free water
10. Luciferase mRNA
11. Random hexamers
12. ;6<%5*UHHQ,PL[
13. 4XDQWLWDWLYH3&5PDFKLQH4LDJHQ5RWRU*HQH4RUHTXLYDOHQW
14. Primers (Table 1)
2.2 Quantitation of chicken type I IFN protein using a bioassay.
1. Culture medium: DMEM, 10% FCS, 100 IU/ml penicillin, 100 µg/ml streptomycin 
2. Stimulation medium: DMEM, 1% FCS, 100 IU/ml penicillin 100 µg/ml streptomycin
3. &(&FKLFNHQ,)1UHSRUWHUFHOOVLQZHOOSODWHVDWFRQÀXHQF\SURYLGHGE\3
Staeheli, see Note 1) (149).
4. 5HFRPELQDQWFKLFNHQLQWHUIHURQDOSKDFK,)1Į/DERPH
5. Multichannel pipet (8 x 200 µL)
6. )LUHÀ\OXFLIHUDVHDVVD\EXIIHU3URPHJD%ULJKW*ORRUHTXLYDOHQW
7. Luminometer
METHODS
3.1 RNA isolation, cDNA synthesis and RT-qPCR on avian cells.
1. Perform the experiment in 24-well plates (see Note 2). Infect or treat cells as desired. 
2. :KHQDSSURSULDWHFHOOVDUHO\VHGE\DGGLQJȝO5/7EXIIHUVSLNHGZLWKQJVDPSOHRI
luciferase mRNA prior to RNA isolation. (see Note 3)
3. Total RNA is isolated using the RNeasy Mini Kit according to the manufacturer’s instructions, 
including an on-column DNase treatment with RNase-free DNase. 
4. Verify RNA integrity on a 1% agarose gel or using a Bioanalyser.
5. 'HWHUPLQH51$FRQFHQWUDWLRQXVLQJDVSHFWURSKRWRPHWHU1DQR'URSRUHTXLYDOHQW
6. Prior to cDNA synthesis, perform a second DNase digestion step using DNase I. 
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7. 6\QWKHVLV RI F'1$ LV SHUIRUPHG RQ  ±  ȝJ WRWDO 51$ XVLQJ 5HYHUVH WUDQVFULSWDVH
and random hexamers according to the manufacturer’s instructions. Incubation steps are 
performed in a regular PCR machine or, alternatively in a waterbath. 
8. $IWHUF'1$V\QWKHVLVVDPSOHVDUHIXUWKHUGLOXWHGLQQXFOHDVHIUHHZDWHUEHIRUHT3&5
analysis. 
9. 3HUVDPSOHSUHSDUHDPDVWHUPL[FRQWDLQLQJȝO[6\EU*UHHQ,0L[DQGOSULPHUPL[
ȝ0IRUZDUGDQGUHYHUVHSULPHU
10. &RPELQHXOPDVWHUPL[DQGȝOGLOXWHGF'1$SHU3&5WXEH
11. 5HDOWLPHTXDQWLWDWLYH3&5LVSHUIRUPHGRQDT3&5PDFKLQHVXFKDV5RWRU*HQH4
cycles, 60 °C annealing temperature, 20 s extension time.
12. &\FOHWKUHVKROGVDQGDPSOL¿FDWLRQHI¿FLHQFLHVDUHFDOFXODWHGXVLQJWKHVRIWZDUHSHUWDLQLQJ
WRWKHT3&5PDFKLQHVXFKDV5RWRU*HQH
13. 8VLQJHTXDWLRQ(TWKHUHODWLYHH[SUHVVLRQUDWLRRIWKHWDUJHWJHQHLVFDOFXODWHGXVLQJ
WKHDYHUDJHUHDFWLRQHI¿FLHQF\IRUHDFKSULPHUVHWDQGWKHF\FOHWKUHVKROG&t) deviation of 
sample vs control at time point 0h (see Note 4).  
 
                   
With: 
R  = fold change of the target gene relative to the control 
Calibrator  = control cells at time point 0 (zero) 
(   DYHUDJHDPSOL¿FDWLRQHI¿FLHQF\IRUWKDWVHWRISULPHUV 
Ct   = cycle threshold
3.2 Quantification of chicken type I IFN protein using a bioassay.
1. If the samples contain virus, heat inactivate at 56 °C for 30 min prior to performing the assay. 
This treatment inactivates coronaviruses but retains bioactivity of type I IFN (see Note 5).
2. Fill a sterile 96-well plate with 50 µl stimulation medium/well.
3. Add 50 µl chIFNĮVWDQGDUG8PORUWHVWVDPSOHWRWKH¿UVWURZYRUWH[EHIRUHDGGLQJ
4. Make serial twofold dilutions in the plate using a multichannel pipet (Fig. 1, see Note 6).
5. Remove the medium from the CEC-32 cells which have been cultured in the 96-well plate 
(see Note 7).
6. Transfer the content of the plate containing the diluted samples and standard to the CEC-32 
cells (see Note 8).
7. Incubate plates at 37 °C and 5%  CO2 for 6 h.
8. 8VHD)LUHÀ\OXFLIHUDVHDVVD\NLW WRGHWHFW OXFLIHUDVHDFWLYLW\DFFRUGLQJWRPDQXIDFWXUHU¶V
instructions.
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Fig. 1  Layout of a 96-well plate to accommodate ten samples and an interferon standard
3.3 Calculation of IFN concentration from luminescence data
1. 7RFDOFXODWHWKHXQLWVRILQWHUIHURQLQWKHRULJLQDOVDPSOHDZRUNÀRZLVSURYLGHGLQ)LJ
2. Transfer the measurements from the luminometer to a spreadsheet program (Microsoft Excel 
RUHTXLYDOHQW
3. Calculate the average value of the background luminescence and subtract this value from all 
wells (Fig. 2, point A). 
4. Calculate the average of the wells incubated with the diluted interferon standard and plot 
them in a scatter plot. This graph is the standard curve (B). 
5. Make a new graph using only the data points that fall within the linear range of the standard 
curve, usually 1 - 12.5 or 1 - 6 U/ml. 
6. 3ORWDOLQHDUWUHQGOLQHWKURXJKWKHVHGDWDSRLQWVDQGGLVSOD\WKHHTXDWLRQRQWKHFKDUW&
7. Next, all luminescence values that fall within the linear range of the standard curve are 
selected (here 2 - 12 U/ml).
8. &DOFXODWHWKH,)1FRQFHQWUDWLRQLQHDFKZHOOXVLQJWKHHTXDWLRQIURPWKHVWDQGDUGFXUYH'
9. Multiply by the dilution factor to obtain the concentration of IFN in the undiluted samples 
(E). 
10. Finally, calculate the average IFN concentration of the wells that fall within the linear range 
XVXDOO\WZRRUWKUHHZHOOVSHUVDPSOH7KLVYDOXHFRUUHVSRQGVWRWKH¿QDOFRQFHQWUDWLRQRI
type I interferon in the original sample (F). 
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Fig. 2  Workflow on how to calculate the concentration of IFN in the original sample from readout of the 
luminometer. 
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Notes
1. For more detail on the construction of CEC-32 chicken-IFN reporter cells, see ref (149).
2. To obtain enough RNA, each well of a 24-well plate should contain around 3 x 105 avian 
cells.
3. For normalisation, a housekeeping gene such as GAPDH is generally used. It is advised to 
ensure that the reference gene selected is stable under the conditions of each experiment 
by performing stability analysis. When the mRNA level of the reference gene is not stable 
during the experimental procedure, such as during prolonged infection with a virus, we use an 
external reference gene for normalisation. The external reference gene we use is luciferase, 
which is added as mRNA (commercially available) to the RLT lysis buffer (1 ng/sample) 
prior to RNA isolation and cell lysis. This guarantees that the external reference RNA and the 
host RNA are subject to the same treatment prior to cDNA synthesis
4. To calculate the fold change of IBV total RNA, CtGHYLDWLRQLVFDOFXODWHGYHUVXVD¿[HG&t 
value (e.g., Ct = 30), because no IBV is present in the non-infected cells that are used as 
control in all the experiments. 
5. Interferon containing samples can be stored at 4 °C overnight. Storage at -20 °C ensures long 
time (> months) stability. One freeze-thaw cycle can reduce the IFN-activity of a sample by 
40%. To  avoid repeated freeze-thawing of samples, avoid measuring the same sample twice. 
To achieve this, ensure that at least one of the dilutions of the samples falls within the linear 
range of the standard curve. 
6. To select the appropriate dilutions it is advisable to perform a pilot experiment. One can 
either make an extensive twofold serial dilution series (for example 2 - 1024 times dilution), 
or use tenfold pre-dilutions. In our hands IFN production by avian cells rarely exceeds 5000 
8POWKHUHIRUHDPD[LPXPRIWLPHVSUHGLOXWLRQVKRXOGVXI¿FH
7. Medium is removed simply by emptying the 96-well plate in the waste and gently tapping it 
dry on a stack of tissues. Sterility is not an issue, the cells will only be incubated for another 
6 h.
8. CEC-32 cells should not be allowed to dry out! Make sure you transfer the samples to the 
cells within minutes. Drying of the monolayer will decrease the luminescence and thereby 
QHJDWLYHO\LQÀXHQFHWKHDVVD\:KHQWUDQVIHUULQJWKHGLOXWHGVDPSOHVWRZHOOSODWHZLWK
CEC-32 cells, start with the lowest concentration and work your way up the dilutions. In this 
way the same tips can be used for multiple dilutions. Do not forget to add medium to the 
negative controls.
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INTRODUCTION
The antiviral type I IFN response (IFN response) has been shown to be crucial for the control of 
coronavirus infection (65, 84, 85). To secure their persistence in the host, coronaviruses have been 
evolutionarily selected to evade and antagonise the IFN response. In this chapter, I will discuss our 
¿QGLQJVRQKRZWKHLQIHFWLRXVEURQFKLWLVYLUXV,%9FRXQWHUDFWVWKH,)1UHVSRQVHZLWKLQWKHFXUUHQW
landscape of knowledge. To provide a framework for this discussion, the IFN response is devided in 
four stages, at which we found that IBV antagonises or evades the IFN response (Fig. 1). Firstly, we 
describe that IBV delays detection by the host (Chapter 2). Secondly, we found that IBV decreases 
translation of host-proteins including that of IFN (Chapter 4). Thirdly, we observed that IBV inhibits 
signaling by IFN, and fourthly we conclude that IBV resists the IFN-induced antiviral state (Chapter 3). 
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Fig. 1 Antagonism of the type I IFN-response by IBV.
7KLV¿JXUHSURYLGHVDIUDPHZRUNIRUWKHGLVFXVVLRQRQWKHIRXUSRLQWVDWZKLFK,%9DQWDJRQLVHVWKH,)1UHVSRQVHDV
LGHQWL¿HGLQWKLVWKHVLV,%9GHOD\VGHWHFWLRQE\WKHKRVW,%9GHFUHDVHVWUDQVODWLRQRIKRVWSURWHLQVLQFOXGLQJ
WKDWRI,)1,%9LQKLELWVVLJQDOLQJE\,)1,%9UHVLVWVWKH,)1LQGXFHGDQWLYLUDOVWDWH7KLV¿JXUHLVLQFOXGHG
at the start of every paragraph to help guide the reader through the discussion.
,Q WKH IROORZLQJ SDUDJUDSKV ,ZLOO GLVFXVV WKH ¿QGLQJV RI WKLV WKHVLV IRU HDFK RI WKH IRXU SRLQWV DW
ZKLFK,%9DQWDJRQLVHVWKH,)1UHVSRQVH,QDGGLWLRQ,ZLOOGLVFXVVVRPHRIWKHUHPDLQLQJTXHVWLRQV
on how IBV antagonises the IFN response, and I will put forward suggestions on how to answer these 
TXHVWLRQV)LJLVLQFOXGHGDWWKHVWDUWRIHYHU\SDUDJUDSKWRJXLGHWKHUHDGHUWKURXJKWKHGLVFXVVLRQ
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1. IBV DELAYS DETECTION BY THE HOST
A common feature of Alpha- and Betacoronaviruses, including human coronavirus 229E (HCoV-
229E), severe acute respiratory syndrome coronavirus (SARS-CoV), and mouse hepatitis virus 
(MHV), is their limited activation of the IFN response (88, 90-93). In fact, these coronaviruses 
have been shown to evade detection by the host-cell in various ways. First of all, coronavirus 
51$VDUHPRGL¿HGE\ WZRYLUXV HQFRGHGPHWK\OWUDQVIHUDVHV SURYLGLQJ D FDS VWUXFWXUH WKDWPDNHV
them undistinguishable from host mRNAs (reviewed in ref. (155)). In addition to this, coronavirus-
infection induces extensive rearrangements of intracellular membranes (reviewed in ref. (95)). These 
membrane structures have been described for many coronaviruses, including IBV, and they have been 
suggested to shield virus induced double-stranded RNA (dsRNA) from detection by pattern-recognition 
receptors (PRRs) (86, 87, 163). Shielding of dsRNA from PRRs is essential for coronaviruses, 
EHFDXVHGV51$LVSURGXFHG LQ ODUJHTXDQWLWLHVGXULQJ LQIHFWLRQ ,QDGGLWLRQ WR WKHVH
hiding strategies, coronaviruses have been shown to block the signaling pathways downstream of 
PRRs. For example, nsp 3 of both MHV and SARS-CoV inhibits signaling by PRRs through de-
XELTXLWLQDWLRQ RI VLJQDOLQJPROHFXOHV WKDW DUH GRZQVWUHDP RI WKHVH 355V  $GGLWLRQDOO\
the nucleocapsid, ORF3b and ORF6 proteins of SARS-CoV and MHV have all been shown to 
interfere with activation of the IFN response via unknown mechanisms (reviewed in ref. (125)). 
        At the start of this thesis, knowledge about activation of the IFN response by IBV was limited. Two 
transcriptional studies found that infection with IBV induced upregulation of various immune-related 
genes, but not of ,IQĮ or ,IQȕ (type I IFN) in the lungs and trachea of chickens (130, 131). Another study 
demonstrated upregulation and protein production of ,IQȖ (type II IFN) but not ,IQĮ or ,IQȕin the lungs of 
IBV-infected chickens (212). Contrary to ,IQĮ and ,IQȕ, production of ,IQȖ does not depend on activation 
of intracellular PRRs, as it is mainly produced by NK cells and activated T cells. Taken together, 
these studies provided no clear evidence for activation of the type I IFN response upon IBV-infection. 
,QFKDSWHUZHTXDQWL¿HGDFWLYDWLRQRIWKHW\SH,,)1UHVSRQVHin vitro and found that IBV-infection 
induces transcription of ,IQȕ (type I IFN) in chicken epithelial cells, but only after the peak of viral 
replication. We also show that transcription of ,IQȕ is dependent on the pattern recognition receptor 
MDA5, showing that MDA5 is the primary PRR involved in detection of IBV. Although virus titres 
UHDFKHGDPD[LPXPEHWZHHQ±KRXUVSRVWLQIHFWLRQKSLZHGLGQRWREVHUYHWUDQVFULSWLRQRI,IQȕ, 
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GXULQJWKH¿UVWKRXUVRIWKHLQIHFWLRQ%HFDXVH,IQȕ transcription seemed to be delayed in respect 
to the peak of viral replication, we investigated whether IBV blocks ,IQȕWUDQVFULSWLRQGXULQJWKH¿UVW
12 hours of infection. Stimulation of IBV-infected cells with dsRNA (poly I:C) or superinfection with 
other RNA viruses indicated that IBV does not interfere with recognition, signaling, or transcription of 
,IQȕGXULQJWKH¿UVWKRXUVRILQIHFWLRQ)LJ
        
Fig. 2 PRR signaling during IBV infection.
'XULQJ WKH ¿UVW  KRXUV RI WKH LQIHFWLRQ ,%9
replicates and new progeny virus is released 
from the cell. During this period, virus-induced 
dsRNA accumulatesin the cell, but does not lead 
to activation of the IFN response. This suggests 
that IBV either avoids or prevents detection of 
dsRNA by the host cell. Our experiments (chapter 
VXJJHVWWKDWGXULQJWKH¿UVWKRXUVVLJQDOLQJ
of non-self RNA (dashed lines) via RNA pattern 
recognition receptors (e.g. MDA5 and TLR3) 
remains fully functional and can be activated by 
stimulation with dsRNA or heterologous RNA 
viruses. We suggest that during this period, IBV 
induced dsRNA is not recognised by PRRs, 
because it is protected by virus-induced membrane 
rearrangements.
Our observation that IBV infection does not reduce ,IQȕ transcription in response to dsRNA or RNA 
YLUXVHVSUREDEO\GRHVQRWH[FOXGHWKHSRVVLELOLW\WKDW,%9FRXOGLQÀXHQFH355VLJQDOLQJEHIRUH
hpi. The nsp3 protein of MHV for example, has been shown to interfere with activation of the IFN 
response (213) however, signaling of poly I:C is not inhibited in MHV-infected cells (163). In fact, 
we investigated whether nsp3 of IBV can interfere with activation of the IFN response. We found that 
overexpression of IBV-nsp3-GFP did not inhibit activation of an ,IQȕreporter (data not shown). This 
result was unexpected, as inhibition of ,IQȕVLJQDOLQJE\QVSLVPHGLDWHGYLDGHXELTXLWLQDWLRQRIKRVW
SURWHLQVDQGQVSRI ,%9KDV UHFHQWO\EHHQVKRZQ WRKDYHGHXELTXLWLQDWLQJDFWLYLW\ )XUWKHU
UHVHDUFKZLOOEHQHHGHGWRGH¿QLWLYHO\HVWDEOLVKZKHWKHUQVSRI,%9DQWDJRQLVHVDFWLYDWLRQRIWKHW\SH
I IFN response. 
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2. IBV DECREASES PRODUCTION OF ANTIVIRAL PROTEINS       
    INCLUDING IFN.
Many viruses inhibit translation of host proteins (host-translation), a process referred to as host shutoff 
+RVWVKXWRIILVEHQH¿FLDOIRUWKHYLUXVDVLWLQFUHDVHVWKHFDSDFLW\RIWKHKRVWFHOOWRSURGXFHVYLUDO
proteins. Simultaneously host shutoff hinders the innate immune response by preventing production 
of antiviral host proteins, including cytokines such as IFNĮDQG,FNȕ (Fig. 1). Coronaviruses from 
the Alpha- and Betacoronavirus genus have also been shown to inhibit translation of host proteins. 
      In chapter 2 we found that accessory protein 3b of IBV decreases the production of IFN protein 
ODWHGXULQJWKHLQIHFWLRQRIFKLFNHQFHOOV±KSL,QWKLVFKDSWHUZHDOVRIRXQGWKDWDQXOOYLUXV
induces less IFN than the parental virus and much less IFN production than 3b-null virus. We speculate 
that decreased IFN production by 3a-null virus is the result of increased translation of 3b. Both protein 
3a and 3b are translated from the same subgenomic mRNA 3 of IBV and translation of 3b is dependent 
RQµOHDN\VFDQQLQJ¶LQZKLFKWKHULERVRPHVNLSVWKH¿UVWVWDUWFRGRQ,%9DWRVWDUWWUDQVODWLRQDWWKH
second start codon (IBV-3b) (215). The scrambled start-codon of the 3a null-virus could thus increase 
translation of 3b, which in turn further inhibits translation of IFN. The expression of the third (E) 
SURWHLQHQFRGHGE\WKLVWULFLVWURQLF51$LVSUREDEO\QRWLQÀXHQFHGE\VFUDPEOLQJRIWKHXSVWUHDPVWDUW
codon, because translation of this protein is initiated via an internal ribosome entry site (IRES) (216). 
      In the same experiment we found that infection with 3b-null virus induced high levels of ,IQȕ 
mRNA at 24 hpi, indicating that IBV imposes an additional block on the translation of ,IQȕ mRNA. 
Indeed, in chapter 4 we show that IBV-infection induces a general decrease in translation of host-
proteins as early as 12 hpi. Using accessory gene null-mutants we further show that accessory 
protein 5b of IBV is essential for establishment of this host shutoff, although the mechanism by 
which 5b decreases host translation remains to be investigated. Interestingly, removal of 5b does 
not affect replication of IBV in vitro, indicating that host shutoff is not essential for viral replication. 
        Like accessory proteins 3b and 5b of IBV, accessory protein 7 of TGEV (TGEV-7) has been 
shown to decrease transcription and translation of IFN (17). In chapter 2 we report that both TGEV-7 
and IBV-3b contain a PP1 binding domain, a domain that was shown to be important for the function 
of TGEV-7. In apparent contrast to its inhibitory effect on production of IFN, TGEV-7 has been shown 
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WR LQFUHDVH WRWDOKRVWWUDQVODWLRQGHFUHDVHSKRVSKRU\ODWLRQRIH,)ĮDQGVWDELOLVHKRVWP51$
Thus far, our observations on IBV3b-null virus are in line with the observations on TGEV-7-null virus 
as both induce increased translation and transcription of IFN and both contain a PP1 binding domain. 
       Taken together, we conclude that IBV inhibits translation of host proteins, including that of type I 
IFN. We demonstrate that accessory protein 5b plays an essential role in the overall inhibition of host-
translation and we show that accessory protein 3b inhibits production of IFN protein. The mechanism(s) 
by which IBV-3b and 5b decrease translation of host-proteins merits further investigation. Additionally, 
it remains to be investigated whether IBV-3b only inhibits production of IFN, or also of other host-
proteins. Because of the similarities between our observations on IBV-3b null and previous observations 
on TGEV-7-null virus, it would be interesting to compare the IBV-3b and TGEV-7 accessory proteins. 
For example, by investigating whether 3b, like TGEV-7 also stabilises host mRNA, increases general 
KRVWWUDQVODWLRQDQGLQKLELWVSKRVSKRU\ODWLRQRIH,)Į
Potential role of stress-granules and processing bodies in IBV-induced host shutoff.
In chapter 4 we demonstrated that IBV inhibits protein production, without inducing degradation of 
host mRNA. Interestingly, some host mRNAs, such as that of ,IQȕ showed increased stability in IBV-
infected cells. The reason for this increased stability is unclear, but one possible explanation could 
be that host mRNAs are recruited to stress granules (SG) in IBV infected cells. SGs are temporary 
repositories of mRNAs and they are formed in response to stress-induced translational arrest (217, 
218). Stress granules have been shown to prevent degradation of mRNAs by cellular ribonucleases. 
,QFUHDVHGSKRVSKRU\ODWLRQRIH,)ĮZKLFKIUHTXHQWO\DFFRPSDQLHVYLUXVLQGXFHGKRVWVKXWRIILVRQH
of the triggers for SG formation (219). Many viruses have been shown to modulate formation of SG, 
EXWLQPRVWFDVHVLWLVXQFOHDUZKHWKHU6*IRUPDWLRQLVEHQH¿FLDOWRWKHKRVWRUWRWKHYLUXVUHYLHZHG
in (220)). Stress-granules have been observed in TGEV and MHV infected cells (115, 221) and in the 
case of TGEV, formation of SG coincided with decreased viral RNA synthesis, suggesting that SGs 
are detrimental to the virus. To evaluate the possible role of SG during IBV infection, we studied SG 
IRUPDWLRQLQ,%9LQIHFWHGFHOOVZLWKDQDQWLERG\VSHFL¿FIRUWKHVWUHVVJUDQXOHPDUNHU5DV*73DVH
activating protein-binding protein 1 (G3BP) (Fig. 3). 
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Our data showed that at aggregates of G3BP could be detected in a subset (~10 - 25%) of IBV-
infected Vero cells. Next, we induced formation of canonical SGs in IBV infected cells and 
found that formation of canonical stress granules was strongly reduced in IBV-infected cells. 
        These results indicate that IBV modulates the localisation of G3BP and inhibits the formation of 
canonical SGs. Preliminary experiments indicate that IBV-induced SG-like aggregates of G3BP are in 
fact different from canonical SGs. Unlike canonical, arsenide induced stress granules, IBV-induced SG-
like aggregates did not dissolve upon treatment with cycloheximide (data not shown). Our observations 
on SG formation in IBV-infected cells are highly reminiscent of observations made on vaccinia virus 
lacking the E3L double-stranded RNA (dsRNA)-binding protein (vacciniaǼ(/), which also induced 
non-canonical SGs (222). In this study SG formation was associated with increased phosphorylation of 
H,)ĮGHFUHDVHGKRVWWUDQVODWLRQDQGGHFUHDVHGYLUXVUHSOLFDWLRQ
Fig. 3 IBV modulates formation of stress granules.
Vero cells were infected with IBV at MOI 0.1 or left untreated (mock). At 18 hpi cells were either left untreated 
PRFNRUVWLPXODWHGZLWKDUVHQLGHIRUPLQXWHVWRLQGXFHIRUPDWLRQRIVWUHVVJUDQXOHV6XEVHTXHQWO\FHOOVZHUH
stained with antibodies against the nucleocapsid of IBV and against G3BP, a marker for stress granules. White 
arrowheads indicate IBV-infected cells that do not contain stress granules, and open arrowheads indicate IBV-
infected cells that contain stress granules. The dotted line in the right column of images delimits an area of IBV-
infected cells to show that IBV inhibits formation of canonical (arsenide induced) stress granules. 
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To evaluate if modulation of stress-granules is essential for inhibition of host-translation by IBV, we 
investigated SG-modulation by IBV-5a/5b null-virus, because this virus allows more translation than the 
parental virus (chapter 4). We found no differences in aggregation of G3BP- or inhibition of arsenide-
induced SG formation between cells infected with 5a/5b null-virus or the parental virus (data not shown). 
     In short, IBV modulates SG formation, but accessory protein 5b, which inhibits host-translation 
does not seem to be involved in modulation of SG formation. These results indicate that inhibition 
of translational by IBV does not depend on activation or inhibition of stress granule-formation. 
     MHV infection induces a general decay of host-mRNAs, which has been associated with the 
formation of processing bodies (PB) (115). processing bodies are cytoplasmic granules present in all 
eukaryotic cells and are linked to mRNA silencing and degradation (218, 223). IBV infection does 
not induce general degradation of host-mRNA, which might suggest that, contrary to MHV, IBV does 
QRW LQGXFH IRUPDWLRQ RI SURFHVVLQJ ERGLHV 8VLQJ LPPXQRÀXRUHVFHQWPLFURVFRS\ ZH LQYHVWLJDWHG
WKHORFDOLVDWLRQRI¶¶H[RULERQXFOHDVH;51ZKLFKLVDPDUNHUIRUSURFHVVLQJERGLHV)LJ 
Fig. 4  IBV modulates distribution of processing bodies
Vero cells were infected with IBV at MOI 0.1 or left untreated (mock) at 18 hpi cells were either mock treated 
RUVWLPXODWHGZLWKF\FORKH[LPLGH&+;IRUPLQXWHVWRGLVVROYHSURFHVVLQJERGLHV6XEVHTXHQWO\FHOOVZHUH
VWDLQHGZLWKDQWLERGLHVDJDLQVWWKHQXFOHRFDSVLGRI,%9DQGDJDLQVWWKHH[RQXFOHDVH;51DPDUNHUIRU3ERGLHV
2SHQDUURZKHDGVLQGLFDWHQRQLQIHFWHGFHOOVVKRZLQJFDQRQLFDOORFDOLVDWLRQRI;51LQSURFHVVLQJERGLHV:KLWH
DUURZKHDGVLQGLFDWH,%9LQIHFWHGFHOOVWKDWVKRZQRQFDQRQLFDOORFDOLVDWLRQRI;51
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,QPRFN WUHDWHGFHOOV;51LV ORFDOLVHG LQD OLPLWHGQXPEHURIGLVFUHWHF\WRSODVPLF IRFLZKHUHDV
LQ,%9LQIHFWHGFHOOV;51ZDVPRUHDEXQGDQWDQGGLIIHUHQWO\ORFDOLVHGFRPSDUHGWRPRFNWUHDWHG
cells. Treatment of cells with cycloheximide (inhibitor of translation) dissolves canonical processing 
ERGLHVOHDGLQJWRDGLIIXVHORFDOLVDWLRQRI;51,Q,%9LQIHFWHGFHOOVF\FORKH[LPLGHGLGQRW
LQGXFHVLJQL¿FDQWDOWHUDWLRQLQWKHORFDOLVDWLRQRI;51VXJJHVWLQJWKDWH[FHSWVWUHVVJUDQXOHV,%9
also modulates formation of processing bodies. Processing bodies are sites of mRNA degradation, and 
although speculative, modulation of PB formation by IBV could reduce degradation of host mRNAs. 
This would offer an explanation for increased stability of host mRNA in IBV-infected cells observed 
in chapter 4. 
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3. IBV INHIBITS IFN-SIGNALING.
In chapter 3 we show that IBV blocks IFN-induced signaling by inhibiting phosphorylation and 
VXEVHTXHQWQXFOHDU WUDQVORFDWLRQRI67$73KRVSKRU\ODWLRQRI67$7LV WKH¿UVWVWHS LQDFWLYDWLRQ
of its function as transcription factor and is mediated by two Janus kinases, JAK1 and TYK2. The 
mechanism by which IBV inhibits STAT1-phosphorylation is unclear; however, as phosphorylation 
of STAT1 is dependent on JAK1 and TYK2 it is reasonable to assume that IBV somehow interferes 
with the function of these kinases. We did not observe STAT1-degradation products in Western blot, 
therefore we can exclude that reduced phosphorylation of STAT1 is caused by degradation of the 
SURWHLQ7RHOXFLGDWHKRZ,%9LQKLELWVSKRVSKRU\ODWLRQRI67$7ZLOOUHTXLUHWKHLGHQWL¿FDWLRQRIWKH
viral protein(s) that mediate this inhibition. In chapter 3 we exclude the involvement of the accessory 
proteins of IBV by showing that IBV-3a/3b and IBV-5a/5b null viruses also inhibit phosphorylation 
of STAT1. The next step would be to test whether the individual structural and non-structural 
proteins of IBV inhibit phosphorylation and translocation of STAT1 when over-expressed in Vero 
cells. The IBV protein responsible for inhibition of STAT1 phosphorylation could then be used to 
identify interacting host proteins, which could provide clues on the potential mechanism of inhibition. 
,QFKDSWHUZHDOVRGHVFULEHWKDW67$7VLJQDOLQJLVQRWLQKLELWHGGXULQJWKH¿UVWKRXUVRI,%9
LQIHFWLRQLQ9HURFHOOV7KH¿UVWSURJHQ\YLUXVLVUHOHDVHGDSSUR[LPDWHO\KRXUVDIWHU,%9LQIHFWLRQRI
Vero cells, which is about four hours later than in chicken cells (4, 172). The replication cycle of IBV in Vero 
FHOOVLVWKXVFRPSOHWHGZLWKLQKRXUVDQGH[FHSWIRUWKHDFFHVVRU\SURWHLQVDOO,%9SURWHLQVDUHUHTXLUHG
IRUJHQHUDWLRQRISURJHQ\YLUXV$VDFRQVHTXHQFHDOO,%9SURWHLQVDUHSUHVHQWLQ9HURFHOOVEHIRUH
10 hpi, indicating that the time-dependency of STAT1-inhibition (not before 12 hpi) must be the result of 
DSRVWWUDQVODWLRQDOHYHQW2QHSRVVLELOLW\LVWKDWWKHORFDOL]DWLRQRIYLUDOSURWHLQVWKDWLQÀXHQFH67$7
phosphorylation changes over time, possibly by disintegration of virus-induced membrane structures. 
      In support of this hypothesis, we observed that activation of ,IQȕ transcription by double stranded 
51$RUKHWHURORJRXV51$YLUXVHVLVQRWLQKLELWHGGXULQJWKH¿UVWKRXUVRI,%9LQIHFWLRQFKDSWHU
UHI&RPELQHG WKHVHREVHUYDWLRQVVXJJHVW WKDWGXULQJWKH¿UVWKRXUVRI LQIHFWLRQ,%9
effectively ‘hides’ from the host-cell and does not inhibit signaling from the interferon receptor or 
PRRs. Later during the infection, virus induced membrane structures may disintegrate, thereby allowing 
detection of IBV, and re-localisation of host or viral proteins to inhibit STAT1 signaling.
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4. IBV ANTAGONISES THE IFN-INDUCED ANTIVIRAL STATE.
,Q WKLV WKHVLV ZH ¿QG WKDW ,%9 HI¿FLHQWO\ LQKLELWV WKH SURGXFWLRQ RI ,)1 in vitro, suggesting that 
IBV does not encounter high concentrations of IFN during infection. If this were the case, IBV 
does not need to be resistant to the IFN induced antiviral state. However, during in vivo infection 
this situation might be different, as birds are often simultaneously infected with various pathogens. 
In fact, IBV-associated mortality is almost exclusively observed in birds infected with another virus, 
EDFWHULXP RU P\FRSODVPD 6XFK FRLQIHFWLRQV RFFXU IUHTXHQWO\ DV ,%9LQIHFWLRQ FRPSURPLVHV
epithelial barriers and thereby facilitates infection by other pathogens. Within this context it is 
OLNHO\WKDW,%9PLJKWIUHTXHQWO\HQFRXQWHUKLJKFRQFHQWUDWLRQVRI,)1DQGWKXVQHHGVWREHUHVLVWDQW
to the IFN-induced antiviral state. In line with this view, coronaviruses such as MHV and feline 
coronavirus (FeCoV) have been shown to be relatively resistant to IFN treatment in vitro (93, 113). 
Although the mechanisms by which these viruses resist IFN treatment is poorly understood, it has 
been shown that several accessory proteins of coronaviruses are important for resistance to IFN 
WUHDWPHQW 3UHYLRXV VWXGLHV RQ ,%9 KDYH GHPRQVWUDWHG WKDW SODTXH IRUPDWLRQ  DQG V\QF\WLD
IRUPDWLRQLVUHGXFHGE\,)1WUHDWPHQWEXWTXDQWLWDWLYHGDWDRQ,)1VHQVLWLYLW\RI,%9LVODFNLQJ 
       In chapter 3 we describe that IBV is relatively resistant to IFN treatment. In addition, we show 
that IBV-3a/3b null virus is less resistant to IFN treatment. The observation that IBV-3a/3b null virus 
LVPRUHVHQVLWLYHWR,)1UDLVHVWKHTXHVWLRQDVWRZKDWH[WHQWLQGLYLGXDODDQGESURWHLQVFRQWULEXWHG
WRWKH,)1UHVLVWDQFHRI,%9DEQXOOYLUXV7RDGGUHVVWKLVTXHVWLRQZHLQYHVWLJDWHGWKHUHVLVWDQFH
RI ,%9DE ,%9D DQG ,%9EQXOO YLUXVHV WR ,)1 WUHDWPHQW LQ') FHOOV E\TXDQWLI\LQJYLUDO
genomes and infectious particles in the supernatant 24 hours post infection. Our preliminary results 
(Fig. 5), indicate that both the 3a- and 3a/3b null viruses were less resistant to IFN treatment than 
the parental virus, whereas IFN-resistance of the 3b-null virus was comparable to the parental virus. 
These results indicate that accessory protein 3a of IBV is primarily responsible for resistance to IFN. 
Interestingly, during infection of primary trachea organ culture (TOC), the titre of both IBV-3a null and 
IBV-3a/3b null viruses declined more rapidly than the titre of the parental virus or IBV-3b null virus 
,QYLHZRURXU¿QGLQJVWKHGHFUHDVHLQWLWUHRI,%9DQXOODQG,%9DEQXOOYLUXVHVLQ72&
could be the result of increased sensitivity of both viruses to IFN produced by cells of the TOC.
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Fig. 5 Accessory protein 3a contributes to IFN resistance in chicken cells. 
') FHOOVZHUH VWLPXODWHGZLWK FKLFNHQ ,)1Į RU ,)1ȕ IRU  KRXUV DQG VXEVHTXHQWO\ LQIHFWHGZLWK%HDX5 RU
accessory protein null viruses (scAUG) at MOI 0.01 in the presence of IFN. (A)$WKSLYLUXVZDVTXDQWL¿HG
E\57T3&5XVLQJSULPHUVDJDLQVW,%91RQ51$LVRODWHGIURPFHOOVXSHUQDWDQW%DUVUHSUHVHQWWKHSHUFHQWDJH
RI JHQRPH HTXLYDOHQWV UHODWLYH WR QRQ,)1 WUHDWHG FHOOV LQIHFWHG ZLWK WKH VDPH YLUXV (UURU EDUV LQGLFDWH
VWDQGDUG GHYLDWLRQ DQG DVWHULVNV LQGLFDWH VLJQL¿FDQW GLIIHUHQFHV  3  3  3 FRPSDUHG
to the parental Beau-R virus as determined using a two-way ANOVA followed by a Holm-Sidak post-hoc test. 
%,QDGXSOLFDWHH[SHULPHQWYLUXVLQWKHVXSHUQDWDQWZDVTXDQWL¿HGE\WLWUDWLRQDQGWKHWLWUHUHODWLYHWRQRQ,)1
treated cells was calculated. Values represent the mean of triplicate wells from a representative experiment, error 
EDUV LQGLFDWH VWDQGDUGGHYLDWLRQDQGDVWHULVNV LQGLFDWH VLJQL¿FDQWGLIIHUHQFHV 3 FRPSDUHG WR WKHSDUHQWDO
Beau-R virus as determined using a two-way ANOVA followed by a Holm-Sidak test for multiple-comparisons.
Currently, we can only speculate about the mechanism by which IBV-3a antagonises the effect of the 
IFN-induced antiviral state. For MHV it was demonstrated that its accessory protein ns2, antagonises 
the 2’-5’-oligoadenylate synthetase (OAS) ribonuclease (RNase) L pathway (109). This pathway is a 
potent antiviral response that is activated by double-stranded RNA. Interestingly, accessory protein 3a 
has previously been shown to partially co-localise with dsRNA in IBV-infected chicken cells, which 
could indicate that 3a, just as MHV ns2 antagonises the OAS-RNase L antiviral pathway (181).
A B
104
General Discussion
7
 
Fig. 6 Timing of events during IBV-infection in vitro. 
7RYLVXDOLVHWKHWHPSRUDOUHODWLRQVKLSEHWZHHQWKH¿QGLQJVGHVFULEHGLQWKLVWKHVLVZHSURYLGHDVFKHPDWLFRYHUYLHZ
RIWKHWLPLQJRIHYHQWVWKDWPD\LQÀXHQFHWKH,)1UHVSRQVHGXULQJ,%9LQIHFWLRQLQYLWUR:HLQGLFDWHLQZKLFKFHOO
W\SHWKH¿QGLQJZDVPDGHEHFDXVHNLQHWLFVRILQIHFWLRQDUHGLIIHUHQWEHWZHHQFKLFNHQDQG9HURFHOOV$WWLPHSRLQW
0, cells are infected by IBV. At three hours post infection (hpi), dsRNA can be detected in chicken cells (Chapter 
7KH¿UVWSURJHQ\YLUXVVWDUWVWREHUHOHDVHGIURPLQIHFWHGFKLFNHQFHOOVDURXQGKSL±KSLLQ9HURFHOOV
Between 6 and 12 hpi, inhibition of host-translation by IBV is detected in Vero cells (Chapter 4). From 6 hpi until 
18 hpi the number of infectious viruses in the supernatant of chicken cells increases exponentially (Chapter 2). 
7UDQVFULSWLRQRI,IQȕLQFKLFNHQFHOOVVWDUWVDURXQGKSL&KDSWHU'XULQJWKH¿UVWKRXUVRIWKHLQIHFWLRQ
VLJQDOLQJRIGV51$KHWHURORJRXV51$YLUXVHVFKLFNHQFHOOVDQGW\SH,,)167$7VLJQDOLQJ±9HURFHOOVLVQRW
inhibited. At 18-24 hpi IBV modulates the formation of stress granules and processing bodies in Vero cells (data 
about modulation of these structures before and after this period is lacking). Starting at 36 hpi, limited amounts of 
IFN protein are detected in the supernatant of chicken cells. 
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6. DESIGN OF RATIONALLY ATTENUATED VACCINES FOR IBV: IM-
PLICATIONS OF OUR FINDINGS.
In this thesis we show the involvement of three of the four accessory proteins of IBV in antagonism 
of the type I interferon response. Proteins 3b and 5b inhibit production of IFN protein and 3a is 
most probably responsible for increased resistance to IFN. The interferon antagonistic properties of 
accessory proteins 3a, 3b and 5b could make them interesting targets for rational attenuation of IBV. 
However, the work described in this thesis was carried out in vitro, using cell lines and primary 
cells isolated from chickens and chicken embryos. In addition to this, all conclusions regarding 
the functions of the accessory proteins of IBV in this thesis are based on experiments using the 
IBV Beaudette strain, which is attenuated and non-pathogenic in vivo. To investigate the role 
of the accessory proteins on the pathogenicity of IBV in vivo ZLOO UHTXLUH WKH JHQHUDWLRQ RI
SDWKRJHQLFVWUDLQVRI,%9VXFKDV0RU4; WKDWGRQRWH[SUHVVRQHRUPRUHDFFHVVRU\SURWHLQV 
     ,W ZLOO EH YHU\ LQWHUHVWLQJ WR VHH ZKDW LQÀXHQFH GHOHWLRQ RI WKH DFFHVVRU\ SURWHLQV RI ,%9
VWUDLQV VXFK DV 0 RU 4; ZLOO KDYH RQ WKHLU SDWKRJHQLFLW\ LQ FKLFNHQV ,Q JHQHUDO GHOHWLRQ
of coronavirus accessory proteins leads to attenuation of the virus in the natural host (11, 12, 
 7KLV KDV EHHQ FRQ¿UPHG IRU WKH DFFHVVRU\ SURWHLQV RI 0+9 )H&R9 DQG 7*(9 )LHOG
LVRODWHV RI ,%9 WKDW ODFN WKUHH RU IRXU RI WKH FDQRQLFDO DFFHVVRU\ SURWHLQV KDYH EHHQ LGHQWL¿HG
and these viruses were attenuated in vivo (35). This observation suggests that deletion of one or 
more accessory proteins of pathogenic IBV viruses will indeed lead to their attenuation in vivo. 
    It remains to be investigated whether the functions we describe in this thesis for the accessory 
SURWHLQVRI,%9%HDXGHWWHWUDQVODWHWRSDWKRJHQLFVWUDLQVRI,%9VXFKDV0RU4;7RYLVXDOLVHWKH
differences between the accessory proteins of different Gammacoronaviruses, we aligned the protein 
VHTXHQFHV RI WKH DFFHVVRU\ SURWHLQV RI WXUNH\ FRURQDYLUXV 7XUNH\&R9 GXFN FRURQDYLUXV 'XFN
&R9DQGIRXU,%9VWUDLQVLQFOXGLQJ0DQG4;7KHUHVXOWRIWKHVHDOLJQPHQWVLVVXPPDULVHGLQ
similarity and identity matrices (Fig. 7).
Fig. 7  Identity and similarity matrices of Gammacoronavirus accessory proteins.
7KHSURWHLQVHTXHQFHVRIVL[Gammacoronaviruses were aligned using ClustalW. The shade of grey indicates the 
SHUFHQWDJHRIVLPLODULWLHVDQGLGHQWLW\EHWZHHQWKHSURWHLQVHTXHQFHVRIWKHLQGLFDWHGYLUXVHV*HQEDQNQXPEHUV
RIWKHVHTXHQFHVXVHGLQWKHDOLJQPHQW0$<%HDX51&B4;-4.)
Turkey CoV, EU022526; Duck CoV, JF705860. 
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When comparing the amino-acid identities of the accessory proteins of different Gammacoronaviruses, 
it becomes apparent that 5b is the most conserved of the four accessory proteins (minimum of 88% 
identity). Accessory protein 3b on the other hand shows the least degree of similarity between 
the different viruses (minimum of 56% identity). The identity matrices also show a high degree 
of amino acid identity between the accessory proteins of the apathogenic Beaudette (Beau-R) 
DQG WKH SDWKRJHQLF 0 VWUDLQ 7KLV PD\ LQGLFDWH WKDW RXU ¿QGLQJV RQ WKH DFFHVVRU\ SURWHLQV
of Beau-R could translate to the accessory proteins of pathogenic IBV strains such as M41. 
      In view of the results presented in this thesis, preventing expression of one or more accessory 
proteins of pathogenic IBV viruses may possibly attenuate these viruses to such an extent that 
they can be used as a live vaccine strain. However, the fact that all accessory proteins are located 
in the same region of the viral genome increases the risk of ‘reversion to virulence’. In theory, an 
DFFHVVRU\SURWHLQQXOOYLUXVFRXOGUHFRPELQHZLWKDQRWKHU,%YLUXVLQWKH¿HOGDQGUHJDLQLWVDFFHVVRU\
proteins and thus, its pathogenicity. To minimise this risk, additional attenuating mutations could be 
introduced in distant parts of the genome such as the replicase gene. IBV viruses lacking accessory 
proteins could possibly even prove safe enough for vaccination in ovo. During in ovo vaccination 
the rationally attenuated live IB virus would be injected into the egg a few days before hatching. 
Because vertical transmission of IBV (from chicken to egg) has never been reported, the chances that 
DOLYHDWWHQXDWHGYDFFLQHZRXOGUHFRPELQHZLWK¿HOGVWUDLQVGXULQJin ovo vaccination are very small. 
,QFRQFOXVLRQWKHZRUNGHVFULEHGLQWKLVWKHVLVGHPRQVWUDWHVIRUWKH¿UVWWLPHKRZ,%9HYDGHV
DFWLYDWHVDQGDQWDJRQLVHVWKH,)1UHVSRQVH,WLVWKH¿UVWVWXG\WKDWGHVFULEHVDIXQFWLRQIRUWKH,%9
accessory proteins and shows that they play a role in antagonism of the type I IFN response. 
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SUMMARY
Viruses are intracellular parasites that exploit the machinery of the host cell to replicate. To defend 
themselves against invading viruses, animal cells have evolved an anti-viral mechanism, known as the type 
I interferon response. Through natural selection viruses have in turn evolved mechanisms to counteract 
or evade the type I IFN response. Coronaviruses are a large group of positive-stranded RNA viruses that 
cause a range of human and veterinary diseases. Infectious bronchitis virus (IBV) is a member of the genus 
Gammacoronavirus and it is the causative agent of a highly contagious respiratory disease of poultry. 
To date, only few studies have investigated the interaction between IBV and the type I IFN response. 
,QWKLVWKHVLVZHGHVFULEHIRUWKH¿UVWWLPHWKHDFWLYDWLRQRIWKHW\SH,LQWHUIHURQUHVSRQVH,)1
response) by the Gammacoronavirus IBV, and the repressive role of accessory proteins therein. In 
Chapter 1 I provide a general introduction into coronaviruses in general and the Gammacoronavirus 
IBV in particular. I also introduce the IFN response, and highlight differences between the mammalian 
and chicken IFN response. Finally, I review current knowledge on the roles of coronavirus accessory 
proteins in counteraction of the IFN response. In Chapter 2 we describe our studies which 
demonstrated that activation of the IFN response by IBV is dependent on the intracellular double-
stranded RNA sensor MDA5. We show that detection of IBV-infection by MDA5 is delayed with 
respect to the peak of viral replication, and demonstrate that this delay is not due to inhibition of 
dsRNA detection by IBV. Using mutant viruses that cannot express accessory proteins (null viruses), 
we found that accessory proteins 3a and 3b of IBV mediate transcription and translation of ,IQȕ mRNA. 
       The observation that IBV delays the activation of the IFN response, prompted us to investigate 
the sensitivity of IBV to IFN treatment in Chapter 3. Here we show that IBV is relatively resistant to 
WUHDWPHQWZLWKW\SH,,)1DVUHODWLYHO\KLJKGRVHVRIW\SH,,)1DUHUHTXLUHGWRGHFUHDVHSURSDJDWLRQ
of the virus. Next, we studied which viral protein(s) contribute to resistance of IBV to type I IFN 
and found that absence of accessory proteins 3a and 3b increased sensitivity of IBV to type I IFN, 
via a presently unknown mechanism. In addition, we observed that independent of accessory proteins 
3a and 3b, IBV blocks signaling of IFN by inhibiting phosphorylation and translocation of the 
transcription factor STAT1. To explain the delayed kinetics of IFN production observed in Chapter 
2, we investigated whether delayed protein production was restricted to IFN, or whether IBV, like 
Alpha- and Betacoronaviruses, inhibits general translation of host proteins (i.e. induces host shutoff). 
In Chapter 4 we demonstrate that IBV-induced transcription of ,IQȕ mRNA leads to the production 
of relatively little IFN protein. We discovered that limited production of IFN protein by IBV-infected 
FHOOV LV WKH UHVXOW RI JHQHUDO LQKLELWLRQ RI KRVW WUDQVODWLRQ FRQ¿UPLQJ WKDW ,%9 LQGXFHV D VKXWRII
RI KRVWSURWHLQ SURGXFWLRQ 7KLV ¿QGLQJ LQGLFDWHV WKDW HYDVLRQ RI WKH LQQDWH LPPXQH V\VWHP E\
Gammacoronaviruses may be more similar to that of Alpha- and Betacoronaviruses than previously 
thought. Using accessory protein null viruses we discovered that accessory protein 5b of IBV is 
essential for the inhibition of host-protein synthesis by IBV. In Chapter 5 and Chapter 6 we describe 
WKHPHWKRGVXVHGLQWKLVWKHVLVWRTXDQWLI\WKHQXPEHURILQIHFWLRXVYLUXVSDUWLFOHVRI,%9DVZHOODV
PHWKRGVXVHGWRTXDQWLI\WKHDFWLYDWLRQRIWKHW\SH,,)1UHVSRQVHLQFKLFNHQFHOOV$OWKRXJKWKHVWXGLHV
GHVFULEHGLQWKLVWKHVLVKDYHDQVZHUHGVHYHUDOTXHVWLRQVDERXWWKHLQWHUDFWLRQRI,%9ZLWKWKHW\SH,,)1
UHVSRQVHRILWVKRVWWKH\KDYHDOVRUDLVHGQHZTXHVWLRQVWREHDGGUHVVHGLQIXWXUHUHVHDUFK,QWKH¿QDO
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Chapter of this thesis (Chapter 7,GLVFXVVDQXPEHURIUHPDLQLQJTXHVWLRQVDQGIXWXUHSHUVSHFWLYHV
regarding evasion of the IFN response by IBV. Finally, I explore the possible implications of our 
¿QGLQJVRQWKH in vivo pathogenicity of IBV and on the rational design of attenuated IBV vaccines. 
,QFRQFOXVLRQWKHZRUNGHVFULEHGLQWKLVWKHVLVGHPRQVWUDWHVIRUWKH¿UVWWLPHKRZ,%9HYDGHV
DFWLYDWHVDQGDQWDJRQLVHVWKH,)1UHVSRQVH$OVRWKLVWKHVLVFRPSULVHVWKH¿UVWVWXG\WKDWGHVFULEHV
a function for the accessory proteins of IBV and shows that these poorly understood proteins play an 
important role in antagonism of the type I IFN response.
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SAMENVATTING
Virussen zijn intracellulaire micro-organismen die de machinerie van hun gastheercel nodig 
hebben om zichzelf te repliceren. Om zich te verdedigen tegen binnendringende virussen hebben 
dierlijke cellen verscheidene anti-virale verdedigingsmechanismen ontwikkeld, waarvan de 
‘type I interferon respons’ één van de belangrijkste is. Door natuurlijke selectie hebben virussen 
op hun beurt manieren gevonden om de type I interferon respons tegen te gaan of te ontwijken. 
Coronavirussen zijn de veroorzakers van verschillende ernstige menselijke- en veterinaire ziekten. Ze 
worden gekenmerkt door hun erfelijk materiaal wat bestaat uit een enkel, zeer groot, enkelstrengs 
positief-RNA molecuul. Het infectieuze bronchitis virus (IBV) is een coronavirus van het genus 
Gammacoronavirus, en veroorzaakt één van de meest besmettelijke respiratoire pluimvee ziektes. 
     Tot op heden zijn slechts weinig studies uitgevoerd naar de interactie tussen IBV en de type I 
interferon respons (IFN respons). In dit proefschrift beschrijven we voor de eerste keer de activatie van 
de IFN respons door IBV, en de repressieve rol die de accessoire eiwitten van IBV hierin spelen. In 
Hoofdstuk 1 introduceer ik: coronavirussen, de werking van de IFN respons en de verschillen tussen de 
IFN response bij zoogdieren en kippen. Daarnaast geef ik in een overzicht aan wat er bekend is over de 
rol van de accessoire eiwitten van Alpha- en Betacoronavirussen in het tegengaan van de IFN respons. 
   In Hoofdstuk 2 tonen we aan dat activering van de IFN-respons in kippencellen tijdens 
een IBV-infectie afhankelijk is van de intracellulaire sensor MDA5 welke aanwezig is in de 
gastheercel. We laten ook zien dat detectie van IBV-infectie door MDA5 vertraagd is ten 
opzichte van de piek van virale replicatie. We tonen daarnaast aan dat de vertraging van de 
herkenning van IBV niet te wijten lijkt te zijn aan inhibitie van MDA5. Met behulp van mutante 
virussen die geen accessoire eiwitten kunnen maken, laten we zien dat accessoire eiwitten 3a 
en 3b van IBV betrokken zijn bij het reguleren van transcriptie en translatie van type I IFN. 
             De waarneming dat IBV de  activatie van de IFN-respons vertraagt, bracht ons ertoe om in Hoofdstuk 
3 de gevoeligheid van IBV voor de aanwezigheid van IFN te onderzoeken. Het bleek dat IBV relatief 
ongevoelig is voor behandeling van gastheer cellen met type I IFN, aangezien zeer hoge doses IFN nodig 
zijn om de groei van IBV te reduceren. Vervolgens hebben we onderzocht welke virale eiwitten bijdragen 
aan de weerstand van IBV tegen IFN. We vonden dat accessoire eiwitten 3a en 3b van IBV ook belangrijk 
zijn voor de ongevoeligheid voor IFN, aangezien het ontbreken van 3a en 3b zorgt voor verhoogde 
gevoeligheid van IBV voor IFN. Het mechanisme waarmee 3a en 3b de IFN response tegengaan is 
vooralsnog onbekend. Daarnaast vonden we dat, zelfs zonder 3a en 3b, IBV de signalering van IFN tegen 
gaat door het remmen van fosforylatie en translocatie van de IFN-geactiveerde transcriptiefactor STAT1. 
    In Hoofdstuk 2 vonden we dat IFN productie tijdens IBV infectie vertraagd wordt. Om een 
verklaring te vinden voor deze vertraging hebben we onderzocht of IBV de productie van alleen 
IFN uitstelt òf dat het virus de algemene productie van eiwitten door de gastheercel uitschakelt, 
net als Alpha- en Betacoronavirussen dat doen. In Hoofdstuk 4 vonden we dat late activatie van 
,IQȕ WUDQVFULSWLH QD ,%9LQIHFWLH YULMZHO QLHW OHLGW WRW SURGXFWLH YDQ ,)1 HLZLW:H RQWGHNWHQ GDW
de beperkte productie van IFN eiwit door IBV-geïnfecteerde cellen een gevolg is van de algemene 
inhibitie van translatie van mRNA naar eiwit door de gastheercel. Deze bevinding laat voor de 
eerste keer zien dat Gammacoronavirussen, net als Alpha- en Betacoronaviruses eiwitsynthese in de 
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gastheercel onderdrukken. Met behulp van de eerdergenoemde mutante virussen ontdekten we dat het 
accessoire eiwit 5b van IBV essentieel is voor het remmen van de eiwitsynthese in de gastheercel. 
  In Hoofdstuk 5 en Hoofdstuk 6 beschrijven we in detail de procedures waarmee 
ZH LQIHFWLHX]H YLUXVGHHOWMHV YDQ ,%9 KHEEHQ JHNZDQWL¿FHHUG HQ EHVFKULMYHQ ZH GH
PHWKRGHQ RP GH DFWLYHULQJ YDQ GH W\SH , ,)1UHVSRQV LQ NLSSHQFHOOHQ WH NZDQWL¿FHUHQ 
     Hoewel dit proefschrift meerdere vragen beantwoordt over de interactie van IBV met de type 
I IFN respons van zijn gastheercel, roept het ook nieuwe vragen op. In het laatste hoofdstuk 
van dit proefschrift (Hoofdstuk 7) bespreek ik een aantal van deze vragen, evenals voorlopige 
resultaten van experimenten om ze te beantwoorden. Tenslotte belicht ik de mogelijke implicaties 
van de bevindingen van onze in vitro experimenten voor de pathogeniciteit van IBV in vivo 
en de daaruit voortvloeiende ontwikkeling van nieuwe-, rationeel verzwakte IBV vaccins. 
       In dit proefschrift tonen we voor het eerst aan hoe IBV de type I IFN respons ontwijkt, activeert en 
tegenwerkt. Het is bovendien de eerste studie welke een functie beschrijft van de accessoire eiwitten 
van IBV en daarmee laat zien dat deze verder slecht gekarakteriseerde eiwitten een belangrijke rol 
spelen bij het tegengaan van de door IBV geïnduceerde IFN-respons.
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toen ik in 2010 begon bij de vakgroep. Dit initiële enthousiasme werd tijdelijk wat minder toen je 
er achter kwam dat ik misschien wel bijna net zo eigenwijs ben als jij. Ondanks en dankzij onze 
meningsverschillen hebben we vele goede en langdurige wetenschappelijke discussies gevoerd. Het 
was mooi om te zien dat we na het na een aantal jaren steeds vaker met elkaar eens waren. Ik heb veel 
van je geleerd en je hebt me ook veel over mezelf geleerd. Dankjewel en sorry voor mijn koppigheid... 
 
Geert, mijn promotor. Waarom je een AIO aannam die ging werken aan een kippenvirus, in een groep 
die onderzoek doet aan parasitaire infecties in vissen heb ik nooit helemaal begrepen, maar ik ben 
blij dat ik bij je terecht ben gekomen! Je hebt me altijd vrij gelaten om mijn eigen draai aan mijn 
onderzoek te geven, en stelde wel de juiste vragen waardoor je me behoedde voor (al te) grote blunders. 
Jij weet als geen ander een goed en duidelijk wetenschappelijk verhaal neer te zetten dat ook nog 
eens interessant is voor de lezer. Dankjewel voor je inspanningen om die kunst op mij over te dragen. 
 
Huub, je hebt je niet heel veel met mijn project bemoeid, maar dat heb ik altijd als compliment opgevat. 
Bedankt voor het afvangen van alle dingen waar je als AIO niet mee geconfronteerd wil worden en 
natuurlijk bedankt voor de mooie avonden in de Jacuzzi! 
Ook bij MSD Animal Health ben ik veel mensen dank verschuldigd; Edwin, jij overtuigde me 
ervan dat het doen van een PhD halen binnen het bedrijf haalbaar was en je leerde me te denken 
in mogelijkheden. Jos, ons visionair opperhoofd; door jouw inspanningen werd dit wilde plan ook 
werkelijkheid. Sjo, jij was de wetenschappelijke motor achter de start van het project en wat mij betreft 
de ideale manager; je was er altijd voor me als ik je nodig had en gaf me de gelegenheid om mijn eigen 
fouten te maken en er van te leren, dankjewel! Natuurlijk was dit PhD-project ook onmogelijk geweest 
zonder de  wetenschappelijke begeleiding van Erik en de continue steun van Pieter, heren mijn dank 
is groot!
Gedurende de promotie hebben vele mensen me ook met praktisch werk geholpen zowel in Wageningen 
als in Boxmeer. Petra DANKE SCHÖN; jij isoleerde keer op keer primaire cellen voor die kumpel aus 
Wageningen en stond áltijd voor me klaar. Du bist der Hammer! Ed en Pieter, bedankt voor het vakkundig 
opereren van ‘mijn’ kippen, ik bewonder jullie doortastendheid en de respectvolle manier waarop 
jullie met proefdieren omgaan! Ook dank aan alle mensen in het lab van BTS-V en in het bijzonder 
Carlien, Louis en Manice die keer op keer klaarstonden om dingen op te zoeken, spullen klaar te zetten, 
pakketjes door te sturen, etc etc. Dan waren er ook nog de kippencel-chauffeurs die keer op keer cellen 
meebrachten vanuit Boxmeer naar Wageningen. Annet, Erwin, Mariëlle en de hele familie Koumans: 
bedankt hiervoor! Pieter vd M bedankt voor je vertrouwen in mijn kunnen. Veronique en Lieke, bedankt 
voor alle administratieve ondersteuning en Erwin, bedankt voor het corrigeren van de introductie van 
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Veel praktische hulp was er ook bij de vakgroep celbiologie en immunologie in Wageningen. Marleen 
bedankt voor je kundige en gestructureerde aanpak van het silencen van genen in kippen cellen. 
Trudy, jij bedankt voor je pragmatische hulp met alle vergunning aanvragen en import-perikelen! 
Anja, dankjewel voor het maken van de preparaten voor elektronen microscopie. Eeuwig zonde dat 
de plaatjes niet in mijn thesis terecht zijn gekomen! Adriaan, Marjolein en Christine, bedankt voor 
jullie hulp met de FACS, Linda, Carla en Wieneke met western blotten, Lieke met microscopie en 
beeld analyse. Thank you Danilo and Carla for the help with in silico analysis of my virus and chicken 
genes. Alberto, my interferon brother, thanks for all the help and fun discussions! Also thanks to 
Carmen, Joop, Edwin, Eva (thanks for the haircuts ;-), Inge, Sylvia, Marloes, Lidy, Ben, Hilda, 
Jules, Sophie, Martin, Nathalie, Hilda, Ruth, Hans, Yvonne, Carla, Gerco, Anders, Mark, Esther, 
Joost and all the students, you made CBI a great and fun place to work! Of course the nice atmosphere 
in the E-wing was not only because of members of CBI. A lot of the fun-moments involved the people 
from Experimental Zoology (EZO) and Host-Microbe Interactomics (HMI). Special fun-credits go to 
EZO’s  Kessels, en Sebas, mijn partners in crime van het beste labuitje van de eeuw, bedankt voor jullie 
creativiteit, humor en vriendschap! Kees, mogelijkerwijs de grappigste man van Wageningen (boks!), 
Remco (Rum-co), (magic)Mike, master chef Marcel, Uroš (pronounce as Euros), Sander K, Gus, 
Florian, Elsita la vecinita, Ansa, Henk (8.5!), moeder Annemarie and of course EZO’s great leader; 
Johan. At HMI, the other neighbors, kudos go to Edo (Tarzanello), Bruno, tregging-Linda, Marcelita, 
Ellen, Sam, Rogier, Nico and Anja. All of you made our corridor the best place in Zodiac! 
Of course a big thank you to the students that helped me: Joris, onze samenwerking was kort, krachtig 
en gezellig! Ik wens je het allebeste met je PhD en hoop dat we nog vele feestjes zullen vieren samen! 
Marcela, jij was mijn eerste ‘echte’ studente en het was vanaf het begin af aan duidelijk dat je voor 
een top resultaat ging. Je bent perfectionistisch, gedreven en slim. Ik ben trots dat ik je heb mogen 
begeleiden en ik weet zeker dat jouw eigen PhD project een succes wordt, zeker als je af en toe even 
stil kunt zijn ;-) Nico, jij verbaasde me vanaf het begin, een Duitser met humor, dat was nieuw voor 
mij! Dankjewel voor je werk aan het opzetten van de bioassay, je kritische blik en je enthousiasme. 
Jasmin, ook jij was gedreven en wilde het best mogelijke resultaat neerzetten, en dat is je gelukt ook! 
Aan het verslag van jouw bachelor stage kan menig masterstudent een puntje zuigen. Bedankt voor je 
harde werk, de gezelligheid en natuurlijk voor het Duitse bier! Nu op naar een PhD! Annemiek, een 
masterthesis en een stage met mij als begeleider, je moet er maar zin in hebben ;-). Gelukkig vormden 
we een fantastisch team! Ik bewonder jouw ongelofelijke doorzettingsvermogen en wilskracht en ik 
vermoed dat we meer van elkaar geleerd hebben dan dat ieder van ons had verwacht. Dankjewel dat 
je mijn studente wilde zijn en als je op dezelfde voet doorgaat wordt je PhD project in Maastricht een 
doorslaand succes! 
'RLQJD3K'DOVRPHDQVVKDULQJDQRI¿FHDQGZLWKURRPPDWHVOLNHMark, Anders, Alberto, Carla, 
Olaf, and DaniloWKDWZDVPRVWGH¿QLWHO\QRWDSXQLVKPHQW7KDQNVIRUDOOWKHIXQZHKDGLQVLGHDV
ZHOODVRXWVLGHWKHRI¿FHDanilo, special thanks to you! You and your ‘brother from another mother’ 
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Alberto made life in the lab fun! Among other things you thought a lot of Italian vocabulary which I 
FDQXQIRUWXQDWHO\RQO\XVHWRJHWLQWRD¿JKWZLWK,WDOLDQV7KDQNVDORWIRUWKDW2IFRXUVHZHDOVRPDGH
the best trip EVER, I heard that Japan is still recovering... We should do that again one day, seriously. 
Stiene bedankt voor je hulp, de goede gesprekken en je geintjes die je samen met partner in crime 
Carmen uithaalde. Legendarisch. En onthoud; er is licht aan het einde van de PhD tunnel!
Ook een andere groep ben ik veel dank verschuldigd: Het laboratorium voor Virologie in Wageningen. 
Gorben en Jelke, bedankt voor alle geanimeerde discussies en goede ideeën over IBV, stress granules, 
P-Bodies en virussen in het algemeen. Jammer dat het niet heeft geleid to een gezamenlijk paper, maar 
wie weet wat de toekomst brengt! Mia, Amaya and Corinne, thank you for the gezelligheid and for 
tirelessly answering the phone, taking messages and reserving the microscope for me! Monique, ook 
jij bedankt voor je input over inhibitie van translatie door virussen en voor het feit dat je mijn opponent 
wil zijn!
Martijn, het was en is nog steeds, een genot om met jou samen te werken, je bent snel, slim en hebt 
ook nog gouden handen in het lab ook! Dankjewel voor alle hulp! En Frank, bedankt dat je ons onze 
gang hebt laten gaan! 
Paul without you this thesis would have turned out a lot less interesting. You supplied the tools 
DQGVXSSRUW WRPDNHLW LQWRDVXFFHVV$SDUWIURPWKLV\RXSRLQWHGRXWÀDZVDQGZHDNVSRWV LQRXU
papers which were essential to mend. Thank you for all your support and I hope we can continue 
our collaboration in the future! Helena and Erica thank you for the supply of materials, ideas, our 
interesting discussions and the occasional English lessons. 
Marcel thank you for all your help with making chicken cell lines and for being such a nice guy! 
Thanks as well to Doreen, Stefan, Daniel and all the others for the nice time at the Drosten lab. I 
hope we will meet again! Volker WKH IRUFH LVGH¿QLWHO\VWURQJ LQ\RX ,HQY\\RXU UHOD[HGZD\RI
being and I love reading your papers, but most of all I like sharing a beer with you! Thank you for 
accepting my invitation to be on my thesis committee. Ronald onze onverwachte samenwerking heeft 
al meer opgeleverd dan ik had durven hopen! Bedankt voor de altijd prettige samenwerking, je rust en 
je gortdroge humor. I like it!
Marjolein, ik ben erg blij dat ik je heb ontmoet tijdens het Nidovirus congres in de US. Je hebt me 
geïntroduceerd in het coronavirus wereldje en me af en toe de duwtje de goede kant op gegeven. Ik 
heb bewondering voor jouw enthousiasme, kunde en kennis en ik hoop dat we in de toekomst nog eens 
samen kunnen werken. Heel erg jammer dat je vanwege bureaucratische redenen niet mijn opponent 
mag zijn, maar ik weet zeker dat Puck deze rol met verve zal vervullen! Hélène wat jammer dat onze 
samenwerking nooit van de grond is gekomen, gelukkig bleef het altijd gezellig en ik hoop daarom 
dat we in de toekomst een goed excuus kunnen vinden om samen te kunnen werken, ik heb er zin in! 
Peter Staeheli, thank you for letting us use and publish on your chicken IFN and the IFN reporter cell 
line! Many thanks to the makers of the TWIV podcast. This Week In Virology was my lifeline to the 
virology community. They provided me with a great source of up-to-date information on the world of 
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viruses during my voyages to and from Dresden, you deserve to go viral!
Natuurlijk is er meer dan alleen werk en gelukkig heb ik me altijd omringd gevonden door fantastische 
vrienden. Klaske, dankjewel voor wie je bent; vriendin, buurvrouw, sportmaatje en gewoon een 
fantastisch mens. Ik ben klaarblijkelijk niet de enige die dat vind, want Julia, Sina, Dorinde, Henny, 
Ellen, Ronald, Mathieu, en Harm	Jantje hebben allemaal een duit in het zakje gedaan zodat je 
ook daadwerkelijk bij mijn promotie aanwezig kunt zijn. Dank daarvoor! Rick, de beste buurman die 
een man zich kan wensen. Bedankt voor alle mooie avondjes, A je to buur! Rico, broertje, vriend en 
klusmaat. Dat we nog maar veel klussen samen mogen uitvoeren onder het genot van een biertje! 
In de uren dat ik niet bezig was met het werken aan mijn PhD waren er gelukkig vele vrienden die 
DOWLMGOHXNHGLQJHQZLOGHQGRHQ=RDOVGHOHGHQYDQKHWOHJHQGDULVFKHSXETXL]WHDP³ELHUGULQNHQLV
belangrijker dan meedoen” o.a. Carlien, Teun, Wouter, Francisca en Joël. Daarnaast natuurlijk ook 
de Nijmeegse party-crew; met o.a. Miel, Charlotte, Wouter, Carlien, Teun, broer Dirk, Michel, 
Marian, Karin, Erik, Floortje, Fabian, Klaartje, Freek, Bas en Sabrina. Ook zijn er mensen die je 
veel te weinig ziet, maar als we elkaar zien is het weer als vanouds Viola, Evelien, Ivo, Tom, Allard, 
Joep, Janus en Sjef en de andere Ronnies. Gezelligheid was er ook altijd te over met de Wageningen 
party-crew; Jeroen, Jelke, miss Maria 	 Angelito, Peter, Christa, Haimil, Sina, Lenneke, 
Wieneke, Peter, Marcela, Franscisco, Lena, Amaya, Mia thank you for all the fun we shared! 
 
Bas en Mathieu, de wetenschap smeedt vriendschappen voor het leven en ik ben blij dat we nog 
regelmatig de samen de bloemetjes buiten zetten! Supertrots ben ik, dat ík je paranimf mocht zijn 
Bas! Julia, jij bent niet alleen een fantastische vriendin, maar ook nog een begaafd en inventief 
wetenschapster! Dankjewel voor alle gezelligheid, je humor en natuurlijk je hulp met graphpad, 
lentivirussen en CRISPRs. Carlien en Teun, bedankt voor jullie vrienschap, gastvrijheid en de best 
liggende bank van Nijmegen! Ellen, ontmoetingen met jou waren altijd inspirerend en leerzaam en 
je enthousiasme is aanstekelijk. Ook al deden we PhD´s in hele andere disciplines, we wisten elkaar 
altijd weer te motiveren om door te gaan. Willem, Marcel, Chris, Jorrit en Rob, party onhne ende! 
En traktorman-Willem, ik kijk uit naar je set tijdens mijn feestje! Caren, Jörg, Vineeth, Florian, Gaia 
and Jochen, my MPI-CBG friends, thank you for making me feel at home in Dresden! 
Naast alle feestjes was er af toe ook nog tijd voor sport. Eén keer per week (yeh right ;-) gingen de 
pipetten aan de kant en werd er hardgelopen vanaf de universiteit met Ellen, Pieters, Lieke en/of 
Sebastiaan. ’s Avonds waren het mijn sport-buddies Haimil, Wieneke, Christa en Klaske die me uit 
het lab sleepten om te gaan sporten. Ook dank aan mijn vlieger-buddy Albert. Nu ik weer wat meer tijd 
heb hoop ik dat we weer eens samen over het strand kunnen gaan racen!
Minha familia Brasileira, Neusa, Danilo, Tatiana y Milena muito obrigado para todas as memorias 
ERDVHHVSHURTXHYmRYLUPXLWRPDLVERQVPRPHQWRVDLQGD8PDEUDFDRGR%UDVLOHLUR IDOVL¿FDGR
tambem para André, Andriana, Museo, y Dani.
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Voor de vormgeving van dit boek heb ik gelukkig hulp gehad van experts. Stephanie, bedankt voor het 
maken van de fantastische cover, het resultaat mag gezien worden! Homies for life! Fenke, jij hebt op 
voortreffelijke wijze de layout van de binnenkant verzorgd, dankjewel daarvoor!
Mijn paranimfen, ik zou voor ze door het vuur gaan. Lieke, jij was de motor achter de activiteiten 
binnen de vakgroep en meerdere malen werd de hele familie Golbach (bedankt!!) ingeschakeld 
om de meest onmogelijke plannen mogelijk te maken. Als jij iets in je hoofd hebt dan gebeurt het, 
Jaloersmakend is dat! Daarnaast ben je ook nog eens lief, attent en behulpzaam. Een vriendin uit 
GXL]HQGHQ2QW]HWWHQGEHGDQNWYRRUDOMHKXOSHQGHIDQWDVWLVFKH¿JXUHQLQKRRIGVWXNHQGHGLVFXVVLH
Ik voel me vereerd dat je tijdens mijn verdediging naast me staat! Mark, Techno-, House-, en bovenal 
Soul-mate; vele feesten en festivals hebben we onveilig gemaakt. We hebben meer gemeen hebben dan 
ons lief is, tot een ongezonde facinatie voor vliegtuigen aan toe. Wie beter dan jij kon daarom mijn 
levensverhaal optekenen. Je bent mijn rots in de branding en mijn klankbord voor de vragen des levens. 
Ik prijs mezelf gelukkig met jou en Sanne als vrienden! Overigens niet in de laatse plaats omdat jullie 
verantwoordelijk zijn voor de set-up met de (met afstand) leukste vrouw ter wereld! Nadine, met jou 
is elke dag een feestje. Wanneer we samen zijn gebeuren er de meest fantastische dingen, ik vind dat 
echt bijzonder en ik vind jou bijzonder! Ik kijk er naar uit om samen met jou de wereld te verkennen 
en te veroveren. I like us!
Pa en ma, jullie hebben me altijd de vrijheid gegeven om mijn nieuwsgierigheid na te jagen. Zelfs toen 
ik op mijn zeventiende voor een jaar naar Brazilië wilde, hebben jullie me geen strobreed in de weg 
gelegd. Pas later heb ik me gerealiseerd hoe moeilijk het moet zijn om je enige kind naar de andere kant 
van de wereld te laten vertrekken. Dank jullie wel voor jullie steun, jullie vertrouwen en de grenzeloze 
liefde! Ik ben apentrots op jullie en daarom heb ik dit boek aan jullie opgedragen!
Was getekend,
Joeri Kint
May 2015
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CURRICULUM VITAE
Wat weinig mensen weten is dat, naast de wereldberoemde acteur en zanger Nicholas Tse uit Hong 
Kong, op 29 Augustus 1980 nóg een grootheid geboren werd: de auteur van dit boek. 
Joeri Kint zag het licht te Hulst in Zeeuws-Vlaanderen als zoon van secretaresse Trees en elektricien Jo. 
Joeri ging naar de katholieke lagere school St. Willibrordus, was zelfs misdienaar (waar zijn die foto’s?) 
en versleet zijn dagen met lego-, judo- en modelvliegtuigjes bouwen. 
Het Reynaertcollege was ten tijde van de eerste twee Paarse kabinetten het leerhuis voor Joeri. Hij 
volgde het Atheneum van 1992 tot 1998. Over zijn uitmuntende schoolprestaties aldaar hoeven niet 
uit te wijden, het is namelijk veel leuker om zijn extra-curriculaire activiteiten tijdens zijn middelbare 
schooltijd te bespreken. Die modelvliegtuigjes werden vervangen door heuse delta vliegtuigen. Joeri 
haalde zelfs zijn eerste brevet. Verder was hij op het strand aan het vliegeren. Niet mijn keuze, maar 
goed, je woont in Zeeland. Wat wel mijn goedkeuring kan wegdragen is zijn toenmalige liefde voor 
5DYH	 +DSS\KDUGFRUHPX]LHN  GLH EHOXLVWHUGZHUGRSYHHO WH JURWH ]HOI LQ HONDDU JHVROGHHUGH
boxen. Zoon van een elektricien! In de vijfde klas ging Joeri twee maanden (!!) naar Argentinië voor 
een jeugduitwisseling. Tot slot ging hij, naast zijn werk in een Grieks restaurant, geregeld tot veel te laat 
uit in shabby discotheken in België. 
Voordat Joeri ging studeren in Wageningen heeft hij een jaar lang in Maringa in Brazilië gewoond (via 
de Youth exchange van de Rotary). Heel Brazilië gezien, veel caipirinhas gedronken, portugees leren 
spreken (Saude!) en de avond voor zijn vertrek verkozen tot Exchange Student of the Year (whatever 
that may be). 
In 1999 start hij met Bioprocestechnologie aan de Wageningse universiteit. Tijdens zijn studie volgde 
hij een stage bij Virologie in Wageningen op het onderwerp ,GHQWL¿FDWLRQRIYLUDOVXSSUHVVRUVRI51$L
in mammalian viruses. Daarna ging hij terug naar Brazilië om aan Instituto Oswaldo Cruz (FioCruz) 
te werken aan het project &KDUDFWHULVDWLRQ RI QHXWUDOLVLQJ DQWLERGLHV DJDLQVW+HSDWLWLV%. Na naar 
Utrecht te zijn verhuisd heeft hij nog eens 6 maanden stage gelopen bij het Nederlands Vaccin Instituut 
te Bilthoven. Hij heeft daar zijn tanden gezet in de Determination of critical process parameters for 
the cultivation of Bordetella Pertussis. Voor al zijn stages haalde hij een 8 of hoger, wat natuurlijk 
voortreffelijk is. 
Naast zijn studie en stages had de promovendus ook nog tijd voor een zwik andere activiteiten. 
Ongelofelijk maar waar: Joeri werkte bij Morres Meubel als verkoper (zou U een bank bij hem 
aanschaffen?). Daarnaast gaf hij zogenaamde mobiele practica op middelbare en lagere scholen 
en organiseerde hij de bijscholingsdagen voor de technisch onderwijs assistenten (TOAs). Hij was 
voorzitter van de studievereniging van de Biotechnologen (Codon) en organisator van buitenlandse 
VWXGLHUHL]HQ QDDU0DGULG 	 'XLWVODQG 2RN ZDV KLM RUJDQLVDWRU YDQ GH -DYD FRPHG\ QLJKW LQ KHW
Scheldetheater in Terneuzen. Wat?! Terwijl een gemiddelde persoon al uitgeteld op de net bij Joeri 
aangeschafte bank zou liggen, had Joeri ook nog energie voor hobby’s zoals hardlopen, skiën, reizen 
en in de kroeg hangen. 
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In 2006 reist Joeri naar de oksel van de Peel, alwaar hij bij Intervet te Boxmeer wordt aangenomen door 
René Aerts in het Trainee programma. In datzelfde jaar verhuist hij naar Nijmegen en begint hij op de 
BAPPP-afdeling. Hij mag een jaar later naar Salamanca waar een grote productie faciliteit van Intervet 
staat. Hij heeft zich daar onsterfelijk gemaakt met een gigantische typefout in een presentatie. (Vraag dit 
maar aan Joeri zelf, want dat kan ik hier niet openbaren.) Ondanks deze blunder mag hij daarna op zijn 
visite kaartje schrijven: Assistant Project Leader development of viral vaccine production processes. 
Vier jaar na Wageningen te hebben verlaten keert Joeri weer terug bij zijn Alma Mater en start zijn 
promotie onderzoek. Helemaal hippe publieke-private samenwerking met de niet hippe titel: Activation 
DQG(YDVLRQRIWKH7\SH,,QWHUIHURQ5HVSRQVHE\,QIHFWLRXV%URQFKLWLV9LUXV%LM.LSSHQ(Q¿Q+LHU
ligt het prachtige resultaat. 
6LQGVQRYHPEHUUHLVWKLMZHHUGDJHOLMNVHQDDU%R[PHHUDOV3URMHFW/HDGHU3URFHVVGHYHORSPHQW	
support of production processes for viral poultry vaccines, verslijt hij kilometers op de duitse Autobahn 
om bij zijn geliefde in Dresden te zijn en geeft hij nog één keer per jaar les op zijn oude middelbare 
school in Hulst. Good on ya’ mate!
Mark Geels
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CURRICULUM VITAE
What only very few people know is that besides the world-famous actor and singer from Hong Kong 
Nicholas Tse, another famous person was born on August 29th 1980: the author of this book. Joeri Kint 
burst into this world in Hulst in the Zeeland province as the son of secretary Trees and electrician Jo. 
Joeri spent his primary education on the devout catholic St. Willibrordus School where he even was 
an altar boy (where are those pictures?) while passing away the rest of his days playing with Lego and 
model planes and being a judoka on the tatami. 
During the nineties, while the liberals and socialists reigned over the Netherlands, Joeri went to the 
Reynaertcollege high school in Hulst. Although we could talk about his excellent results, it is simply 
much more fun to discuss his extracurricular activities. He dropped the small-plane thing and switched 
WRVHULRXVKDQJJOLGLQJ6RPHERG\HYHQJDYHKLPDOLFHQVH+HDOVROLNHGWRÀ\WKHNLWHRQWKHEHDFK
Not my cup of tea, but hey, what do you do when you live in Zeeland (= Sea-land…)? What I certainly 
can appreciate is the love for rave and (happy) hardcore music that blossomed during this period and 
was listened to on DIY loudspeakers personally soldered together. Son of an electrician. He spent two 
whole months (!!) in Argentina during high school on an exchange visit. The rest of his time he worked 
DWD*UHHNUHVWDXUDQWDQGKHZDVVSRWWHGRQPDQ\RFFDVLRQVLQVKDEE\%HOJLDQGLVFRWKHTXHVMXVWDFURVV
the border.
Prior to going to college, Joeri lived a year in Maringa in Brazil through a youth exchange of the 
Rotary. He saw every corner of the country, drank some caipirinhas, learned Portuguese (saude!) and 
got elected as Exchange Student of the Year (whatever that may be).
In 1999 he started as a freshman in college majoring in Bioprocesstechnology. He performed several 
LQWHUQVKLSV+LV¿UVW LQWHUQVKLSZDV DW WKH YLURORJ\GHSDUWPHQW RQ D SURMHFW FDOOHG ,GHQWL¿FDWLRQRI
viral suppressors of RNAi in mammalian viruses. Then the prospect of returning to samba soccer on 
the beach in Rio led him back to Brazil to do an internship at Instituto Oswaldo Cruz (FioCruz) called 
&KDUDFWHULVDWLRQRIQHXWUDOLVLQJDQWLERGLHVDJDLQVW+HSDWLWLV%. Back in the Netherlands he moved to 
Utrecht and interned at the Dutch Vaccine Institute. He worked on the Determination of critical process 
parameters for cultivation of Bordetella Pertussis. He scored an 8 or higher for all his internships which 
truly is exceptional. 
+LV H[WUDFXUULFXODU DFWLYLWLHV ZHUH HTXDOO\ LPSUHVVLYH RU VKRFNLQJ 8QEHOLHYDEOH EXW WUXH -RHUL
worked as a salesman in a furniture shop. Would you buy a couch from Joeri? Besides this, he taught 
so-called mobile practical lab courses on elementary and high schools and he organised refresher 
courses for technical support staff on high schools. He managed to become chair of the Student Faculty 
organisation (Codon) and organised exchange trips for students to Madrid and Germany. He also was 
one of the organisers of the Java comedy night in the Scheldetheater in Terneuzen. What?! Where?! 
And while a normal person would need a breather on the couch (freshly bought from Joeri), Joeri found 
enough time and energy for hobbies such as running, skiing, travelling and drinking beer in the pub. 
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In 2006, Joeri was hired as a trainee at Intervet in Boxmeer. Boxmeer, for those who do not know, is 
at the end of the world. That year he moved to Nijmegen to cut the commute short and starts working 
at the Biological All Purpose Pilot Plant or BAPPP. A year later he works for a month in the Intervet 
facilities in Salamanca, Spain. It is during that visit that he makes an epic typo during a presentation 
that I cannot repeat because there are small children in the room here but you should ask him about 
LW'HVSLWH WKLVHSLF IDLOKHVXFFHVVIXOO\¿QLVKHV WKHZRUNDQGEHFRPHVDQAssistant Project Leader 
development of viral vaccine production processes at Intervet. 
Four years after having left Wageningen, Joeri returns to his Alma Mater and starts his PhD research 
project. State-of-the-art public private collaboration with the not-so-exciting title: Activation and 
(YDVLRQRIWKH7\SH,,QWHUIHURQ5HVSRQVHE\,QIHFWLRXV%URQFKLWLV9LUXV,QFKLFNHQV(Q¿Q,WLVWKH
beautiful result that counts and lies before you. 
In the fall of 2014, he restarts his daily commute to Boxmeer but this time as a Project Leader Process 
development & support of production processes for viral poultry vaccines. He also burns many miles on 
German Autobahns to be with his loved one in Dresden and he still teaches once a year at his old high 
school in Hulst. Good on ya’ mate!
Mark Geels
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